1 | (RS)-baclofen, naltrexone hydrochloride and D-sorbitol (Sorbitol 3% in plastic container (TN)) | 3件: Baclofen Baclofen (Co Baclofen Tablets 20mg), Naltrexone (Contrave Extended-Release), Sorbitol | 3件: Sorbitol solution
Sorbitol solution
(Sorbitol 3% in plastic container (TN)),
Baclofen
,
Naltrexone
💬 | 5件: GABBR1 GABBR1, GABBR2, OPRD1, OPRK1, OPRM1 💬 | 9件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 10 10 💬 |
2 | **Comment**- IMP inhalation solution identical to ventavis inhalation solution, but IMP is in a different volume presentation. Please see covering letter. | 1件: Iloprost Iloprost | 1件: Iloprost
Iloprost
💬 | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 💬 |
3 | 0.9% normal saline (control) | - | - | - | - | 1件: 299 299 💬 |
4 | 0.9% sodium chloride (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 4件: 6 6, 14, 51, 53 💬 |
5 | 0.9% sodium chloride (normal saline) (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 1件: 6 6 💬 |
6 | 0.9% Sodium Chloride Injection (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 1件: 168 168 💬 |
7 | 0.9% w/v isotonic sodium chloride solution (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 1件: 50 50 💬 |
8 | 0.9% w/v sodium chloride solution (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 1件: 299 299 💬 |
9 | 100 mg ELX/50 mg TEZ/75 mg IVA fixed dose combination | - | - | - | - | 1件: 299 299 💬 |
10 | 13 valent conjugated pneumococcal vaccine | - | - | - | - | 1件: 265 265 💬 |
11 | 13-valent pneumococcal conjugate vaccine | - | - | - | - | 2件: 46 46, 53 💬 |
12 | 13-valent pneumococcal conjugate vaccine (13-PCV) | - | - | - | - | 1件: 13 13 💬 |
13 | 13-valent pneumococcal conjugated vaccine (PCV13) | - | - | - | - | 1件: 96 96 💬 |
14 | 15-O labeled water (Purified water in containers (JP18)) | 1件: Water Water (FIRST AID Contains 202 PIECES) | 1件: Water
Water
(Purified water in containers (JP18)) 💬 | - | - | 1件: 46 46 💬 |
15 | 150 mg double-blinded secukinumab (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 💬 |
16 | 150 mg open-label secukinumab (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 💬 |
17 | 15N ammonium chloride (15NH4Cl) (Conclyte-A (TN)) | 2件: Ammonium chloride Ammonium chloride (Damylin Avec Codeine Sirop), Chloride ion | 1件: Ammonium chloride
Ammonium chloride
(Conclyte-A (TN)) 💬 | - | - | 1件: 251 251 💬 |
18 | 26 common Fabry mutation types in Taiwan | - | - | - | - | 1件: 19 19 💬 |
19 | 3-hydroxy-2-methyl-4H-pyrane-4-one iron (III) complex (3:1), Ferric (3-hydroxy-2-methyl-4-pyrone), Tris-maltol-iron (III), Tri=maltol-iron (III) | 1件: Tromethamine Tromethamine | 1件: Tromethamine
Tromethamine
💬 | - | - | 2件: 96 96, 97 💬 |
20 | 300 mg double-blinded secukinumab (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 💬 |
21 | 5 ASA, enemas, suppositories, corticosteroids | - | - | - | - | 1件: 97 97 💬 |
22 | 5% glucose water solution (Purified water in containers (JP18)) | 2件: Dextrose, unspecified form Dextrose, unspecified form (Acid Concentrate D 12219 Liq), Water (FIRST AID Contains 202 PIECES) | 1件: Water
Water
(Purified water in containers (JP18)) 💬 | - | - | 1件: 2 2 💬 |
23 | 5% lidocaine/5 mg/ml 0.02% estradiol compound cream | 2件: Estradiol Estradiol (CombiPatch), Lidocaine (Cool and Heat Evora Labs) | 3件: Estradiol
Estradiol
,
Lidocaine
,
Lidocaine hydrochloride monohydrate
💬 | 7件: ESR1 ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Breast cancer, Chemical carcinogenesis - receptor activation, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway 💬 | 1件: 226 226 💬 |
24 | 5-probe cocktail | - | - | - | - | 1件: 254 254 💬 |
25 | 50 mg ELX/25 mg TEZ/37.5 mg IVA fixed dose combination | - | - | - | - | 1件: 299 299 💬 |
26 | 5000 IU of cholecalciferol (Colecalciferol (INN)) | 1件: Cholecalciferol Cholecalciferol (natelle COMPLETE) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol (INN)) 💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 💬 |
27 | 7-valent Pneumococcal Conjugate vaccine | - | - | - | - | 1件: 46 46 💬 |
28 | 90 mg hydrocortisone acetate suppository with Sephure suppository applicator (Colocort (TN)) | 3件: Acetate Acetate, Hydrocortisone (Cortane-B), Hydrocortisone acetate (Super Cortisone) | 2件: Hydrocortisone
Hydrocortisone
(Colocort (TN)),
Hydrocortisone acetate
(Cortifoam (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬 |
29 | 90 mg idrocortisone acetato in supposta con appli | - | - | - | - | 1件: 97 97 💬 |
30 | 90 mg idrocortisone acetato in supposta con applicatore per supposte Sephure | - | - | - | - | 1件: 97 97 💬 |
31 | [15-O]water (Purified water in containers (JP18)) | 1件: Water Water (FIRST AID Contains 202 PIECES) | 1件: Water
Water
(Purified water in containers (JP18)) 💬 | - | - | 1件: 206 206 💬 |
32 | A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine | 3件: Clarithromycin Clarithromycin, Clofazimine, Rifabutin | 3件: Clarithromycin
Clarithromycin
,
Clofazimine
,
Rifabutin
💬 | - | - | 1件: 96 96 💬 |
33 | A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) | - | - | - | - | 1件: 60 60 💬 |
34 | A Natural Remedy for Rheumatoid Arthritis vs. Common Drugs | - | - | - | - | 1件: 46 46 💬 |
35 | A-glucosidasi acida umana ricombinante coniugata con multiple copie di bis-mannosio-6- fosfato-tetra-mannosio glicano sintetico (NEOGAA) | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: Avalglucosidase alfa
Avalglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
36 | AAV9-CAG-coh-SGSH | - | - | - | - | 1件: 19 19 💬 |
37 | AAVrh.10CUhCLN2 vector 2.85x10^11 genome copies | - | - | - | - | 1件: 19 19 💬 |
38 | AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies | - | - | - | - | 1件: 19 19 💬 |
39 | ACE-031 (Extension of cohort 1 from core study, A031-03) | - | - | - | - | 1件: 113 113 💬 |
40 | ACE-031 (Extension of cohort 2 from core study, A031-03) | - | - | - | - | 1件: 113 113 💬 |
41 | ACE-031 (Extension of cohort 3 from core study, A031-03) | - | - | - | - | 1件: 113 113 💬 |
42 | ACEI/ARB and corticosteroids | - | - | - | - | 1件: 66 66 💬 |
43 | ACH-0144471 compresse | - | - | - | - | 1件: 222 222 💬 |
44 | ACH0144471 compresse | - | - | - | - | 1件: 222 222 💬 |
45 | ACOMPLIA 20 mg film-coated tablets | 1件: Rimonabant Rimonabant | 1件: Rimonabant
Rimonabant
💬 | 1件: CNR1 CNR1 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 193 193 💬 |
46 | Active comparator | - | - | - | - | 2件: 6 6, 46 💬 |
47 | Active Comparator receiving Extavia® | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬 | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬 |
48 | Active Control | - | - | - | - | 1件: 13 13 💬 |
49 | Actonel 5mg Film Coated Tablets | 1件: Risedronic acid Risedronic acid | 1件: Risedronic acid
Risedronic acid
💬 | 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 💬 |
50 | Actonel Once a Week 35 mg film-coated tablets | 1件: Risedronic acid Risedronic acid | 1件: Risedronic acid
Risedronic acid
💬 | 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 💬 |
51 | Actonel Once a week 5mg film coated tablets | 1件: Risedronic acid Risedronic acid | 1件: Risedronic acid
Risedronic acid
💬 | 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 113 113 💬 |
52 | Actonel/Optinate 5mg film-coated tablets | 1件: Risedronic acid Risedronic acid | 1件: Risedronic acid
Risedronic acid
💬 | 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 💬 |
53 | Ad26.COV2-S.02 | - | - | - | - | 1件: 299 299 💬 |
54 | Ad26.COV2.S | - | - | - | - | 7件: 13 13, 35, 46, 49, 50, 51, 107 💬 |
55 | ADA Umbilical Cord Blood Cells | - | - | - | - | 1件: 65 65 💬 |
56 | ADCIRCA 20 mg film-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
57 | ADEMPAS - 0,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
58 | ADEMPAS - 1 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 💬 |
59 | ADEMPAS - 1,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 💬 |
60 | ADEMPAS - 2 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 💬 |
61 | ADEMPAS - 2,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 💬 |
62 | Adempas 0.5 mg Film Coated Tablet | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
63 | Adempas 1 mg Film Coated Tablet | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
64 | Adempas 1.5 mg Film Coated Tablet | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
65 | Adempas 2 mg Film Coated Tablet | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
66 | Adempas 2.5 mg Film Coated Tablet | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
67 | Adempas® 0.5 mg film-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
68 | Adempas® 1.0 mg film-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
69 | Adempas® 1.5 mg film-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
70 | Adempas® 2.0 mg film-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
71 | Adempas® 2.5 mg film-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
72 | Adempas¿ 0.5 mg compressa rivestita con film | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
73 | Adeno-associated viral vector serotype 8 containing the human MD1 gene | - | - | - | - | 1件: 113 113 💬 |
74 | Adeno-associated viral vector serotype 9 containing the human mini-dystrophin gene | - | - | - | - | 1件: 113 113 💬 |
75 | Adeno-associated viral vector serotype 9 containing the human N-acetyl-alpha-glucosaminidase gene | - | - | - | - | 1件: 19 19 💬 |
76 | ADENO-ASSOCIATED VIRAL VECTOR SEROTYPE RH10 CONTAINING THE HUMAN CHOLESTEROL 24-HYDROXYLASE GENE | 1件: Cholesterol Cholesterol | 1件: Cholesterol
Cholesterol
💬 | - | - | 1件: 8 8 💬 |
77 | Adeno-associated virus serotype hu68 containing the human GALC gene | - | - | - | - | 1件: 19 19 💬 |
78 | ADENO-ASSOCIATED VIRUS SEROTYPE RH74 CONTAINING THE HUMAN MICRO-DYSTROPHIN GENE | - | - | - | - | 1件: 113 113 💬 |
79 | Adipose-cord mesenchymal stromal cells (A-MSCs) | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 97 97 💬 |
80 | Adjuvant without active component | - | - | - | - | 2件: 6 6, 17 💬 |
81 | Adrenal cortical hormone | - | - | - | - | 1件: 224 224 💬 |
82 | Aesculus Hippocastanum / Horse Chestnut (Conker tree) | 1件: Horse chestnut Horse chestnut | 1件: Horse chestnut
Horse chestnut
(Conker tree) 💬 | - | - | 1件: 210 210 💬 |
83 | Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994 | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 1件: 46 46 💬 |
84 | Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994) | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 1件: 46 46 💬 |
85 | Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells | - | - | - | - | 1件: 13 13 💬 |
86 | ALLOGENEIC MESENCHYMAL STROMAL CELLS DERIVED FROM THE UMBILICAL CORD | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 49 49 💬 |
87 | Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation | - | - | - | - | 1件: 17 17 💬 |
88 | Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation | - | - | - | - | 1件: 17 17 💬 |
89 | Allogeneic umbilical cord mesenchymal stem cells | - | - | - | - | 1件: 13 13 💬 |
90 | Ambrisentan 5 mg film-coated tablets | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬 | 1件: EDNRA EDNRA 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
91 | Ambrisentan 5mg film-coated tablets [marketed product] | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬 | 1件: EDNRA EDNRA 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
92 | Amitriptyline, fluoxetine and tramadol alone (control group) | 3件: Amitriptyline Amitriptyline (Equipto - Amitriptyline External Cream Compounding Kit), Fluoxetine, Tramadol (ConZip) | 3件: Fluoxetine
Fluoxetine
,
Amitriptyline
,
Tramadol
💬 | 3件: OPRM1 OPRM1, SLC6A2, SLC6A4 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 78 78 💬 |
93 | Ammonium chloride (Conclyte-A (TN)) | 2件: Ammonium chloride Ammonium chloride (Damylin Avec Codeine Sirop), Chloride ion | 1件: Ammonium chloride
Ammonium chloride
(Conclyte-A (TN)) 💬 | - | - | 3件: 96 96, 107, 251 💬 |
94 | Amplification by PCR and direct sequencing on the entire coding sequence and intron-exons boundaries of the candidate gene | - | - | - | - | 1件: 265 265 💬 |
95 | Androgel 10 grams of gel containing 100 mg of testosterone | 1件: Testosterone Testosterone | 1件: Testosterone
Testosterone
💬 | 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 13 13 💬 |
96 | Angiotensin-converting enzyme (ACE) inhibitor | 1件: Angiotensin II Angiotensin II | 2件: Angiotensin II
Angiotensin II
,
Angiotensin II
💬 | 2件: AGTR1 AGTR1, AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 224 224 💬 |
97 | Angiotensin-converting enzyme inhibitor(ACEI) | 1件: Angiotensin II Angiotensin II | 2件: Angiotensin II
Angiotensin II
,
Angiotensin II
💬 | 2件: AGTR1 AGTR1, AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 224 224 💬 |
98 | Anit human granulocyt-macrophage colony-stimulating factor (GM-CSF)monoclonal | - | - | - | - | 1件: 46 46 💬 |
99 | Anti human granulocyte-macrophage colo | - | - | - | - | 1件: 46 46 💬 |
100 | Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) MONOCLONAL | - | - | - | - | 1件: 46 46 💬 |
101 | Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal antibody | - | - | - | - | 1件: 46 46 💬 |
102 | Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF)monoclonal | - | - | - | - | 1件: 46 46 💬 |
103 | Anti TNF humanized antibody Fab fragment-PEG conjugate | - | - | - | - | 1件: 96 96 💬 |
104 | Anti-(complement C5a) IgG4 chimeric monoclonal antibody | - | - | - | - | 1件: 269 269 💬 |
105 | Anti-TNF humanized antibody Fab fragment - PEG conjugate | - | - | - | - | 1件: 46 46 💬 |
106 | Anti-TNF humanized antibody Fab' fragment - PEG conjugate | - | - | - | - | 1件: 46 46 💬 |
107 | Anti-TNFa continued perioperatively | - | - | - | - | 1件: 46 46 💬 |
108 | Antibiotic cocktail | - | - | - | - | 1件: 97 97 💬 |
109 | Antihuman granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal | - | - | - | - | 1件: 46 46 💬 |
110 | Antimicrobial therapy: Co-trimoxazole or Doxycycline | 1件: Doxycycline Doxycycline | 2件: Doxycycline
Doxycycline
,
Doxycycline
💬 | - | - | 1件: 85 85 💬 |
111 | Antioxidant Cocktail | - | - | - | - | 1件: 299 299 💬 |
112 | ARCOXIA 90 mg comprimidos recubiertos con película | - | - | - | - | 1件: 271 271 💬 |
113 | ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬 |
114 | ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬 |
115 | Atazanavir (ATV) + ritonavir (RTV), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (NRTIs) | 2件: Atazanavir Atazanavir, Ritonavir (Ritonavir film coated) | 2件: Ritonavir
Ritonavir
,
Atazanavir
💬 | - | - | 1件: 265 265 💬 |
116 | ATG conditioning regimen | - | - | - | - | 1件: 60 60 💬 |
117 | AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BISTER (ALU/ALU) PERFORATO MONODOSE - 10 X 1 COMPRESSA | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬 | 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 13 13 💬 |
118 | AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (ALU/ALU) - 28 COMPRESSE | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬 | 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 13 13 💬 |
119 | Aubagio 14 mg film-coated tablets | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬 | 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 13 13 💬 |
120 | Autologous (self) mononuclear cells derived from umbilical cord blood | - | - | - | - | 1件: 211 211 💬 |
121 | Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene | - | - | - | - | 1件: 65 65 💬 |
122 | AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING THE HUMAN SGSH GENE | - | - | - | - | 1件: 19 19 💬 |
123 | Autologous CD34+ cells transduced with the Lentiviral vector containing the human Wiskott Aldrich Sy | - | - | - | - | 1件: 65 65 💬 |
124 | Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with lentiviral vector that encodes for the human Wiskott Aldrich Syndrome (WAS) cDNA sequence | - | - | - | - | 1件: 65 65 💬 |
125 | Autologous Umbilical Cord Blood | - | - | - | - | 2件: 211 211, 294 💬 |
126 | AVONEX - 30 MCG (6 MILIONI UI) POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 4 FLACONI CON DISPOSITIVO BIOSET + 4 SIRINGHE PRERIEMPITE USO INTRAMUSCOLARE | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬 | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬 |
127 | Avonex/Betaseron/Copaxone/Rebif | 3件: Glatiramer Glatiramer (Copolymer-1), Interferon beta-1a, Interferon beta-1b | 2件: Interferon beta-1b
Interferon beta-1b
,
Interferon beta-1a
💬 | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬 |
128 | AZAFOR - 50 MG COMPRESSE RIVESTITE CON FILM 50 COMPRESSE IN BLISTER PVC/PVDC/AL | - | - | - | - | 1件: 97 97 💬 |
129 | AZATIOPRINA ASPEN - 50 COMPRESSE | 1件: Azathioprine Azathioprine | 1件: Azathioprine
Azathioprine
💬 | - | - | 1件: 96 96 💬 |
130 | AZD4017 and prednisolone (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 75 75 💬 |
131 | AZILECT 1 mg comprimidos | 1件: Rasagiline Rasagiline | 2件: Rasagiline
Rasagiline
,
Rasagiline tartrate
💬 | 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 💬 |
132 | Azithromycin + N-acetylcystein + inhaled corticosteroid | 1件: Azithromycin Azithromycin | 2件: Azithromycin
Azithromycin
,
Azithromycin
💬 | - | - | 1件: 228 228 💬 |
133 | Azithromycin 500 mg film-coated tablet | 1件: Azithromycin Azithromycin | 2件: Azithromycin
Azithromycin
,
Azithromycin
💬 | - | - | 1件: 299 299 💬 |
134 | B-peptide-CRM197 conjugate | 1件: Corynebacterium diphtheriae CRM197 protein Corynebacterium diphtheriae CRM197 protein | - | - | - | 1件: 11 11 💬 |
135 | BAY 63-2521 coated tablets 0.5 mg | - | - | - | - | 2件: 86 86, 88 💬 |
136 | BAY 63-2521 coated tablets 1 mg | - | - | - | - | 2件: 86 86, 88 💬 |
137 | BAY 63-2521 coated tablets 1.5 mg | - | - | - | - | 2件: 86 86, 88 💬 |
138 | BAY 63-2521 coated tablets 2 mg | - | - | - | - | 2件: 86 86, 88 💬 |
139 | BAY 63-2521 coated tablets 2.5 mg | - | - | - | - | 2件: 86 86, 88 💬 |
140 | BAY 63-2521 IR coated tablet 1.0 mg | - | - | - | - | 1件: 88 88 💬 |
141 | BAY 63-2521 IR coated tablet 1.5 mg | - | - | - | - | 1件: 88 88 💬 |
142 | BAY 63-2521 IR coated tablet 2.0 mg | - | - | - | - | 1件: 88 88 💬 |
143 | BAY 63-2521 IR coated tablet 2.5 mg | - | - | - | - | 1件: 88 88 💬 |
144 | BEFIZAL L.P. 400 mg, comprimé enrobé à libération prolongée | - | - | - | - | 1件: 94 94 💬 |
145 | BENLYSTA - 120 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 120 MG 1 FLACONCINO | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬 | 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 53 53 💬 |
146 | Benlysta 400 mg powder for concentrate for solution for infusion | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬 | 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 2件: 43 43, 49 💬 |
147 | Benlysta 400 mg powder for concentrate for solution for infusions | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬 | 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 49 49 💬 |
148 | Benlysta 400mg polvere per concentrato per soluzione per infusione | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬 | 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 43 43 💬 |
149 | Beta-Adrenergic cocktail | - | - | - | - | 1件: 299 299 💬 |
150 | BEXSERO - SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - SIRINGA PRERIEMPITA (VETRO) - 0.5ML - 1 SIRINGA PRERIEMPITA CON AGO | 4件: Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle, Neisseria meningitidis serogroup b fhbp fusion protein antigen, Neisseria meningitidis serogroup b nada protein antigen, Neisseria meningitidis serogroup b nhba fusion protein antigen | - | - | - | 1件: 66 66 💬 |
151 | BI 1015550 18 mg Film Coated Tablet | - | - | - | - | 1件: 85 85 💬 |
152 | BI 1015550 9 mg Film Coated Tablet | - | - | - | - | 1件: 85 85 💬 |
153 | BIIB033 (ANTI-LINGO) - EV Substance Code SUB118957 | - | - | - | - | 1件: 13 13 💬 |
154 | Bio-enhanced Curcumin Soft Gelatin Capsule (Asini corii collas) | 2件: Curcumin Curcumin, Gelatin (Sulfur Colloid) | 2件: Gelatin
Gelatin
,
Donkey glue
(Asini corii collas) 💬 | - | - | 1件: 97 97 💬 |
155 | BLOKIUM 50 mg comprimidos | - | - | - | - | 1件: 167 167 💬 |
156 | Blood coagulation Factor VIII and vWF, human | 1件: Beroctocog alfa Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex) | - | - | - | 1件: 288 288 💬 |
157 | Blood coagulation factor XIII | 1件: Factor XIII (human) Factor XIII (human) (Corifact 250) | - | - | - | 1件: 51 51 💬 |
158 | Blood collection | - | - | - | - | 2件: 229 229, 271 💬 |
159 | Blood or Saliva Sample Collection | - | - | - | - | 1件: 299 299 💬 |
160 | Blood sample collection | - | - | - | - | 1件: 85 85 💬 |
161 | Blood Sampling and DNA collection | - | - | - | - | 1件: 6 6 💬 |
162 | BMS Drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) | 5件: Digoxin Digoxin, Flurbiprofen, Midazolam, Montelukast, Omeprazole (Heartburn Control) | 5件: Digoxin
Digoxin
,
Flurbiprofen
,
Omeprazole
,
Midazolam
,
Montelukast
💬 | 25件: ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP4A, ATP4B, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, PTGS1, PTGS2 💬 | 49件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 💬 |
163 | Bone Marrow Concentrate | - | - | - | - | 1件: 70 70 💬 |
164 | Boots High Strength Garlic Odour Controlled | 1件: Garlic Garlic | 1件: Garlic
Garlic
💬 | - | - | 1件: 299 299 💬 |
165 | BOTULINUM TOXIN A - HAEMAGGLUTININ COMPLEX | 1件: Botulinum toxin type A Botulinum toxin type A (Xeomin Cosmetic) | 1件: Botulinum toxin type A
Botulinum toxin type A
💬 | 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 13 13 💬 |
166 | Bovine type I collagen | 1件: Bovine type I collagen Bovine type I collagen | - | - | - | 1件: 51 51 💬 |
167 | BPR277 ointment (controlled application) | - | - | - | - | 1件: 160 160 💬 |
168 | BRAMITOB - 300 MG/4 ML SOLUZIONE DA NEBULIZZARE 56 CONTENITORI MONODOSE 4 ML | - | - | - | - | 1件: 299 299 💬 |
169 | Bronchial mucus collection | - | - | - | - | 1件: 299 299 💬 |
170 | Bronchoalveolar lavage fluid collection | - | - | - | - | 1件: 229 229 💬 |
171 | Budesonide 0.5 mg compresse orodispersibili | 1件: Budesonide Budesonide (Cortiment) | 1件: Budesonide
Budesonide
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬 |
172 | Budesonide 1 mg compresse orodispersibili | 1件: Budesonide Budesonide (Cortiment) | 1件: Budesonide
Budesonide
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬 |
173 | Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine (CERTA DOSE EPINEPHRINE CONVENIENCE KIT) | 3件: Bupivacaine Bupivacaine (Cortaren Corticosteroid/Anti-Inflammatory System), Clonidine, Epinephrine (Gingi-pak Cotton Coil) | 3件: Epinephrine
Epinephrine
(CERTA DOSE EPINEPHRINE CONVENIENCE KIT),
Clonidine
,
Bupivacaine
💬 | 14件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 70 70 💬 |
174 | Bupivacaine/epinephrine/dexamethasone (CERTA DOSE EPINEPHRINE CONVENIENCE KIT) | 3件: Bupivacaine Bupivacaine (Cortaren Corticosteroid/Anti-Inflammatory System), Dexamethasone (Cortaren Corticosteroid/Anti-Inflammatory System), Epinephrine (Gingi-pak Cotton Coil) | 3件: Epinephrine
Epinephrine
(CERTA DOSE EPINEPHRINE CONVENIENCE KIT),
Dexamethasone
,
Bupivacaine
💬 | 15件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 96 96 💬 |
175 | BUSILVEX - 6 MG/ML - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO - 10 ML 8 FLACONCINI | 1件: Busulfan Busulfan | 1件: Busulfan
Busulfan
💬 | - | - | 2件: 19 19, 65 💬 |
176 | Busulfan, Cyclophosphamide, Thymoglobulin, Fludarabine (Conditioning regimen) | 4件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Busulfan, Cyclophosphamide, Fludarabine | 4件: Busulfan
Busulfan
,
Cyclophosphamide
,
Cyclophosphamide
,
Fludarabine
💬 | 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 326 326 💬 |
177 | C-type natriuretic peptide conjugated to a multi-arm polyethylene glycol carrier molecule through a cleavable linker | 1件: Polyethylene glycol Polyethylene glycol (Injoy Constipation Relief) | 1件: Polyethylene glycol 3350
Polyethylene glycol 3350
💬 | - | - | 1件: 276 276 💬 |
178 | C-TYPE NATRIURETIC PEPTIDE CONJUGATED TO MULTI-ARM POLYETHYLENE GLYCOL CARRIER THROUGH A CLEAVABLE LINKER | 1件: Polyethylene glycol Polyethylene glycol (Injoy Constipation Relief) | 1件: Polyethylene glycol 3350
Polyethylene glycol 3350
💬 | - | - | 1件: 276 276 💬 |
179 | C1 inhibitor concentrate | 1件: Human C1-esterase inhibitor Human C1-esterase inhibitor | - | - | - | 1件: 65 65 💬 |
180 | Cabozantinib (Cometriq (TN)) | 1件: Cabozantinib Cabozantinib (Cometriq) | 1件: Cabozantinib
Cabozantinib
(Cometriq (TN)) 💬 | 3件: AXL AXL, KDR, MET 💬 | 25件: Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, EGFR tyrosine kinase inhibitor resistance, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 34 34 💬 |
181 | CALCIO CARBONATO/COLECALCIFEROLO | 2件: Calcium Calcium (Revitex Ampoules Et Comprimes), Calcium carbonate (Up and Up dual action acid controller complete) | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬 | - | - | 1件: 274 274 💬 |
182 | Calcium and cholecalciferol (Colecalciferol (INN)) | 2件: Calcium Calcium (Revitex Ampoules Et Comprimes), Cholecalciferol (natelle COMPLETE) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol (INN)) 💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 46 46 💬 |
183 | Calcium and Vitamin D combination | 2件: Calcium Calcium (Revitex Ampoules Et Comprimes), Vitamin D (Adc Comprimes) | - | - | - | 1件: 13 13 💬 |
184 | CALCIUM D3 SANDOZ - 1000 MG + 880 U.I. COMPRESSE EFFERVESCENTI 30 COMPRESSE DIVISIBILI | 2件: Calcium Calcium (Revitex Ampoules Et Comprimes), Calcium carbonate (Up and Up dual action acid controller complete) | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬 | - | - | 1件: 274 274 💬 |
185 | Canakinumab (company code: ACZ885D) | 1件: Canakinumab Canakinumab | 1件: Canakinumab
Canakinumab
💬 | 1件: IL1B IL1B 💬 | 44件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | 1件: 106 106 💬 |
186 | Capillary colchicine dosage in colchicine-resistant Familial Mediterranean Fever patients. | 1件: Colchicine Colchicine | 1件: Colchicine
Colchicine
💬 | 9件: TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 10件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 266 266 💬 |
187 | Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg) | 3件: Carbidopa Carbidopa (Corbilta), Entacapone (Comtan), Levodopa (Corbilta) | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
(Comtan (TN)) 💬 | 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
188 | Carbidopa and Levodopa Controlled Release Tablets | 2件: Carbidopa Carbidopa (Corbilta), Levodopa (Corbilta) | 2件: Levodopa
Levodopa
,
Carbidopa
💬 | 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
189 | Carbidopa, levodopa, entacapone (Comtan (TN)) | 3件: Carbidopa Carbidopa (Corbilta), Entacapone (Comtan), Levodopa (Corbilta) | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
(Comtan (TN)) 💬 | 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
190 | Carbidopa/l-dopa/entacapone (Comtan (TN)) | 3件: Carbidopa Carbidopa (Corbilta), Entacapone (Comtan), Levodopa (Corbilta) | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
(Comtan (TN)) 💬 | 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
191 | Carbidopa/Levodopa/Entacapone (Comtan (TN)) | 3件: Carbidopa Carbidopa (Corbilta), Entacapone (Comtan), Levodopa (Corbilta) | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
(Comtan (TN)) 💬 | 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
192 | CARVEDILOL (Coreg (TN)) | 1件: Carvedilol Carvedilol (Coreg CR) | 1件: Carvedilol
Carvedilol
(Coreg (TN)) 💬 | 5件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 | 13件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 57 57, 86, 113, 210 💬 |
193 | CBD - Solution Orale, conosciuto come Epidiolex, questo è il nome approvato negli Stati Uniti | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬 | 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬 |
194 | CBD soluzione orale nota come Epidyolex e con tale nome è stato approvato in UE | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬 | 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬 |
195 | CBDV Compound | 1件: Cannabidivarin Cannabidivarin | - | - | - | 1件: 193 193 💬 |
196 | CellCept 500 mg comprimidos recubiertos | - | - | - | - | 1件: 35 35 💬 |
197 | CellCept 500 mg film-coated tablets | 1件: Mycophenolate mofetil Mycophenolate mofetil (Co Mycophenolate) | 1件: Mycophenolate mofetil
Mycophenolate mofetil
💬 | 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 1件: 11 11 💬 |
198 | CellCept®500 mg comprimidos | - | - | - | - | 1件: 35 35 💬 |
199 | Cellule CD34+ autologhe trasdotte con IDUA LV codificante per il cDNA dell'alfa-L-iduronidasi | - | - | - | - | 1件: 19 19 💬 |
200 | Cerezyme 400 Units Powder for concentrate for solution for infusion | 1件: Imiglucerase Imiglucerase | 1件: Imiglucerase
Imiglucerase
💬 | 1件: GBA1 GBA1 💬 | 4件: Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | 1件: 19 19 💬 |
201 | CETIRIZINA SANDOZ - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE IN BLISTER PVC/ALU | 1件: Cetirizine Cetirizine (Core Values Allergy Relief) | 1件: Cetirizine
Cetirizine
💬 | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 300 300 💬 |
202 | CFZ533 active - Cohort 1 | - | - | - | - | 1件: 53 53 💬 |
203 | CFZ533 active - Cohort 2 | - | - | - | - | 1件: 53 53 💬 |
204 | CFZ533 active - Cohort 3 | - | - | - | - | 1件: 53 53 💬 |
205 | CFZ533 active -Cohort 3 | - | - | - | - | 1件: 53 53 💬 |
206 | Chemical conjugate of recombinant human growth hormone (rhGH) and human immunoglobulin G4 fragment (HMC001) | 1件: Somatotropin Somatotropin | - | - | - | 1件: 78 78 💬 |
207 | Chicken type II collagen | 1件: Chicken Chicken | - | - | - | 1件: 46 46 💬 |
208 | Chinese herbal concoction twice a day for 6 months | - | - | - | - | 1件: 60 60 💬 |
209 | CHOLECALCIFEROL (Colecalciferol (INN)) | 1件: Cholecalciferol Cholecalciferol (natelle COMPLETE) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol (INN)) 💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 9件: 13 13, 19, 34, 46, 49, 96, 97, 298, 299 💬 |
210 | Cholecalciferol (Vitamin D3) (Colecalciferol (INN)) | 1件: Cholecalciferol Cholecalciferol (natelle COMPLETE) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol (INN)) 💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 2件: 13 13, 299 💬 |
211 | Cholecalciferol (vitaminD3) (Colecalciferol (INN)) | 1件: Cholecalciferol Cholecalciferol (natelle COMPLETE) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol (INN)) 💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 💬 |
212 | Cholecalciferol 10,000 IU (Colecalciferol (INN)) | 1件: Cholecalciferol Cholecalciferol (natelle COMPLETE) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol (INN)) 💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 96 96 💬 |
213 | Cholecalciferol 400 IU (Colecalciferol (INN)) | 1件: Cholecalciferol Cholecalciferol (natelle COMPLETE) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol (INN)) 💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 96 96 💬 |
214 | Cholecalciferol and C. Xanthorrhiza (Colecalciferol (INN)) | 1件: Cholecalciferol Cholecalciferol (natelle COMPLETE) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol (INN)) 💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 49 49 💬 |
215 | CHOLECALCIFEROL CONCENTRATE | 1件: Cholecalciferol Cholecalciferol (natelle COMPLETE) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol (INN)) 💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 96 96 💬 |
216 | CHOLECALCIFEROL CONCENTRATE (WATER-DISPERSIBLE FORM) | 2件: Cholecalciferol Cholecalciferol (natelle COMPLETE), Water (FIRST AID Contains 202 PIECES) | 2件: Water
Water
(Purified water in containers (JP18)),
Cholecalciferol
(Colecalciferol (INN)) 💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 96 96 💬 |
217 | Cholecalciferol Pill (Colecalciferol (INN)) | 1件: Cholecalciferol Cholecalciferol (natelle COMPLETE) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol (INN)) 💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 💬 |
218 | Cholecalciferol, Vitamin D3 (Colecalciferol (INN)) | 1件: Cholecalciferol Cholecalciferol (natelle COMPLETE) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol (INN)) 💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 13 13 💬 |
219 | Chronic Corticosteroid Therapy | - | - | - | - | 1件: 113 113 💬 |
220 | CIALIS - 20 MG 2 COMPRESSE RIVESTITE CON FILM IN BLISTER USO ORALE | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 75 75 💬 |
221 | Cialis 10 mg film-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬 |
222 | Cialis 2.5 mg film-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬 |
223 | CIALIS 20 mg comprimidos recubiertos con película | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
224 | Cialis 20 mg film-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬 |
225 | Cialis 5 mg film-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬 |
226 | CIPROXIN - 500 MG COMPRESSE RIVESTITE 14 COMPRESSE | - | - | - | - | 1件: 299 299 💬 |
227 | CIRCADIN 2 mg comprimidos de liberación prolongada | 1件: Melatonin Melatonin | 1件: Melatonin
Melatonin
💬 | 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 90 90 💬 |
228 | Claritromycin 500mg film coated tablets | - | - | - | - | 1件: 299 299 💬 |
229 | Clenbuterol (Contraspasmin (TN)) | 1件: Clenbuterol Clenbuterol | 1件: Clenbuterol
Clenbuterol
(Contraspasmin (TN)) 💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 1 1, 2, 6, 256 💬 |
230 | Clenbuterol HCl (Contraspasmin (TN)) | 1件: Clenbuterol Clenbuterol | 1件: Clenbuterol
Clenbuterol
(Contraspasmin (TN)) 💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬 |
231 | CLENBUTEROL HYDROCHLORIDE (Contraspasmin (TN)) | 1件: Clenbuterol Clenbuterol | 1件: Clenbuterol
Clenbuterol
(Contraspasmin (TN)) 💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬 |
232 | Clobetasol propionate (Cormax (TN)) | 2件: Clobetasol Clobetasol, Clobetasol propionate (Cormax Scalp Application) | 2件: Clobetasol propionate
Clobetasol propionate
(Cormax (TN)),
Clobetasol
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 46 46, 162 💬 |
233 | Clobetasol propionate + Methotrexate (Cormax (TN)) | 3件: Clobetasol Clobetasol, Clobetasol propionate (Cormax Scalp Application), Methotrexate | 3件: Methotrexate
Methotrexate
,
Clobetasol propionate
(Cormax (TN)),
Clobetasol
💬 | 3件: DHFR DHFR, DHFR2, NR3C1 💬 | 6件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬 | 1件: 162 162 💬 |
234 | Clobetasol propionate alone (Cormax (TN)) | 2件: Clobetasol Clobetasol, Clobetasol propionate (Cormax Scalp Application) | 2件: Clobetasol propionate
Clobetasol propionate
(Cormax (TN)),
Clobetasol
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 162 162 💬 |
235 | Clobetasol Propionate cream treatment (Cormax (TN)) | 2件: Clobetasol Clobetasol, Clobetasol propionate (Cormax Scalp Application) | 2件: Clobetasol propionate
Clobetasol propionate
(Cormax (TN)),
Clobetasol
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 162 162 💬 |
236 | CO | - | - | - | - | 3件: 13 13, 53, 85 💬 |
237 | CO-14 | - | - | - | - | 1件: 13 13 💬 |
238 | Co-medication: Synthetic DMARDs | - | - | - | - | 1件: 46 46 💬 |
239 | CO-TRIMOXAZOLE | - | - | - | - | 1件: 85 85 💬 |
240 | Coagadex | 1件: Coagulation factor X human Coagulation factor X human | - | - | - | 1件: 288 288 💬 |
241 | Coagulación factor VIII | 1件: Beroctocog alfa Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex) | - | - | - | 1件: 288 288 💬 |
242 | Coagulation factor VIII | 1件: Beroctocog alfa Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex) | - | - | - | 1件: 288 288 💬 |
243 | Coagulation factor X | 1件: Coagulation factor X human Coagulation factor X human | - | - | - | 1件: 288 288 💬 |
244 | Coagulation factor XIII | 1件: Factor XIII (human) Factor XIII (human) (Corifact 250) | - | - | - | 1件: 288 288 💬 |
245 | Coamoxiclav | - | - | - | - | 1件: 97 97 💬 |
246 | Coarse wheat bran | 2件: Wheat Wheat, Wheat bran | 1件: Wheat
Wheat
💬 | - | - | 1件: 6 6 💬 |
247 | Cobalt | 1件: Cobalt Cobalt | - | - | - | 1件: 46 46 💬 |
248 | Cobamamide | 1件: Cobamamide Cobamamide | 1件: Cobamamide
Cobamamide
💬 | - | - | 1件: 299 299 💬 |
249 | Cobimetinib | 1件: Cobimetinib Cobimetinib | 1件: Cobimetinib
Cobimetinib
💬 | 2件: MAP2K1 MAP2K1, MAP2K2 💬 | 89件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 280 280 💬 |
250 | Cobiprostone | 1件: Cobiprostone Cobiprostone | 1件: Cobiprostone
Cobiprostone
💬 | - | - | 1件: 46 46 💬 |
251 | COBITOLIMOD | 1件: Cobitolimod Cobitolimod | 1件: Cobitolimod
Cobitolimod
💬 | 1件: TLR9 TLR9 💬 | 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 💬 |
252 | Cobitolimod 250 mg | 1件: Cobitolimod Cobitolimod | 1件: Cobitolimod
Cobitolimod
💬 | 1件: TLR9 TLR9 💬 | 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 💬 |
253 | Cobitolimod 500 mg | 1件: Cobitolimod Cobitolimod | 1件: Cobitolimod
Cobitolimod
💬 | 1件: TLR9 TLR9 💬 | 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 💬 |
254 | Cobitolimod 500mg | 1件: Cobitolimod Cobitolimod | 1件: Cobitolimod
Cobitolimod
💬 | 1件: TLR9 TLR9 💬 | 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 💬 |
255 | Cocoa | 1件: Cocoa Cocoa | - | - | - | 1件: 6 6 💬 |
256 | Coconut | 1件: Coconut Coconut | - | - | - | 1件: 13 13 💬 |
257 | Coconut oil | 2件: Coconut Coconut, Coconut oil | 1件: Coconut oil
Coconut oil
💬 | - | - | 1件: 13 13 💬 |
258 | Coconut oil and epigallocatechin gallate | 4件: Coconut Coconut, Coconut oil, Epigallocatechin, Epigallocatechin gallate | 1件: Coconut oil
Coconut oil
💬 | - | - | 1件: 13 13 💬 |
259 | Cod | - | - | - | - | 1件: 46 46 💬 |
260 | Cod liver oil | 1件: Cod liver oil Cod liver oil | 1件: Cod liver oil
Cod liver oil
💬 | - | - | 1件: 46 46 💬 |
261 | Coenzym Q10 Nanodispersion | - | - | - | - | 1件: 5 5 💬 |
262 | Coenzym Q10, Ubiquinon, Ubichinon | - | - | - | - | 1件: 5 5 💬 |
263 | Coenzyme A | 1件: Coenzyme A Coenzyme A | - | - | - | 1件: 246 246 💬 |
264 | Coenzyme Q-10 | 1件: Ubidecarenone Ubidecarenone (Coenzyme Q10 80mg) | 1件: Ubidecarenone
Ubidecarenone
💬 | - | - | 1件: 86 86 💬 |
265 | Coenzyme Q-10 in Normal Control subjects | 1件: Ubidecarenone Ubidecarenone (Coenzyme Q10 80mg) | 1件: Ubidecarenone
Ubidecarenone
💬 | - | - | 1件: 86 86 💬 |
266 | Coenzyme Q-10 in Pulmonary Hypertension subjects | 1件: Ubidecarenone Ubidecarenone (Coenzyme Q10 80mg) | 1件: Ubidecarenone
Ubidecarenone
💬 | - | - | 1件: 86 86 💬 |
267 | Coenzyme Q10 | 1件: Ubidecarenone Ubidecarenone (Coenzyme Q10 80mg) | 1件: Ubidecarenone
Ubidecarenone
💬 | - | - | 11件: 2 2, 5, 6, 8, 10, 18, 46, 57, 113, 214, 215 💬 |
268 | Coenzyme Q10 and Lisinopril | 2件: Lisinopril Lisinopril, Ubidecarenone (Coenzyme Q10 80mg) | 3件: Lisinopril
Lisinopril
,
Ubidecarenone
,
Lisinopril
💬 | 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 113 113 💬 |
269 | Coenzyme Q10 Nanodispersion (Nanoquinone) | 1件: Ubidecarenone Ubidecarenone (Coenzyme Q10 80mg) | 1件: Ubidecarenone
Ubidecarenone
💬 | - | - | 1件: 6 6 💬 |
270 | Coenzyme Q10 with vitamin E | 2件: Ubidecarenone Ubidecarenone (Coenzyme Q10 80mg), Vitamin E (natelle COMPLETE) | 2件: Ubidecarenone
Ubidecarenone
,
Vitamin E
💬 | - | - | 1件: 6 6 💬 |
271 | CoenzymeQ10 | - | - | - | - | 1件: 21 21 💬 |
272 | CoFactor | - | - | - | - | 2件: 265 265, 288 💬 |
273 | Cofactor supplementation (thiamine, riboflavin, L-carnitine) | 3件: Levocarnitine Levocarnitine, Riboflavin (Stresstabs + Zinc-copper), Thiamine (Stresstabs + Zinc-copper) | 3件: Riboflavin
Riboflavin
,
Levocarnitine
,
Thiamine
💬 | - | - | 1件: 265 265 💬 |
274 | Coffee | 2件: Arabica coffee bean Arabica coffee bean, Coffea arabica seed, roasted | - | - | - | 1件: 97 97 💬 |
275 | COFFEE COAL | 2件: Arabica coffee bean Arabica coffee bean, Coffea arabica seed, roasted | - | - | - | 1件: 97 97 💬 |
276 | Cogane | - | - | - | - | 1件: 6 6 💬 |
277 | Cogane™ (PYM50028) | - | - | - | - | 1件: 6 6 💬 |
278 | Cohort 1 0.225g | - | - | - | - | 1件: 240 240 💬 |
279 | Cohort 1: 1.0 x 10^8 PolyTregs | - | - | - | - | 1件: 35 35 💬 |
280 | Cohort 1: hATG, CsA, EPAG Day 14 to Month 6 | 1件: Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | - | - | - | 1件: 60 60 💬 |
281 | Cohort 1:Nilotinib Oral Capsules (150mg or 300mg) | 1件: Nilotinib Nilotinib | 1件: Nilotinib
Nilotinib
💬 | 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | 33件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 6 6 💬 |
282 | Cohort 2 0.75g | - | - | - | - | 1件: 240 240 💬 |
283 | Cohort 2: 2.5x10^8 PolyTregs | - | - | - | - | 1件: 35 35 💬 |
284 | Cohort 2: hATG, CsA, EPAG Day 14 to Month 3 | 1件: Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | - | - | - | 1件: 60 60 💬 |
285 | Cohort 2: Nilotinib Oral Capsules (dose to be determined from Cohort 1) | 1件: Nilotinib Nilotinib | 1件: Nilotinib
Nilotinib
💬 | 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | 33件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 6 6 💬 |
286 | Cohort 3 2.25 g | - | - | - | - | 1件: 240 240 💬 |
287 | Cohort 3: hATG, CsA (dose reduced), EPAG day 1 to month 6 | 1件: Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | - | - | - | 1件: 60 60 💬 |
288 | Cohort1 | - | - | - | - | 1件: 6 6 💬 |
289 | Cohort2 | - | - | - | - | 1件: 6 6 💬 |
290 | COL7A1-SIN retroviral vector engineered autologous tissue-engineered skin | - | - | - | - | 1件: 36 36 💬 |
291 | COLAL PRED | - | - | - | - | 1件: 97 97 💬 |
292 | COLAL-PRED | - | - | - | - | 1件: 97 97 💬 |
293 | COLAL-PRED® | - | - | - | - | 1件: 97 97 💬 |
294 | Colazide | - | - | - | - | 1件: 97 97 💬 |
295 | COLCHICINA | 1件: Colchicine Colchicine | 1件: Colchicine
Colchicine
💬 | 9件: TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 10件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 2 2 💬 |
296 | COLCHICINA LIRCA - 1 MG COMPRESSE 60 COMPRESSE | 1件: Colchicine Colchicine | 1件: Colchicine
Colchicine
💬 | 9件: TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 10件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 2 2 💬 |
297 | Colchicine | 1件: Colchicine Colchicine | 1件: Colchicine
Colchicine
💬 | 9件: TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 10件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 7件: 2 2, 42, 46, 56, 93, 210, 266 💬 |
298 | Colchicine 1 MG Oral Tablet | 1件: Colchicine Colchicine | 1件: Colchicine
Colchicine
💬 | 9件: TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 10件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 2 2 💬 |
299 | Colchicine sprinkle capsules | 1件: Colchicine Colchicine | 1件: Colchicine
Colchicine
💬 | 9件: TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 10件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 266 266 💬 |
300 | Cold Cadioplegia | - | - | - | - | 1件: 215 215 💬 |
301 | COLECALCIFEROL | 1件: Cholecalciferol Cholecalciferol (natelle COMPLETE) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol (INN)) 💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 4件: 13 13, 46, 96, 228 💬 |
302 | COLECALCIFEROL CONCENTRATE (OILY FORM) | 1件: Cholecalciferol Cholecalciferol (natelle COMPLETE) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol (INN)) 💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 13 13 💬 |
303 | Colecalciferol D3 (Vigantol Oil) | 1件: Cholecalciferol Cholecalciferol (natelle COMPLETE) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol (INN)) 💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 96 96 💬 |
304 | Colesevelam | 1件: Colesevelam Colesevelam | 1件: Colesevelam
Colesevelam
💬 | - | - | 2件: 96 96, 260 💬 |
305 | Colestipol | 1件: Colestipol Colestipol | 1件: Colestipol
Colestipol
💬 | - | - | 1件: 254 254 💬 |
306 | COLESTIRAMINA | 1件: Cholestyramine Cholestyramine (Colestyramine) | - | - | - | 1件: 13 13 💬 |
307 | COLESTYRAMINE | 1件: Cholestyramine Cholestyramine (Colestyramine) | - | - | - | 1件: 254 254 💬 |
308 | Colfinair 2 MIU Powder for Nebuliser Solution | - | - | - | - | 1件: 299 299 💬 |
309 | Colimicina | - | - | - | - | 1件: 299 299 💬 |
310 | COLIMICINA - 1000000 U/4 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 4 ML | - | - | - | - | 1件: 299 299 💬 |
311 | Colimycine | - | - | - | - | 1件: 299 299 💬 |
312 | COLIMYCINE inhalation | - | - | - | - | 1件: 299 299 💬 |
313 | COLIMYCINE injectable | - | - | - | - | 1件: 299 299 💬 |
314 | COLISTIMETATO SODICO | - | - | - | - | 1件: 299 299 💬 |
315 | Colistimethat-Natrium | - | - | - | - | 1件: 299 299 💬 |
316 | COLISTIMETHATE | 1件: Colistimethate Colistimethate | - | - | - | 1件: 299 299 💬 |
317 | Colistimethate 75 mg inhaled two times daily | 1件: Colistimethate Colistimethate | - | - | - | 1件: 299 299 💬 |
318 | COLISTIMETHATE SODIUM | 1件: Colistimethate Colistimethate | - | - | - | 1件: 299 299 💬 |
319 | COLISTIMETHATE SODIUM (A COMPONENT) | 1件: Colistimethate Colistimethate | - | - | - | 1件: 299 299 💬 |
320 | Colistimethate sodium (BAN, USAN), Colistimethatum natricum, Colistin sodium methanesulfonate | 2件: Colistimethate Colistimethate, Colistin | 1件: Colistin
Colistin
💬 | - | - | 1件: 299 299 💬 |
321 | Colistimethate sodium (CMS) | 1件: Colistimethate Colistimethate | - | - | - | 1件: 299 299 💬 |
322 | Colistimethate sodium (promixin) | 1件: Colistimethate Colistimethate | - | - | - | 1件: 299 299 💬 |
323 | COLISTIN | 1件: Colistin Colistin | 1件: Colistin
Colistin
💬 | - | - | 1件: 299 299 💬 |
324 | Colistin CF | 1件: Colistin Colistin | 1件: Colistin
Colistin
💬 | - | - | 1件: 299 299 💬 |
325 | Colistin Forest - Trockenstechampullen mit Lösungsmittel | 1件: Colistin Colistin | 1件: Colistin
Colistin
💬 | - | - | 1件: 299 299 💬 |
326 | COLISTIN MESILATE SODIUM | 1件: Colistin Colistin | 1件: Colistin
Colistin
💬 | - | - | 1件: 299 299 💬 |
327 | Colistineb | - | - | - | - | 1件: 299 299 💬 |
328 | COLISTINEB 2MUI | - | - | - | - | 1件: 299 299 💬 |
329 | Collect of 10 ml of peripheric blood for DNA extraction | - | - | - | - | 1件: 46 46 💬 |
330 | Collection of biological sample (blood and/or CSF) | - | - | - | - | 2件: 2 2, 6 💬 |
331 | Collection of blood and urine | - | - | - | - | 1件: 25 25 💬 |
332 | Collection of samples | - | - | - | - | 4件: 49 49, 65, 95, 107 💬 |
333 | Collection of samples of blood and urine | - | - | - | - | 1件: 167 167 💬 |
334 | Colobreathe | 1件: Colistimethate Colistimethate | - | - | - | 1件: 299 299 💬 |
335 | Colomycin | - | - | - | - | 1件: 299 299 💬 |
336 | Colonoscopic fecal microbiota material (colo-FMT) | - | - | - | - | 1件: 96 96 💬 |
337 | Colony-purified Bacteroides thetaiotaomicron (B.theta) | - | - | - | - | 1件: 96 96 💬 |
338 | ColoVit capsule | - | - | - | - | 1件: 96 96 💬 |
339 | Coltect | - | - | - | - | 1件: 97 97 💬 |
340 | Combination | - | - | - | - | 1件: 46 46 💬 |
341 | Combination antiviral therapy | - | - | - | - | 1件: 93 93 💬 |
342 | Combination fish oil and borage seed oil | 1件: Fish oil Fish oil (Fish oil containing omega-3 acids) | - | - | - | 1件: 46 46 💬 |
343 | Combination injection of EPO and G-CSF | 1件: Filgrastim Filgrastim (Granulocyte Colony Stimulating Factor) | 1件: Filgrastim
Filgrastim
💬 | 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 6 6 💬 |
344 | Combination of a single dose anti-CD20 antibody and bortezomib | 1件: Bortezomib Bortezomib | 1件: Bortezomib
Bortezomib
💬 | 1件: PSMB5 PSMB5 💬 | 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 1件: 61 61 💬 |
345 | Combination of DMARDs | - | - | - | - | 1件: 107 107 💬 |
346 | Combination of fish oil and colesevelam | 2件: Colesevelam Colesevelam, Fish oil (Fish oil containing omega-3 acids) | 1件: Colesevelam
Colesevelam
💬 | - | - | 1件: 260 260 💬 |
347 | Combination of Minocycline and MTX or MTX alone | 1件: Minocycline Minocycline | 1件: Minocycline
Minocycline
💬 | - | - | 1件: 46 46 💬 |
348 | Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine | 3件: Azathioprine Azathioprine, Dexamethasone (Cortaren Corticosteroid/Anti-Inflammatory System), Rituximab | 3件: Azathioprine
Azathioprine
,
Dexamethasone
,
Rituximab
💬 | 2件: MS4A1 MS4A1, NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 35 35 💬 |
349 | Combination of Rituximab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 💬 |
350 | Combination of Rituximab with subcutaneous belimumab | 2件: Belimumab Belimumab, Rituximab | 2件: Rituximab
Rituximab
,
Belimumab
💬 | 2件: MS4A1 MS4A1, TNFSF13B 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 63 63 💬 |
351 | Combination of thrombopoietin mimetic and cyclosporin A | 2件: Cyclosporine Cyclosporine, Thrombopoietin | 1件: Cyclosporine
Cyclosporine
💬 | 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 60 60 💬 |
352 | Combination Oral Budesonide and Rectal Hydrocortisone | 2件: Budesonide Budesonide (Cortiment), Hydrocortisone (Cortane-B) | 2件: Hydrocortisone
Hydrocortisone
(Colocort (TN)),
Budesonide
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬 |
353 | Combination Product: | - | - | - | - | 1件: 86 86 💬 |
354 | Combination Product: Active treatment with dual therapy | - | - | - | - | 1件: 2 2 💬 |
355 | Combination Product: Beclomethasone dipropionate in addition to MC-EVOO | 1件: Beclomethasone dipropionate Beclomethasone dipropionate | 1件: Beclomethasone dipropionate
Beclomethasone dipropionate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬 |
356 | Combination Product: Beclomethasone dipropionate in addition to refined oil | 1件: Beclomethasone dipropionate Beclomethasone dipropionate | 1件: Beclomethasone dipropionate
Beclomethasone dipropionate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬 |
357 | Combination Product: Belimumab | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬 | 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 49 49 💬 |
358 | Combination Product: EGCG 300 mg + Nintedanib | 2件: Epigallocatechin gallate Epigallocatechin gallate, Nintedanib | 1件: Nintedanib
Nintedanib
💬 | 8件: FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 | 34件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 85 85 💬 |
359 | Combination Product: EGCG 300 mg + Pirfenidone | 2件: Epigallocatechin gallate Epigallocatechin gallate, Pirfenidone | 1件: Pirfenidone
Pirfenidone
💬 | 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | 84件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬 |
360 | Combination Product: EGCG 600 mg + Nintedanib | 2件: Epigallocatechin gallate Epigallocatechin gallate, Nintedanib | 1件: Nintedanib
Nintedanib
💬 | 8件: FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 | 34件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 85 85 💬 |
361 | Combination Product: EGCG 600 mg + Pirfenidone | 2件: Epigallocatechin gallate Epigallocatechin gallate, Pirfenidone | 1件: Pirfenidone
Pirfenidone
💬 | 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | 84件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬 |
362 | Combination Product: Exercise, and methotrexate | 1件: Methotrexate Methotrexate | 1件: Methotrexate
Methotrexate
💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
363 | Combination Product: Goldic serum | - | - | - | - | 1件: 70 70 💬 |
364 | Combination Product: high MCT formula | - | - | - | - | 1件: 296 296 💬 |
365 | Combination Product: Humira (adalimumab) | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬 |
366 | Combination Product: Implantable System for Remodulin (treprostinil) | 1件: Treprostinil Treprostinil | 1件: Treprostinil
Treprostinil
💬 | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 💬 |
367 | Combination Product: L-dopa 140 mg | 1件: Levodopa Levodopa (Corbilta) | 1件: Levodopa
Levodopa
💬 | 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
368 | Combination Product: L-dopa 35 mg | 1件: Levodopa Levodopa (Corbilta) | 1件: Levodopa
Levodopa
💬 | 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
369 | Combination Product: L-dopa 70mg | 1件: Levodopa Levodopa (Corbilta) | 1件: Levodopa
Levodopa
💬 | 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
370 | Combination Product: L-dopa 70mg/carbidopa 7mg | 2件: Carbidopa Carbidopa (Corbilta), Levodopa (Corbilta) | 2件: Levodopa
Levodopa
,
Carbidopa
💬 | 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
371 | Combination Product: Laser, exercise, and methotrexate | 1件: Methotrexate Methotrexate | 1件: Methotrexate
Methotrexate
💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
372 | Combination Product: lipid injectable emulsion with Fish oil | 1件: Fish oil Fish oil (Fish oil containing omega-3 acids) | - | - | - | 1件: 294 294 💬 |
373 | Combination Product: mavrilimumab | 1件: Mavrilimumab Mavrilimumab | 1件: Mavrilimumab
Mavrilimumab
💬 | 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 41 41 💬 |
374 | Combination Product: Methotrexate | 1件: Methotrexate Methotrexate | 1件: Methotrexate
Methotrexate
💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
375 | Combination Product: ND0612 Solution for SC infusion | - | - | - | - | 1件: 6 6 💬 |
376 | Combination Product: ofatumumab with AI | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬 |
377 | Combination Product: ofatumumab with PRF | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬 |
378 | Combination Product: PRP combined Magnovision | - | - | - | - | 1件: 90 90 💬 |
379 | Combination Product: Ravulizumab OBDS | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬 | 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬 |
380 | Combination Product: Sanacoach Parkinson (SCP) | - | - | - | - | 1件: 6 6 💬 |
381 | Combination Product: TransCon PTH | - | - | - | - | 1件: 235 235 💬 |
382 | Combination Product: Treprostinil via implanted pump | 1件: Treprostinil Treprostinil | 1件: Treprostinil
Treprostinil
💬 | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 💬 |
383 | Combination Steroid | - | - | - | - | 1件: 46 46 💬 |
384 | Combination therapy with vigabatrin and prednisolone | 2件: Prednisolone Prednisolone, Vigabatrin | 2件: Prednisolone
Prednisolone
(Delta-cortef (TN)),
Vigabatrin
💬 | 2件: ABAT ABAT, NR3C1 💬 | 8件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 145 145 💬 |
385 | Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 85 85 💬 |
386 | COMBIVIR | 2件: Lamivudine Lamivudine (Combivir), Zidovudine (Combivir) | 2件: Lamivudine
Lamivudine
,
Zidovudine
💬 | - | - | 1件: 265 265 💬 |
387 | Combivir (zidovudine [AZT] / lamivudine [3TC]) | 2件: Lamivudine Lamivudine (Combivir), Zidovudine (Combivir) | 2件: Lamivudine
Lamivudine
,
Zidovudine
💬 | - | - | 1件: 265 265 💬 |
388 | Comirnaty | 1件: Tozinameran Tozinameran (Comirnaty) | 1件: Tozinameran
Tozinameran
(COVID-19 mRNA vaccine (nucleoside-modified)) 💬 | - | - | 5件: 13 13, 46, 51, 53, 299 💬 |
389 | Comirnaty concentrate for dispersion for injection | 1件: Tozinameran Tozinameran (Comirnaty) | 1件: Tozinameran
Tozinameran
(COVID-19 mRNA vaccine (nucleoside-modified)) 💬 | - | - | 2件: 53 53, 299 💬 |
390 | Comirnaty Konzentrat zur Herstellung einer Injektionsdispersion | 1件: Tozinameran Tozinameran (Comirnaty) | 1件: Tozinameran
Tozinameran
(COVID-19 mRNA vaccine (nucleoside-modified)) 💬 | - | - | 1件: 13 13 💬 |
391 | Commercial Formulation Etanercept | 1件: Etanercept Etanercept | 1件: Etanercept
Etanercept
💬 | 2件: LTA LTA, TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
392 | Commercial Ventavis® (iloprost) | 1件: Iloprost Iloprost | 1件: Iloprost
Iloprost
💬 | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 💬 |
393 | Common Name: Sialic Acid | - | - | - | - | 1件: 30 30 💬 |
394 | Comparator: carbidopa | 1件: Carbidopa Carbidopa (Corbilta) | 1件: Carbidopa
Carbidopa
💬 | 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬 |
395 | Comparator: diclofenac | 1件: Diclofenac Diclofenac (Nu-diclo Enteric Coated Tab 50mg) | 1件: Diclofenac
Diclofenac
💬 | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬 |
396 | Comparator: Diclofenac sodium | 1件: Diclofenac Diclofenac (Nu-diclo Enteric Coated Tab 50mg) | 1件: Diclofenac
Diclofenac
💬 | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬 |
397 | Comparator: ezetimibe | 1件: Ezetimibe Ezetimibe | 1件: Ezetimibe
Ezetimibe
💬 | 1件: NPC1L1 NPC1L1 💬 | 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 2件: 79 79, 260 💬 |
398 | Comparator: levodopa | 1件: Levodopa Levodopa (Corbilta) | 1件: Levodopa
Levodopa
💬 | 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
399 | Comparator: naproxen tablet 500 mg | 1件: Naproxen Naproxen (Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Cold) | 1件: Naproxen
Naproxen
💬 | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬 |
400 | COMPLEMENT C1 ESTERASE INHIBITOR | 1件: Conestat alfa Conestat alfa | 1件: Conestat alfa
Conestat alfa
💬 | 3件: C1R C1R, C1S, KLKB1 💬 | 6件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 61 61 💬 |
401 | Compound 1a | - | - | - | - | 2件: 246 246, 299 💬 |
402 | COMPOUND 21 | - | - | - | - | 1件: 85 85 💬 |
403 | Compound thrombosis capsule sig: 1.5g/tid | - | - | - | - | 1件: 90 90 💬 |
404 | Compressa effervescente 0,5 mg di budesonide per uso orodispersibile | 1件: Budesonide Budesonide (Cortiment) | 1件: Budesonide
Budesonide
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬 |
405 | Compressa effervescente 1 mg di budesonide per uso orodispersibile | 1件: Budesonide Budesonide (Cortiment) | 1件: Budesonide
Budesonide
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬 |
406 | COMTAN | 1件: Entacapone Entacapone (Comtan) | 1件: Entacapone
Entacapone
(Comtan (TN)) 💬 | 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬 |
407 | COMTAN 200* 60 CPR 200 MG | 1件: Entacapone Entacapone (Comtan) | 1件: Entacapone
Entacapone
(Comtan (TN)) 💬 | 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬 |
408 | COMTAN® | 1件: Entacapone Entacapone (Comtan) | 1件: Entacapone
Entacapone
(Comtan (TN)) 💬 | 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬 |
409 | Comtan® | - | - | - | - | 1件: 6 6 💬 |
410 | Comtess | 1件: Entacapone Entacapone (Comtan) | 1件: Entacapone
Entacapone
(Comtan (TN)) 💬 | 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬 |
411 | Comtess® | - | - | - | - | 1件: 6 6 💬 |
412 | Concentration unit: mg milligram(s) | - | - | - | - | 1件: 254 254 💬 |
413 | Concerta | - | - | - | - | 1件: 203 203 💬 |
414 | Conditioned Medium (CM) | - | - | - | - | 1件: 90 90 💬 |
415 | Confortid | - | - | - | - | 1件: 225 225 💬 |
416 | Conivaptan | 1件: Conivaptan Conivaptan | 1件: Conivaptan
Conivaptan
💬 | 2件: AVPR1A AVPR1A, AVPR2 💬 | 5件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬 | 1件: 86 86 💬 |
417 | Conjugated equine estrogens | 1件: Conjugated estrogens Conjugated estrogens | 1件: Estrogens, conjugated
Estrogens, conjugated
💬 | - | - | 1件: 49 49 💬 |
418 | Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d | 1件: Conjugated estrogens Conjugated estrogens | 1件: Estrogens, conjugated
Estrogens, conjugated
💬 | - | - | 1件: 49 49 💬 |
419 | Conjugated pneumococcal vaccine (Prevenar) | - | - | - | - | 1件: 65 65 💬 |
420 | Conscious sedation | - | - | - | - | 1件: 6 6 💬 |
421 | Continuation of azathioprine | 1件: Azathioprine Azathioprine | 1件: Azathioprine
Azathioprine
💬 | - | - | 1件: 49 49 💬 |
422 | Continuation of current HAART (boosted protease inhibitor [PI] combination + 2 NRTIs) | - | - | - | - | 1件: 265 265 💬 |
423 | Continue IS (B cell depletion therapy) | - | - | - | - | 7件: 13 13, 35, 46, 49, 50, 51, 107 💬 |
424 | Continue IS (MMF or MPA) | - | - | - | - | 7件: 13 13, 35, 46, 49, 50, 51, 107 💬 |
425 | Continue IS (MTX) | - | - | - | - | 7件: 13 13, 35, 46, 49, 50, 51, 107 💬 |
426 | Continued Ocrelizumab | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬 |
427 | Continuous Apomorphine infusion | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
428 | Continuous infusion Cefepime | 1件: Cefepime Cefepime | 1件: Cefepime
Cefepime
💬 | - | - | 1件: 299 299 💬 |
429 | Continuous infusion Ceftazidime | 1件: Ceftazidime Ceftazidime | 2件: Ceftazidime
Ceftazidime
,
Ceftazidime
💬 | - | - | 1件: 299 299 💬 |
430 | Continuous infusion Meropenem | 1件: Meropenem Meropenem | 2件: Meropenem
Meropenem
,
Meropenem
💬 | - | - | 1件: 299 299 💬 |
431 | Continuous infusion Piperacillin tazobactam | 2件: Piperacillin Piperacillin (Zosyn in Galaxy Containers), Tazobactam (Zosyn in Galaxy Containers) | 3件: Tazobactam
Tazobactam
,
Piperacillin
,
Piperacillin
💬 | - | - | 1件: 299 299 💬 |
432 | Continuous infusion Ticarcillin-clavulanate | 2件: Clavulanic acid Clavulanic acid, Ticarcillin | 2件: Clavulanic acid
Clavulanic acid
,
Ticarcillin
💬 | - | - | 1件: 299 299 💬 |
433 | Continuous intrajejunal infusion of levodopa-carbidopa | 2件: Carbidopa Carbidopa (Corbilta), Levodopa (Corbilta) | 2件: Levodopa
Levodopa
,
Carbidopa
💬 | 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
434 | Continuous oxygen | 1件: Oxygen Oxygen (Compressed Oxidizing) | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN) 💬 | - | - | 1件: 90 90 💬 |
435 | Continuous Release Dopamine Agonists | 1件: Dopamine Dopamine | 1件: Dopamine
Dopamine
💬 | 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
436 | Continuous Subcutaneous Lisuride Infusion | 1件: Lisuride Lisuride | 1件: Lisuride
Lisuride
💬 | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
437 | Contrast enhanced ultrasound | - | - | - | - | 1件: 96 96 💬 |
438 | Contrast Enhanced Voiding Urosonography with Urodynamic Testing | - | - | - | - | 1件: 118 118 💬 |
439 | Control | - | - | - | - | 4件: 6 6, 46, 168, 299 💬 |
440 | Control gel | - | - | - | - | 1件: 36 36 💬 |
441 | Control group | - | - | - | - | 4件: 2 2, 13, 46, 70 💬 |
442 | Control Group 0.9% Isotonic Saline | - | - | - | - | 1件: 299 299 💬 |
443 | Control intervention (no dexamethasone) | 1件: Dexamethasone Dexamethasone (Cortaren Corticosteroid/Anti-Inflammatory System) | 1件: Dexamethasone
Dexamethasone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬 |
444 | Control multivitamin | - | - | - | - | 1件: 299 299 💬 |
445 | Controlled-release levodopa / carbidopa | 2件: Carbidopa Carbidopa (Corbilta), Levodopa (Corbilta) | 2件: Levodopa
Levodopa
,
Carbidopa
💬 | 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
446 | Convection enhanced delivery/AAV2-GDNF | - | - | - | - | 1件: 6 6 💬 |
447 | Conventional | - | - | - | - | 1件: 63 63 💬 |
448 | Conventional DMARD combination | - | - | - | - | 1件: 46 46 💬 |
449 | Conventional DMARDs | - | - | - | - | 1件: 46 46 💬 |
450 | Conventional drug therapy(expectorant,bronchodilator) | - | - | - | - | 1件: 86 86 💬 |
451 | Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) | 7件: Acetate Acetate, Cortisone, Cortisone acetate, Dexamethasone (Cortaren Corticosteroid/Anti-Inflammatory System), Hydrocortisone (Cortane-B), Prednisolone, Prednisone (Contrast Allergy PreMed Pack) | 6件: Hydrocortisone
Hydrocortisone
(Colocort (TN)),
Dexamethasone
,
Prednisolone
(Delta-cortef (TN)),
Prednisone
,
Cortisone acetate
,
Cortisone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
452 | Conventional medication | - | - | - | - | 1件: 6 6 💬 |
453 | Conventional synthetic antirheumatic drugs | - | - | - | - | 1件: 46 46 💬 |
454 | Conventional Synthetic DMARD | - | - | - | - | 1件: 46 46 💬 |
455 | Conventional therapy | - | - | - | - | 2件: 67 67, 222 💬 |
456 | Conventional therapy users for the last 5 years | - | - | - | - | 1件: 271 271 💬 |
457 | Conventional treatment | - | - | - | - | 1件: 97 97 💬 |
458 | Conventional treatment (glucocoticoid, immunosupressive drugs and/or mesalazine) | 1件: Mesalazine Mesalazine (Salofalk 5-asa Enteric Coated Tab- 250mg) | 1件: Mesalamine
Mesalamine
💬 | - | - | 2件: 96 96, 97 💬 |
459 | Coozar | - | - | - | - | 1件: 167 167 💬 |
460 | COP | - | - | - | - | 1件: 13 13 💬 |
461 | COP-1 | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
462 | COP-1/Copolymer-1 | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
463 | COPAXONE | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
464 | COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE 28 SIRINGHE PRERIEMPITE | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
465 | COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE 30 SIRINGHE | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
466 | COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
467 | COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA 12 SIRINGHE PRERIEMPITE DA 1 ML CON AGO | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
468 | Copaxone 20 mg | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
469 | Copaxone 20 mg/ml | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
470 | COPAXONE 20 mg/ml solución inyectable en jeringa precargada | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
471 | Copaxone 20 mg/ml solución para inyección en jeringa precargada | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
472 | Copaxone 20 mg/ml Solution for Injection, pre-filled syringe | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
473 | Copaxone 20 mg/ml, Solution for Injection, pre-filled syringes | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
474 | Copaxone 20mg/ml Solution for Injection, pre-filled syringe | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
475 | Copaxone 40 mg/ml | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
476 | Copaxone 40 mg/ml solution for injection, pre-filled syringe | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
477 | Copaxone subcutaneous injection syringe | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
478 | COPAXONE*SC 28SIR 20MG/ML | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
479 | Copaxone-Teva | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
480 | Copaxone® | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
481 | Copegus | 1件: Ribavirin Ribavirin (Copegus) | 1件: Ribavirin
Ribavirin
(Copegus (TN)) 💬 | - | - | 1件: 2 2 💬 |
482 | Copolymer 1 | - | - | - | - | 1件: 13 13 💬 |
483 | Copolymer-1 | 1件: Glatiramer Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
484 | Copper | 1件: Copper Copper | - | - | - | 4件: 2 2, 169, 170, 171 💬 |
485 | COPPER (64CU) CHLORIDE | 2件: Chloride ion Chloride ion, Copper | - | - | - | 1件: 171 171 💬 |
486 | Copper Histidinate | 1件: Copper Copper | - | - | - | 1件: 169 169 💬 |
487 | Copper Histidine | 2件: Copper Copper, Histidine | 1件: Histidine
Histidine
💬 | - | - | 2件: 169 169, 170 💬 |
488 | CoQ10 | - | - | - | - | 3件: 5 5, 6, 8 💬 |
489 | COQUN | - | - | - | - | 1件: 90 90 💬 |
490 | COR-003 | - | - | - | - | 1件: 75 75 💬 |
491 | Cord blood | - | - | - | - | 1件: 60 60 💬 |
492 | Cord blood sampling | - | - | - | - | 1件: 227 227 💬 |
493 | Cord Blood Transplant | - | - | - | - | 1件: 60 60 💬 |
494 | Cord Blood Units | - | - | - | - | 1件: 60 60 💬 |
495 | Cord sampling | - | - | - | - | 1件: 227 227 💬 |
496 | Corn | 1件: Corn Corn | - | - | - | 2件: 46 46, 240 💬 |
497 | Corn oil capsules | 1件: Corn Corn | - | - | - | 1件: 46 46 💬 |
498 | Corn/soy oil | 1件: Corn Corn | - | - | - | 1件: 240 240 💬 |
499 | Cornstarch | 1件: Starch, corn Starch, corn | 1件: Corn starch
Corn starch
💬 | - | - | 2件: 90 90, 257 💬 |
500 | Cornstarch control | 1件: Starch, corn Starch, corn | 1件: Corn starch
Corn starch
💬 | - | - | 1件: 90 90 💬 |
501 | CORT125134 | 1件: Relacorilant Relacorilant (CORT125134) | 1件: Relacorilant
Relacorilant
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 75 75 💬 |
502 | Cortancyl | 1件: Prednisone acetate Prednisone acetate (delta1-Cortisone-21-acetate) | 1件: Prednisone acetate
Prednisone acetate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 35 35, 41, 162 💬 |
503 | CORTANCYL 20 mg | 1件: Prednisone acetate Prednisone acetate (delta1-Cortisone-21-acetate) | 1件: Prednisone acetate
Prednisone acetate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 35 35, 162 💬 |
504 | Cortancyl ® 1 mg | 1件: Prednisone acetate Prednisone acetate (delta1-Cortisone-21-acetate) | 1件: Prednisone acetate
Prednisone acetate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬 |
505 | Cortancyl ® 20 mg | 1件: Prednisone acetate Prednisone acetate (delta1-Cortisone-21-acetate) | 1件: Prednisone acetate
Prednisone acetate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬 |
506 | Cortancyl ® 5 mg | 1件: Prednisone acetate Prednisone acetate (delta1-Cortisone-21-acetate) | 1件: Prednisone acetate
Prednisone acetate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬 |
507 | Cortecosteroid | - | - | - | - | 1件: 96 96 💬 |
508 | Cortef | 2件: Hydrocortisone Hydrocortisone (Cortane-B), Hydrocortisone cypionate (Cortisol 21-cyclopentanepropionate) | 2件: Hydrocortisone
Hydrocortisone
(Colocort (TN)),
Hydrocortisone cypionate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 81, 83 💬 |
509 | Cortef (hydrocortisone) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 💬 |
510 | Cortef 5 mg | 1件: Hydrocortisone cypionate Hydrocortisone cypionate (Cortisol 21-cyclopentanepropionate) | 1件: Hydrocortisone cypionate
Hydrocortisone cypionate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 💬 |
511 | Corticoids+ tocilizumab 8mg/Kg/4 weeks | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬 | 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 41 41 💬 |
512 | Corticosteroid | - | - | - | - | 9件: 13 13, 42, 43, 44, 45, 66, 96, 97, 222 💬 |
513 | Corticosteroid (CS) | - | - | - | - | 1件: 41 41 💬 |
514 | Corticosteroid and azathioprine | 1件: Azathioprine Azathioprine | 1件: Azathioprine
Azathioprine
💬 | - | - | 4件: 42 42, 43, 44, 45 💬 |
515 | Corticosteroid and non-biological agents. | - | - | - | - | 1件: 46 46 💬 |
516 | Corticosteroid or NSAID | - | - | - | - | 1件: 46 46 💬 |
517 | Corticosteroid treatment (Methylprednisolone or prednisolone) | 2件: Methylprednisolone Methylprednisolone, Prednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 64 64 💬 |
518 | Corticosteroids | - | - | - | - | 12件: 41 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300 💬 |
519 | Corticosteroids & tanCART19/20 | - | - | - | - | 1件: 13 13 💬 |
520 | Corticosteroids (Aprednislon) | - | - | - | - | 1件: 63 63 💬 |
521 | Corticosteroids (prednisone or prednisolone) | 2件: Prednisolone Prednisolone, Prednisone (Contrast Allergy PreMed Pack) | 2件: Prednisolone
Prednisolone
(Delta-cortef (TN)),
Prednisone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 49 49 💬 |
522 | Corticosteroids +immune suppressive +amino salicylic acid | 1件: Salicylic acid Salicylic acid (Compound W Maximum Strength One Step Invisible) | 1件: Salicylic acid
Salicylic acid
💬 | - | - | 1件: 97 97 💬 |
523 | Corticosteroids for Systemic Use | - | - | - | - | 1件: 41 41 💬 |
524 | Corticosteroids only | - | - | - | - | 1件: 97 97 💬 |
525 | Corticosteroids'therapy | - | - | - | - | 1件: 35 35 💬 |
526 | Corticotherapy | - | - | - | - | 1件: 66 66 💬 |
527 | Corticotrophin | 1件: Corticotropin Corticotropin | 1件: Corticotropin
Corticotropin
💬 | 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 46 46 💬 |
528 | Corticotrophin 80 units | 1件: Corticotropin Corticotropin | 1件: Corticotropin
Corticotropin
💬 | 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 46 46 💬 |
529 | Corticotropin | 1件: Corticotropin Corticotropin | 1件: Corticotropin
Corticotropin
💬 | 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 7件: 2 2, 13, 46, 75, 81, 84, 222 💬 |
530 | Corticotropin-releasing hormone | 2件: Corticorelin Corticorelin, Corticotropin | 2件: Corticotropin
Corticotropin
,
Corticorelin
💬 | 3件: CRHR1 CRHR1, CRHR2, MC2R 💬 | 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬 |
531 | CortimentMMX 9 mg | - | - | - | - | 1件: 97 97 💬 |
532 | Cortisol | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
533 | Cortison | - | - | - | - | 1件: 81 81 💬 |
534 | Cortisone | 2件: Cortisone Cortisone, Hydrocortisone (Cortane-B) | 2件: Hydrocortisone
Hydrocortisone
(Colocort (TN)),
Cortisone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
535 | Cortisone acetate | 4件: Acetate Acetate, Cortisone, Cortisone acetate, Hydrocortisone (Cortane-B) | 3件: Hydrocortisone
Hydrocortisone
(Colocort (TN)),
Cortisone acetate
,
Cortisone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
536 | Corynebacterium diphtheriae | 1件: Corynebacterium diphtheriae Corynebacterium diphtheriae | - | - | - | 1件: 11 11 💬 |
537 | Cosentyx | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 4件: 41 41, 107, 269, 271 💬 |
538 | COSENTYX - 150 MG - SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA -USO SOTTOCUTANEO - SIRINGA (VETRO) 1 ML (150MG/ML)- 1 SIRINGA PRERIEMPITA | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 107 107 💬 |
539 | COSENTYX - 150 MG - SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA -USO SOTTOCUTANEO - SIRINGA (VETRO) 1 ML (150MG/ML)- 2 SIRINGHE PRERIEMPITE | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 107 107 💬 |
540 | Cosentyx 300 mg solution for injection in pre-filled syringe | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 💬 |
541 | Cosentyx 300mg solution for injection in pre-filled syringe | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 💬 |
542 | Cosentyx® | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 269 269 💬 |
543 | Cosintropina acetato | - | - | - | - | 1件: 113 113 💬 |
544 | CosmoFer | - | - | - | - | 3件: 86 86, 96, 97 💬 |
545 | CosmoFer 50mg/ml solution for infusion or injection | - | - | - | - | 2件: 96 96, 97 💬 |
546 | Costicosteroids | - | - | - | - | 1件: 26 26 💬 |
547 | Cosyntropin | 1件: Tetracosactide Tetracosactide (Corticotropin tetracosapeptide) | 1件: Cosyntropin
Cosyntropin
💬 | 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 2件: 113 113, 145 💬 |
548 | Cosyntropin acetate | 2件: Acetate Acetate, Tetracosactide (Corticotropin tetracosapeptide) | 1件: Cosyntropin
Cosyntropin
💬 | 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 113 113 💬 |
549 | Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin | 2件: Tetracosactide Tetracosactide (Corticotropin tetracosapeptide), Vigabatrin | 2件: Cosyntropin
Cosyntropin
,
Vigabatrin
💬 | 2件: ABAT ABAT, MC2R 💬 | 12件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway 💬 | 1件: 145 145 💬 |
550 | Cosyntropin Injectable Suspension, 1 mg/mL | 1件: Tetracosactide Tetracosactide (Corticotropin tetracosapeptide) | 1件: Cosyntropin
Cosyntropin
💬 | 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 145 145 💬 |
551 | Cotoretigene Toliparvovec | 1件: Cotoretigene toliparvovec Cotoretigene toliparvovec | - | - | - | 1件: 90 90 💬 |
552 | Cotrimoxazole | - | - | - | - | 2件: 85 85, 97 💬 |
553 | COVERSIN | 1件: Nomacopan Nomacopan (COVERSIN) | 1件: Nomacopan
Nomacopan
💬 | 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 2件: 62 62, 109 💬 |
554 | Coversyl | 1件: Perindopril Perindopril (Coversyl Plus) | 1件: Perindopril
Perindopril
💬 | 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 2件: 19 19, 167 💬 |
555 | Coversyl (perindopril) | 1件: Perindopril Perindopril (Coversyl Plus) | 1件: Perindopril
Perindopril
💬 | 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 167 167 💬 |
556 | Coversyl PLUS | - | - | - | - | 1件: 19 19 💬 |
557 | COVID-19 mRNA Vaccine (nucleoside modified) | - | - | - | - | 3件: 13 13, 46, 51 💬 |
558 | COVID-19 mRNA vaccine (nucleoside-modified) | - | - | - | - | 4件: 13 13, 46, 51, 299 💬 |
559 | COVID-19 mRNA vaccine Moderna (CX-024414) | - | - | - | - | 4件: 13 13, 46, 51, 299 💬 |
560 | COVID-19 vaccination | - | - | - | - | 1件: 13 13 💬 |
561 | COVID-19 vaccine | - | - | - | - | 3件: 46 46, 49, 51 💬 |
562 | COVID-19 vaccine (Ad26.COV2-S [recombinant]) | - | - | - | - | 1件: 299 299 💬 |
563 | COVID-19 Vaccine (ChAdOx1-S [recombinant]) | - | - | - | - | 3件: 46 46, 51, 299 💬 |
564 | COVID-19 Vaccine AstraZeneca | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 3件: 46 46, 51, 53 💬 |
565 | COVID-19 vaccine AstraZeneca (ChAdOx1 nCoV-19) | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 3件: 46 46, 51, 299 💬 |
566 | COVID-19 Vaccine AstraZeneca suspension for injection COVID-19 Vaccine (ChAdOx1-S [recombinant]) | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 1件: 53 53 💬 |
567 | Covid-19 Vaccine Janssen | 1件: Janssen COVID-19 Vaccine Janssen COVID-19 Vaccine | 1件: COVID-19 vaccine
COVID-19 vaccine
💬 | - | - | 2件: 53 53, 299 💬 |
568 | COVID-19 Vaccine Janssen suspension for injection | 1件: Janssen COVID-19 Vaccine Janssen COVID-19 Vaccine | 1件: COVID-19 vaccine
COVID-19 vaccine
💬 | - | - | 1件: 299 299 💬 |
569 | COVID-19 Vaccine Janssen suspension for injection COVID-19 vaccine (Ad26.COV2-S [recombinant]) | 1件: Janssen COVID-19 Vaccine Janssen COVID-19 Vaccine | 1件: COVID-19 vaccine
COVID-19 vaccine
💬 | - | - | 2件: 53 53, 299 💬 |
570 | COVID-19 Vaccine Moderna | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: Elasomeran
Elasomeran
(COVID-19 mRNA vaccine (nucleotide modified)) 💬 | - | - | 4件: 46 46, 51, 65, 299 💬 |
571 | COVID-19 Vaccine Moderna dispersion for injection | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: Elasomeran
Elasomeran
(COVID-19 mRNA vaccine (nucleotide modified)) 💬 | - | - | 1件: 299 299 💬 |
572 | COVID19 vaccine | - | - | - | - | 1件: 13 13 💬 |
573 | Cozaar | 1件: Losartan Losartan (Cozaar) | 1件: Losartan
Losartan
💬 | 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 167 167 💬 |
574 | Cozaar 50 | 1件: Losartan Losartan (Cozaar) | 1件: Losartan
Losartan
💬 | 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 167 167 💬 |
575 | COZAAR 50 mg comprimidos recubierto con pelicula | 1件: Losartan Losartan (Cozaar) | 1件: Losartan
Losartan
💬 | 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 179 179 💬 |
576 | COZAAR INICIO 12,5 mg comprimidos recubiertos con pelicula | 1件: Losartan Losartan (Cozaar) | 1件: Losartan
Losartan
💬 | 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 167 167 💬 |
577 | Crestor Film-Coated Tablet | 1件: Rosuvastatin Rosuvastatin | 1件: Rosuvastatin
Rosuvastatin
💬 | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 79 79 💬 |
578 | Crestor Tablets (calcium rosuvastatin) Film-Coated tablets | 2件: Calcium Calcium (Revitex Ampoules Et Comprimes), Rosuvastatin | 1件: Rosuvastatin
Rosuvastatin
💬 | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 79 79 💬 |
579 | Crinecerfont is a novel non-peptide selective corticotropin releasing factor 1 (CRF1 ) receptor antagonist. | 1件: Corticotropin Corticotropin | 1件: Corticotropin
Corticotropin
💬 | 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 81 81 💬 |
580 | CRYOPRESERVED AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING HUMAN SGSH GENE | - | - | - | - | 1件: 19 19 💬 |
581 | CS (corticosteroids) Only | - | - | - | - | 1件: 97 97 💬 |
582 | CSM allogéniques issues de cordons ombilicaux ( MTI-PP) | - | - | - | - | 1件: 49 49 💬 |
583 | Cumulative corticosteroid exposure | - | - | - | - | 1件: 49 49 💬 |
584 | Cuprior 150 mg film-coated tablets | 1件: Triethylenetetramine Triethylenetetramine | - | - | - | 1件: 171 171 💬 |
585 | Cuprior 150mg film-coated tablets | 1件: Triethylenetetramine Triethylenetetramine | - | - | - | 1件: 171 171 💬 |
586 | Currently available therapy in the community | - | - | - | - | 1件: 51 51 💬 |
587 | Cushing's syndrome confirmation | - | - | - | - | 1件: 75 75 💬 |
588 | Cyclosporine combine with mycophenolate mofetil | 3件: Cyclosporine Cyclosporine, Mycophenolate mofetil (Co Mycophenolate), Mycophenolic acid | 3件: Cyclosporine
Cyclosporine
,
Mycophenolate mofetil
,
Mycophenolic acid
💬 | 7件: IMPDH1 IMPDH1, IMPDH2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 37件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Nucleotide metabolism, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 283 283 💬 |
589 | Cystic fibrosis transmembrane conductance regulator | - | - | - | - | 1件: 299 299 💬 |
590 | Cytotoxic Combination | - | - | - | - | 1件: 56 56 💬 |
591 | D-SORBITOL (Sorbitol 3% in plastic container (TN)) | 1件: Sorbitol Sorbitol | 1件: Sorbitol solution
Sorbitol solution
(Sorbitol 3% in plastic container (TN)) 💬 | - | - | 1件: 10 10 💬 |
592 | D.3.2 Product code where applicable13: | - | - | - | - | 1件: 193 193 💬 |
593 | Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) | 3件: Daratumumab Daratumumab, Hyaluronidase, Hyaluronidase (human recombinant) | 4件: Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
,
Daratumumab
💬 | 1件: CD38 CD38 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 1件: 28 28 💬 |
594 | Daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20) | 1件: Daratumumab Daratumumab | 1件: Daratumumab
Daratumumab
💬 | 1件: CD38 CD38 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 1件: 28 28 💬 |
595 | Dark chocolate (85% cocoa) | 1件: Cocoa Cocoa | - | - | - | 1件: 6 6 💬 |
596 | Data collection | - | - | - | - | 1件: 65 65 💬 |
597 | DECORTIN (PREDNISONA) 5 MG COMPRIMIDOS | 1件: Prednisone Prednisone (Contrast Allergy PreMed Pack) | 1件: Prednisone
Prednisone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬 |
598 | Depot tetracosactide (Cosyntropin) | 1件: Tetracosactide Tetracosactide (Corticotropin tetracosapeptide) | 1件: Cosyntropin
Cosyntropin
💬 | 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 83 83 💬 |
599 | Dexamethasone (50mg 1dd6, 3 consecutive days/month) | 1件: Dexamethasone Dexamethasone (Cortaren Corticosteroid/Anti-Inflammatory System) | 1件: Dexamethasone
Dexamethasone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 35 35 💬 |
600 | Dextrose, 5% in Water (Purified water in containers (JP18)) | 2件: Dextrose, unspecified form Dextrose, unspecified form (Acid Concentrate D 12219 Liq), Water (FIRST AID Contains 202 PIECES) | 1件: Water
Water
(Purified water in containers (JP18)) 💬 | - | - | 1件: 65 65 💬 |
601 | Diammonium glycyrrhizinate enteric-coated capsule | - | - | - | - | 1件: 63 63 💬 |
602 | Diazoxide choline controlled-release tablet | 2件: Choline Choline (Timed Release B Complex 100 Srt), Diazoxide | 2件: Diazoxide
Diazoxide
,
Choline
💬 | 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 1件: 193 193 💬 |
603 | Diethyl-[6-(4-hydroxycarbamoyl- phenyl carbamoyloxymethyl)-naphthalen-2-yl methyl]-ammonium chloride (Conclyte-A (TN)) | 2件: Ammonium chloride Ammonium chloride (Damylin Avec Codeine Sirop), Chloride ion | 1件: Ammonium chloride
Ammonium chloride
(Conclyte-A (TN)) 💬 | - | - | 1件: 107 107 💬 |
604 | Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphtalen-2-ylmethyl]-ammonium chloride mon (Conclyte-A (TN)) | 2件: Ammonium chloride Ammonium chloride (Damylin Avec Codeine Sirop), Chloride ion | 1件: Ammonium chloride
Ammonium chloride
(Conclyte-A (TN)) 💬 | - | - | 1件: 96 96 💬 |
605 | Dihydroergotoxine (Co-Dergocrin (TN)) | 1件: Dihydroergotoxine Dihydroergotoxine | 1件: Dihydroergotoxine
Dihydroergotoxine
(Co-Dergocrin (TN)) 💬 | - | - | 1件: 6 6 💬 |
606 | Dihydroergotoxine Mesylate (Co-Dergocrin (TN)) | 2件: Dihydroergotoxine Dihydroergotoxine, Ergoloid mesylate (co-dergocrine mesylate) | 1件: Dihydroergotoxine
Dihydroergotoxine
(Co-Dergocrin (TN)) 💬 | - | - | 1件: 6 6 💬 |
607 | Diosmin and Hesperidin Combination | 2件: Diosmin Diosmin, Hesperidin | 2件: Hesperidin
Hesperidin
,
Diosmin
💬 | - | - | 1件: 46 46 💬 |
608 | Discontinuation of respiratory co-therapy (azithromycin, RhDNase, or inhaled antibiotics) | 1件: Azithromycin Azithromycin | 2件: Azithromycin
Azithromycin
,
Azithromycin
💬 | - | - | 1件: 299 299 💬 |
609 | Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhithmias) | 1件: Amiodarone Amiodarone (Cordarone Tab 200mg) | 1件: Amiodarone
Amiodarone
💬 | 16件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 32件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 28 28 💬 |
610 | Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhythmias) plus EGCG | 2件: Amiodarone Amiodarone (Cordarone Tab 200mg), Epigallocatechin gallate | 1件: Amiodarone
Amiodarone
💬 | 16件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 32件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 28 28 💬 |
611 | DMSO cocktail | 1件: Dimethyl sulfoxide Dimethyl sulfoxide | 1件: Dimethyl sulfoxide
Dimethyl sulfoxide
💬 | - | - | 1件: 226 226 💬 |
612 | DMT continuation | - | - | - | - | 1件: 13 13 💬 |
613 | Doptelet 20 mg film-coated tablets | 1件: Avatrombopag Avatrombopag | 1件: Avatrombopag
Avatrombopag
💬 | 1件: MPL MPL 💬 | 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬 |
614 | Drug free, IS monotherapy and GC combined with IS | - | - | - | - | 1件: 300 300 💬 |
615 | Dual release hydrocortisone (plenadren) (Colocort (TN)) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
616 | E. coli Nissle | - | - | - | - | 1件: 97 97 💬 |
617 | E. coli Nissle 1917 (Mutaflor®) | - | - | - | - | 1件: 97 97 💬 |
618 | Echo and myocardial contrast echocardiography perfusion imaging | - | - | - | - | 1件: 58 58 💬 |
619 | Efgartigimod concentrate for solution for infusion 20 mg/mL | - | - | - | - | 1件: 11 11 💬 |
620 | Eflornithine plus Nifurtimox combination therapy | 2件: Eflornithine Eflornithine, Nifurtimox | 2件: Nifurtimox
Nifurtimox
,
Eflornithine
💬 | 1件: ODC1 ODC1 💬 | 3件: Arginine and proline metabolism Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬 | 1件: 65 65 💬 |
621 | Eltrombopag combining rituximab | 2件: Eltrombopag Eltrombopag, Rituximab | 1件: Rituximab
Rituximab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 💬 |
622 | Enalapril and other angiotensin converting enzyme inhibitors | 2件: Angiotensin II Angiotensin II, Enalapril | 3件: Angiotensin II
Angiotensin II
,
Angiotensin II
,
Enalapril
💬 | 3件: ACE ACE, AGTR1, AGTR2 💬 | 18件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 19 19 💬 |
623 | End-of-life nursing education consortium-pediatric palliative care as web based-training plus usual care | - | - | - | - | 2件: 113 113, 299 💬 |
624 | ENDOPROST - 0.05 MG/0.5 ML CONCENTRATO PER SOLUZIONE PER INFUSIONE 1 FIALA | - | - | - | - | 1件: 51 51 💬 |
625 | Entacapone (Comtan (TN)) | 1件: Entacapone Entacapone (Comtan) | 1件: Entacapone
Entacapone
(Comtan (TN)) 💬 | 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 2件: 6 6, 17 💬 |
626 | Entacapone 400mg oral dose (Comtan (TN)) | 1件: Entacapone Entacapone (Comtan) | 1件: Entacapone
Entacapone
(Comtan (TN)) 💬 | 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 2件: 6 6, 17 💬 |
627 | Entacapone and carbidopa (Comtan (TN)) | 2件: Carbidopa Carbidopa (Corbilta), Entacapone (Comtan) | 2件: Carbidopa
Carbidopa
,
Entacapone
(Comtan (TN)) 💬 | 2件: COMT COMT, DDC 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬 |
628 | ENTACAPONE INN (Comtan (TN)) | 1件: Entacapone Entacapone (Comtan) | 1件: Entacapone
Entacapone
(Comtan (TN)) 💬 | 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬 |
629 | Enteric coated mycophenolate sodium | 1件: Mycophenolic acid Mycophenolic acid | 1件: Mycophenolic acid
Mycophenolic acid
💬 | 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 1件: 228 228 💬 |
630 | Enteric-Coated Mycophenolate Sodium | 1件: Mycophenolic acid Mycophenolic acid | 1件: Mycophenolic acid
Mycophenolic acid
💬 | 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 1件: 49 49 💬 |
631 | ENTYVIO - 300 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬 | 2件: ITGA4 ITGA4, ITGB7 💬 | 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 1件: 97 97 💬 |
632 | Epilim Chrono 200 Controlled Released tablets | - | - | - | - | 1件: 256 256 💬 |
633 | Epilim Chrono 300 Controlled Released tablets | - | - | - | - | 1件: 256 256 💬 |
634 | Epilim Chrono 500 Controlled Released tablets | - | - | - | - | 1件: 256 256 💬 |
635 | Epinephrine (CERTA DOSE EPINEPHRINE CONVENIENCE KIT) | 1件: Epinephrine Epinephrine (Gingi-pak Cotton Coil) | 1件: Epinephrine
Epinephrine
(CERTA DOSE EPINEPHRINE CONVENIENCE KIT) 💬 | 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 46 46, 70, 96 💬 |
636 | Escherichia coli | 1件: Escherichia coli Escherichia coli | - | - | - | 2件: 53 53, 78 💬 |
637 | Etanercept, Methotrexate, Prednisolone (Delta-cortef (TN)) | 3件: Etanercept Etanercept, Methotrexate, Prednisolone | 3件: Methotrexate
Methotrexate
,
Prednisolone
(Delta-cortef (TN)),
Etanercept
💬 | 5件: DHFR DHFR, DHFR2, LTA, NR3C1, TNF 💬 | 72件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 56 56 💬 |
638 | ETIMS (EDC-fixed autologous PBMCs coupled with 7 immunodominant myelin peptides in MS patients) | 1件: Myelin basic protein Myelin basic protein | - | - | - | 1件: 13 13 💬 |
639 | EV substance code: SUB188638 | - | - | - | - | 1件: 113 113 💬 |
640 | Ex-vivo approach concerning 25 patients | - | - | - | - | 2件: 102 102, 299 💬 |
641 | Ex-vivo expanded autologous human keratinocytes suspension containing epidermal stem cells genetically modified with a gamma-retroviral (rv) vector expressing the full-length LAMB3 cDNA. | - | - | - | - | 1件: 36 36 💬 |
642 | Extension Cohort | - | - | - | - | 1件: 60 60 💬 |
643 | Ezetimibe+Simvastatin Drug Combination | 2件: Ezetimibe Ezetimibe, Simvastatin | 2件: Simvastatin
Simvastatin
,
Ezetimibe
💬 | 2件: HMGCR HMGCR, NPC1L1 💬 | 5件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Fat digestion and absorption, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 49 49 💬 |
644 | FABRAZYME - 35 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE ENDOVENOSA 1 FLACONCINO | 1件: Agalsidase beta Agalsidase beta | 1件: Agalsidase beta
Agalsidase beta
💬 | 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 💬 |
645 | Factor VIII concentrate | 1件: Beroctocog alfa Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex) | - | - | - | 1件: 288 288 💬 |
646 | Factor XIII Concentrate (Human) | 1件: Factor XIII (human) Factor XIII (human) (Corifact 250) | - | - | - | 1件: 288 288 💬 |
647 | Factor XIII Concentrate (Human), Pasteurized | 1件: Factor XIII (human) Factor XIII (human) (Corifact 250) | - | - | - | 1件: 288 288 💬 |
648 | FAMPYRA - 10 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - FLACONE (HDPE) 56 COMPRESSE (4 FLACONI DA 14) | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬 | 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬 |
649 | FDL176 & FDL169 coadministration | 1件: FDL169 FDL169 | - | - | - | 1件: 299 299 💬 |
650 | FENFLURAMINE HYDROCHLORIDE (colorless) | 1件: Fenfluramine Fenfluramine | 1件: Fenfluramine
Fenfluramine
💬 | 5件: HTR1D HTR1D, HTR2A, HTR2C, SIGMAR1, SLC6A4 💬 | 10件: Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬 | 2件: 140 140, 144 💬 |
651 | Fenofibrate Combined With Ursodeoxycholic Acid | 2件: Fenofibrate Fenofibrate (Fenofibrate film coated), Ursodeoxycholic acid | 2件: Fenofibrate
Fenofibrate
,
Ursodiol
💬 | 2件: NR1H4 NR1H4, PPARA 💬 | 11件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 💬 |
652 | Ferinject or CosmoFer | - | - | - | - | 1件: 86 86 💬 |
653 | Fibrinogen (coagulation factorI) | 1件: Fibrinogen human Fibrinogen human (Coagulation Factor I) | - | - | - | 1件: 65 65 💬 |
654 | Fibrinogen concentrate | 1件: Fibrinogen human Fibrinogen human (Coagulation Factor I) | - | - | - | 1件: 14 14 💬 |
655 | Fibrinogen Concentrate from Human Plasma | 1件: Fibrinogen human Fibrinogen human (Coagulation Factor I) | - | - | - | 1件: 65 65 💬 |
656 | Fibrogammin®P, coagulation factor XIII concentrate (Human) | 1件: Factor XIII (human) Factor XIII (human) (Corifact 250) | - | - | - | 1件: 51 51 💬 |
657 | Film-coated tablet | - | - | - | - | 1件: 97 97 💬 |
658 | Fipamezole ODT Cohort 2 | 1件: Fipamezole Fipamezole | - | - | - | 1件: 6 6 💬 |
659 | FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE | 1件: Amifampridine Amifampridine | 1件: Amifampridine
Amifampridine
💬 | 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 3 3, 11 💬 |
660 | Fish oil concentrate | 1件: Fish oil Fish oil (Fish oil containing omega-3 acids) | - | - | - | 1件: 13 13 💬 |
661 | Fixed dose combination Ciprofloxacin/Celecoxib | 2件: Celecoxib Celecoxib (Consensi), Ciprofloxacin | 2件: Ciprofloxacin
Ciprofloxacin
,
Celecoxib
💬 | 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 2 2 💬 |
662 | Flaxseed lignan-enriched complex (FLC) | 1件: Flax seed Flax seed | - | - | - | 1件: 97 97 💬 |
663 | FLUDARABINA ACCORD - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 5 FLACONCINI IN VETRO DA 2 ML | 1件: Fludarabine Fludarabine | 1件: Fludarabine
Fludarabine
💬 | 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 19 19 💬 |
664 | FLUDARABINA TEVA - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 1 FLACONCINO DI VETRO DA 2 ML | 1件: Fludarabine Fludarabine | 1件: Fludarabine
Fludarabine
💬 | 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 65 65 💬 |
665 | Follow-up study of the treated cohort | - | - | - | - | 1件: 193 193 💬 |
666 | FORMISTIN - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE | - | - | - | - | 1件: 13 13 💬 |
667 | Fostamatinib 50 mg blue film-coated tablet | 1件: Fostamatinib Fostamatinib | 1件: Fostamatinib
Fostamatinib
💬 | 1件: SYK SYK 💬 | 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬 |
668 | Furosemide (14-PANEL TOXICOLOGY MEDICATED COLLECTION SYSTEM) | 1件: Furosemide Furosemide (Urinx Medicated Specimen Collection) | 1件: Furosemide
Furosemide
(14-PANEL TOXICOLOGY MEDICATED COLLECTION SYSTEM) 💬 | 1件: SLC12A2 SLC12A2 💬 | 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 2件: 6 6, 86 💬 |
669 | Furosemide Injection (14-PANEL TOXICOLOGY MEDICATED COLLECTION SYSTEM) | 1件: Furosemide Furosemide (Urinx Medicated Specimen Collection) | 1件: Furosemide
Furosemide
(14-PANEL TOXICOLOGY MEDICATED COLLECTION SYSTEM) 💬 | 1件: SLC12A2 SLC12A2 💬 | 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 1件: 6 6 💬 |
670 | FXIII Concentrate (Human) | - | - | - | - | 1件: 288 288 💬 |
671 | FXIII Concentrate (Human) (FXIII) | - | - | - | - | 1件: 288 288 💬 |
672 | G-CSF for Conditioning before HSCT. | 1件: Filgrastim Filgrastim (Granulocyte Colony Stimulating Factor) | 1件: Filgrastim
Filgrastim
💬 | 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 65 65 💬 |
673 | Gaboxadol monohydrate 0.5 mg (intended commercial formulation) | 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol
Gaboxadol
💬 | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 💬 |
674 | Gaboxadol monohydrate 2 mg (intended commercial formulation) | 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol
Gaboxadol
💬 | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 💬 |
675 | Gaboxadol monohydrate 5 mg (intended commercial formulation) | 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol
Gaboxadol
💬 | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 💬 |
676 | Gadolinium contrast | 1件: Gadolinium Gadolinium | - | - | - | 1件: 34 34 💬 |
677 | Gadolinium-based contrast | 1件: Gadolinium Gadolinium | - | - | - | 1件: 13 13 💬 |
678 | GAZYVARO - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO - 1000MG/40ML - 1 FLACONCINO | 1件: Obinutuzumab Obinutuzumab | 1件: Obinutuzumab
Obinutuzumab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 💬 |
679 | Gelatin (Asini corii collas) | 1件: Gelatin Gelatin (Sulfur Colloid) | 2件: Gelatin
Gelatin
,
Donkey glue
(Asini corii collas) 💬 | - | - | 5件: 28 28, 62, 78, 97, 269 💬 |
680 | General Corticotherapy | - | - | - | - | 1件: 35 35 💬 |
681 | Genetically corrected cultured epidermal autograft (ATMP) | - | - | - | - | 1件: 36 36 💬 |
682 | GENOTROPIN (Somatropin) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference is that GENOTROPIN is man-made. | 1件: Somatotropin Somatotropin | - | - | - | 1件: 193 193 💬 |
683 | Glatiramer Acetate (Copaxone®) | 2件: Acetate Acetate, Glatiramer (Copolymer-1) | - | - | - | 2件: 13 13, 156 💬 |
684 | Glatiramer acetate 150mg enteric coated tablets | 2件: Acetate Acetate, Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
685 | Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets | 2件: Acetate Acetate, Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
686 | Glatiramer acetate, (Copaxone®) | 2件: Acetate Acetate, Glatiramer (Copolymer-1) | - | - | - | 1件: 13 13 💬 |
687 | Glentek 50 mg compresse rivestite con film | - | - | - | - | 1件: 18 18 💬 |
688 | Glentek 50 mg film-coated tablets | - | - | - | - | 1件: 18 18 💬 |
689 | GLIVEC 100 mg comprimidos recubiertos con película | 1件: Imatinib Imatinib | 1件: Imatinib
Imatinib
💬 | 3件: ABL1 ABL1, KIT, PDGFRA 💬 | 32件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 2件: 34 34, 86 💬 |
690 | GLIVEC 400 mg comprimidos recubiertos con película | 1件: Imatinib Imatinib | 1件: Imatinib
Imatinib
💬 | 3件: ABL1 ABL1, KIT, PDGFRA 💬 | 32件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 34 34 💬 |
691 | Global DNA methylation will be quantified in the DNA samples by colorimetry | - | - | - | - | 1件: 63 63 💬 |
692 | GLPG3970 film-coated tablet | - | - | - | - | 1件: 49 49 💬 |
693 | Glucocorticoid (prednisone or prednisolone) (Delta-cortef (TN)) | 2件: Prednisolone Prednisolone, Prednisone (Contrast Allergy PreMed Pack) | 2件: Prednisolone
Prednisolone
(Delta-cortef (TN)),
Prednisone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 💬 |
694 | Glucocorticoid combined with cyclophosphamide induction + maintenance | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | 1件: 222 222 💬 |
695 | GM-CSF (granulocyte-macrophage colony-stimulating factor, sargramostim) | 1件: Sargramostim Sargramostim (Recombinant human granulocyte-macrophage colony stimulating factor) | 1件: Sargramostim
Sargramostim
💬 | 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 229 229 💬 |
696 | Granulocyte - colony stimulating factor (G-CSF) | 1件: Filgrastim Filgrastim (Granulocyte Colony Stimulating Factor) | 1件: Filgrastim
Filgrastim
💬 | 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 2 2 💬 |
697 | Granulocyte Colony Stimulating Factor | 1件: Filgrastim Filgrastim (Granulocyte Colony Stimulating Factor) | 1件: Filgrastim
Filgrastim
💬 | 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 6件: 2 2, 28, 36, 57, 65, 85 💬 |
698 | Granulocyte colony stimulating factor (G-CSF) | 1件: Filgrastim Filgrastim (Granulocyte Colony Stimulating Factor) | 1件: Filgrastim
Filgrastim
💬 | 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 65 65 💬 |
699 | Granulocyte Colony Stimulating Factor (GCSF) | 1件: Filgrastim Filgrastim (Granulocyte Colony Stimulating Factor) | 1件: Filgrastim
Filgrastim
💬 | 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 2件: 36 36, 57 💬 |
700 | Granulocyte Colony-Stimulating Factor | - | - | - | - | 1件: 296 296 💬 |
701 | Granulocyte colony-stimulating factor (Filgrastim) | 1件: Filgrastim Filgrastim (Granulocyte Colony Stimulating Factor) | 1件: Filgrastim
Filgrastim
💬 | 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 113 113 💬 |
702 | Granulocyte-colony stimulating factor (G-CSF) and prednisone | 2件: Filgrastim Filgrastim (Granulocyte Colony Stimulating Factor), Prednisone (Contrast Allergy PreMed Pack) | 2件: Prednisone
Prednisone
,
Filgrastim
💬 | 2件: CSF3R CSF3R, NR3C1 💬 | 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 13 13 💬 |
703 | Granulocyte-macrophage colony stimulating factor (GM-CSF) | - | - | - | - | 1件: 229 229 💬 |
704 | Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) | - | - | - | - | 1件: 11 11 💬 |
705 | Group 1- Control Diet | - | - | - | - | 1件: 97 97 💬 |
706 | Group C meningococcal conjugate vaccine | - | - | - | - | 1件: 14 14 💬 |
707 | GSK1265744B (sodium salt) containing 14C-GSK1265744B | - | - | - | - | 1件: 265 265 💬 |
708 | H.P. Acthar Gel (repository corticotropin injection) | 1件: Corticotropin Corticotropin | 1件: Corticotropin
Corticotropin
💬 | 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 13 13 💬 |
709 | H02 - Corticosteroidi Sistemici | - | - | - | - | 1件: 299 299 💬 |
710 | Haemate P® (Human Coagulation Factor VIII) | 2件: Antihemophilic factor human Antihemophilic factor human (Wilate - von Willebrand Factor/Coagulation Factor VIII Complex), Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex) | - | - | - | 1件: 288 288 💬 |
711 | HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE) | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) | - | - | - | 2件: 13 13, 14 💬 |
712 | Haemophilus type b vaccine (conjugated) | - | - | - | - | 1件: 14 14 💬 |
713 | Haplo/cord transplant | - | - | - | - | 1件: 60 60 💬 |
714 | HCQ/CQ and CAB combined treatment | - | - | - | - | 1件: 74 74 💬 |
715 | Helium / oxygen mixed gas inhalation therapy (COMPRESSED OXYGEN) | 2件: Helium Helium (Co-HE-O2-N2 Mixture), Oxygen (Compressed Oxidizing) | 2件: Oxygen
Oxygen
(COMPRESSED OXYGEN),
Helium
💬 | - | - | 1件: 330 330 💬 |
716 | High dose vehicle control | - | - | - | - | 1件: 46 46 💬 |
717 | High water intake (Purified water in containers (JP18)) | 1件: Water Water (FIRST AID Contains 202 PIECES) | 1件: Water
Water
(Purified water in containers (JP18)) 💬 | - | - | 1件: 67 67 💬 |
718 | Hiomega-3 supplement of Naturalis® company - | - | - | - | - | 1件: 49 49 💬 |
719 | HMG-Coenzyme inhibitor (statin) | - | - | - | - | 1件: 218 218 💬 |
720 | Horse chestnut (Conker tree) | 1件: Horse chestnut Horse chestnut | 1件: Horse chestnut
Horse chestnut
(Conker tree) 💬 | - | - | 1件: 210 210 💬 |
721 | HOV-12020 (Palm tocotrienols complex) | - | - | - | - | 1件: 124 124 💬 |
722 | HUMAN COAGULATION FACTOR VIII | 2件: Antihemophilic factor human Antihemophilic factor human (Wilate - von Willebrand Factor/Coagulation Factor VIII Complex), Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex) | - | - | - | 1件: 288 288 💬 |
723 | Human coagulation Factor VIII / von Willebrand Factor | 3件: Antihemophilic factor human Antihemophilic factor human (Wilate - von Willebrand Factor/Coagulation Factor VIII Complex), Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex), Von Willebrand factor human (Factor con Willebrand) | - | - | - | 1件: 288 288 💬 |
724 | Human coagulation factor VIII associated with Von Willebrand factor (VWF) | 3件: Antihemophilic factor human Antihemophilic factor human (Wilate - von Willebrand Factor/Coagulation Factor VIII Complex), Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex), Von Willebrand factor human (Factor con Willebrand) | - | - | - | 1件: 288 288 💬 |
725 | Human Coagulation Factor VIII, Von Willebrand Factor | 3件: Antihemophilic factor human Antihemophilic factor human (Wilate - von Willebrand Factor/Coagulation Factor VIII Complex), Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex), Von Willebrand factor human (Factor con Willebrand) | - | - | - | 1件: 288 288 💬 |
726 | HUMAN COAGULATION FACTOR VIII, VON WILLEBRAND FACTOR COMPLEX | 3件: Antihemophilic factor human Antihemophilic factor human (Wilate - von Willebrand Factor/Coagulation Factor VIII Complex), Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex), Von Willebrand factor human (Factor con Willebrand) | - | - | - | 1件: 288 288 💬 |
727 | HUMAN COAGULATION FACTOR VIII, VON WILLEBRAND HUMAN COAGULATION FACTOR | 2件: Antihemophilic factor human Antihemophilic factor human (Wilate - von Willebrand Factor/Coagulation Factor VIII Complex), Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex) | - | - | - | 1件: 288 288 💬 |
728 | Human Coagulation FACTOR X | 1件: Coagulation factor X human Coagulation factor X human | - | - | - | 1件: 288 288 💬 |
729 | Human Fibrinogen Concentrate | 1件: Fibrinogen human Fibrinogen human (Coagulation Factor I) | - | - | - | 1件: 65 65 💬 |
730 | Human monoclonal antibody directed against complement 5 protein | - | - | - | - | 1件: 62 62 💬 |
731 | Human Umbilical Cord Blood-derived Mesenchymal Stem Cells | - | - | - | - | 1件: 36 36 💬 |
732 | Human umbilical cord derived MSC transplantation for SLE | - | - | - | - | 1件: 49 49 💬 |
733 | Human umbilical cord mesenchymal stem cell injection | - | - | - | - | 1件: 85 85 💬 |
734 | Human Umbilical Cord Mesenchymal Stem Cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 3件: 13 13, 96, 113 💬 |
735 | Human umbilical cord mesenchymal stem cells (UC-MSCs) | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 96 96 💬 |
736 | Human umbilical cord-derived MSCs | - | - | - | - | 1件: 271 271 💬 |
737 | Human von Willebrand factor (VWF) and coagulation factor VIII (FVIII) | 2件: Beroctocog alfa Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex), Von Willebrand factor human (Factor con Willebrand) | - | - | - | 1件: 288 288 💬 |
738 | Human VWF/FVIII concentrate | - | - | - | - | 1件: 288 288 💬 |
739 | Hydrocortisone (Colocort (TN)) | 2件: Hydrocortisone Hydrocortisone (Cortane-B), Hydrocortisone acetate (Super Cortisone) | 2件: Hydrocortisone
Hydrocortisone
(Colocort (TN)),
Hydrocortisone acetate
(Cortifoam (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 10件: 6 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 💬 |
740 | Hydrocortisone (Solucortef) (Colocort (TN)) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
741 | Hydrocortisone 100mg/ml (Colocort (TN)) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 💬 |
742 | Hydrocortisone 10mg (Colocort (TN)) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬 |
743 | Hydrocortisone 10mg Tablet (Colocort (TN)) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
744 | Hydrocortisone 10mg Tablets (Colocort (TN)) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
745 | Hydrocortisone 20mg Tablets (Colocort (TN)) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
746 | HYDROCORTISONE ACETATE (Colocort (TN)) | 3件: Acetate Acetate, Hydrocortisone (Cortane-B), Hydrocortisone acetate (Super Cortisone) | 2件: Hydrocortisone
Hydrocortisone
(Colocort (TN)),
Hydrocortisone acetate
(Cortifoam (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬 |
747 | Hydrocortisone cream (Colocort (TN)) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬 |
748 | Hydrocortisone cream 1% (Colocort (TN)) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬 |
749 | Hydrocortisone cream 10mg/g FNA Fagron (Colocort (TN)) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬 |
750 | HYDROCORTISONE HYDROGEN SUCCINATE (Colocort (TN)) | 3件: Hydrocortisone Hydrocortisone (Cortane-B), Hydrocortisone succinate (Solu-Cortef), Hydrogen | 2件: Hydrocortisone
Hydrocortisone
(Colocort (TN)),
Hydrocortisone succinate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 💬 |
751 | HYDROCORTISONE MICRONIZED (Colocort (TN)) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
752 | Hydrocortisone Modified Release Capsules (Colocort (TN)) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
753 | HYDROCORTISONE ROUSSEL (Colocort (TN)) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 💬 |
754 | Hydrocortisone sodium acetate (Colocort (TN)) | 3件: Acetate Acetate, Hydrocortisone (Cortane-B), Sodium acetate (D12046 Conc Electrolyte Renal Dialysis) | 2件: Hydrocortisone
Hydrocortisone
(Colocort (TN)),
Sodium acetate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
755 | HYDROCORTISONE SODIUM PHOSPHATE (Colocort (TN)) | 2件: Hydrocortisone Hydrocortisone (Cortane-B), Phosphate ion | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 53 53, 81, 83 💬 |
756 | HYDROCORTISONE SODIUM SUCCINATE (Colocort (TN)) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 81 81, 83, 97 💬 |
757 | Hydrocortisone tablet 2.5 mg (Colocort (TN)) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
758 | Hydrocortisone TAKEDA, tabletter (Colocort (TN)) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 78 78 💬 |
759 | HYDROCORTISONE- hydrocortisone tablet (Colocort (TN)) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
760 | Hyperglycemic Clamp with concurrent GIP infusion | - | - | - | - | 1件: 299 299 💬 |
761 | Hyperglycemic clamp with concurrent GLP-1 infusion | - | - | - | - | 1件: 299 299 💬 |
762 | Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF) Treatment | 1件: Xenon Xenon | 2件: Xenon
Xenon
,
Xenon Xe 133
💬 | - | - | 1件: 85 85 💬 |
763 | Hyperpolarized 129 Xenon Gas Comparing Progressive Pulmonary Fibrosis Treatment | 1件: Xenon Xenon | 2件: Xenon
Xenon
,
Xenon Xe 133
💬 | - | - | 1件: 85 85 💬 |
764 | IC Cocktail | - | - | - | - | 1件: 226 226 💬 |
765 | Idebenone 150 mg film-coated tablets | 1件: Idebenone Idebenone | 1件: Idebenone
Idebenone
💬 | - | - | 1件: 113 113 💬 |
766 | Identification of COMT HH, COMT HL or COMT LL genes | - | - | - | - | 1件: 6 6 💬 |
767 | Immunosuppression Only Conditioning | - | - | - | - | 1件: 65 65 💬 |
768 | Immunosuppression Only Conditioning -Closed with amendment L | - | - | - | - | 1件: 65 65 💬 |
769 | In-vitro approach concerning 25 patients | - | - | - | - | 2件: 102 102, 299 💬 |
770 | INALOSSIN - 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO BOMBOLA IN ALLUMINIO CON VALVOLA VI DA 20 LITRI | - | - | - | - | 1件: 294 294 💬 |
771 | INALOSSIN 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO | - | - | - | - | 1件: 294 294 💬 |
772 | INFLECTRA - 100 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 1 FLACONCINO | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 56 56 💬 |
773 | Inflectra 100 mg powder for concentrate for solution for infusion | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬 |
774 | Infliximab and azathioprine combination at week 0 | 2件: Azathioprine Azathioprine, Infliximab | 2件: Azathioprine
Azathioprine
,
Infliximab
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬 |
775 | Infliximab and azathioprine combination at week 14 | 2件: Azathioprine Azathioprine, Infliximab | 2件: Azathioprine
Azathioprine
,
Infliximab
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬 |
776 | Infliximab Control | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
777 | Inhibace/Cozaar | - | - | - | - | 1件: 66 66 💬 |
778 | Injection of Umbilical cord derived MSCs | - | - | - | - | 1件: 6 6 💬 |
779 | INN COLECALCIFEROL | 1件: Cholecalciferol Cholecalciferol (natelle COMPLETE) | 1件: Cholecalciferol
Cholecalciferol
(Colecalciferol (INN)) 💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 13 13 💬 |
780 | INTELENCE - 200 MG - COMPRESSA -USO ORALE - FLACONE (HDPE) 60 COMPRESSE | 1件: Etravirine Etravirine | 1件: Etravirine
Etravirine
💬 | - | - | 1件: 18 18 💬 |
781 | Intra-articular Compound Betamethasone | 1件: Betamethasone Betamethasone (Betamethasone Combo 6mg/mL PF) | 1件: Betamethasone
Betamethasone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬 |
782 | Intra-articular corticosteroid injection | - | - | - | - | 1件: 46 46 💬 |
783 | Intravenous methyl prednisolone (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 43 43 💬 |
784 | Iron sucrose (Sugar, compressible (NF)) | 3件: Iron Iron (Concept DHA), Iron sucrose (Iron sucrose complex), Sucrose | 2件: Sucrose
Sucrose
(Sugar, compressible (NF)),
Iron sucrose
💬 | - | - | 3件: 62 62, 96, 97 💬 |
785 | Iron sulphate 200mg coated tablets | 1件: Iron Iron (Concept DHA) | - | - | - | 2件: 96 96, 97 💬 |
786 | Iron(III)- hydroxide dextran complex | 3件: Dextran Dextran (Visine for Red Eye Cool), Hydroxide ion, Iron (Concept DHA) | 1件: Dextran 1
Dextran 1
💬 | - | - | 2件: 96 96, 97 💬 |
787 | Isotonic sodium chloride solution (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 1件: 34 34 💬 |
788 | IV Corticosteroid | - | - | - | - | 1件: 97 97 💬 |
789 | JINARC - 15 MG +45 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28X15 MG + 28 X 45 MG) | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬 | 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬 |
790 | JINARC - 15 MG - COMPRESSA - USO ORALE - BLISTER (ALU/PVC) - 28 COMPRESSE | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬 | 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬 |
791 | JINARC - 30 MG + 60 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28 X 30 MG + 28 X 60 MG) | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬 | 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬 |
792 | JINARC - 30 MG +90 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28 X 30 MG + 28 X 90 MG) | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬 | 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬 |
793 | JINARC - 30 MG - COMPRESSA - USO ORALE - BLISTER (ALU/PVC) - 28 COMPRESSE | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬 | 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬 |
794 | JNJ-38518168-ZBQ - film-coated tablet - 10 mg | - | - | - | - | 1件: 46 46 💬 |
795 | JNJ-38518168-ZBQ - film-coated tablet - 10mg | - | - | - | - | 1件: 46 46 💬 |
796 | JNJ-38518168-ZBQ - film-coated tablet - 3 mg | - | - | - | - | 1件: 46 46 💬 |
797 | JNJ-38518168-ZBQ - film-coated tablet - 30 mg | - | - | - | - | 1件: 46 46 💬 |
798 | JNJ-38518168-ZBQ - film-coated tablet - 30mg | - | - | - | - | 1件: 46 46 💬 |
799 | JNJ-38518168-ZBQ - film-coated tablet - 3mg | - | - | - | - | 1件: 46 46 💬 |
800 | JNJ-39758979-AAC - enteric coated tablet - 10 mg | - | - | - | - | 1件: 46 46 💬 |
801 | JNJ-39758979-AAC - enteric coated tablet - 100 mg | - | - | - | - | 1件: 46 46 💬 |
802 | JNJ-39758979-AAC - enteric coated tablet - 30 mg | - | - | - | - | 1件: 46 46 💬 |
803 | Jorveza 0.5 mg compresse orodispersibili | 1件: Budesonide Budesonide (Cortiment) | 1件: Budesonide
Budesonide
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬 |
804 | Jorveza 1 mg compresse orodispersibili | 1件: Budesonide Budesonide (Cortiment) | 1件: Budesonide
Budesonide
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬 |
805 | Jyseleca 100 mg film-coated tablets | 1件: Filgotinib Filgotinib | 1件: Filgotinib
Filgotinib
💬 | 1件: JAK1 JAK1 💬 | 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬 |
806 | Jyseleca 200 mg film-coated tablets | 1件: Filgotinib Filgotinib | 1件: Filgotinib
Filgotinib
💬 | 1件: JAK1 JAK1 💬 | 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬 |
807 | Kalydeco 150 mg film-coated tablets | 1件: Ivacaftor Ivacaftor | 1件: Ivacaftor
Ivacaftor
💬 | 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬 |
808 | KVD824 300 mg Compresse a rilascio modificato | - | - | - | - | 1件: 65 65 💬 |
809 | KVD900 100 mg Film Coated Tablet | - | - | - | - | 1件: 65 65 💬 |
810 | KVD900 300 mg Film Coated Tablet | - | - | - | - | 1件: 65 65 💬 |
811 | L01X CO2 | - | - | - | - | 1件: 46 46 💬 |
812 | L04AA04 - IMMUNOGLOBULINA ANTITIMOCITARIA (DI CONIGLIO) IMMUNOGLOBULINA DI CONIGLIO ANTITIMOCITI UMANI THYMOGLOBULINE | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | 1件: 13 13 💬 |
813 | Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers | 1件: Lactobacillus acidophilus Lactobacillus acidophilus | 1件: Lactomin
Lactomin
💬 | - | - | 1件: 6 6 💬 |
814 | Lactose in water (Purified water in containers (JP18)) | 2件: Lactose Lactose, Water (FIRST AID Contains 202 PIECES) | 3件: Water
Water
(Purified water in containers (JP18)),
Anhydrous lactose
,
Lactose
💬 | - | - | 1件: 97 97 💬 |
815 | Lap TAP Bupivacaine/Epinephrine (CERTA DOSE EPINEPHRINE CONVENIENCE KIT) | 2件: Bupivacaine Bupivacaine (Cortaren Corticosteroid/Anti-Inflammatory System), Epinephrine (Gingi-pak Cotton Coil) | 2件: Epinephrine
Epinephrine
(CERTA DOSE EPINEPHRINE CONVENIENCE KIT),
Bupivacaine
💬 | 14件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 96 96 💬 |
816 | Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP | 5件: Dapsone Dapsone, Mycophenolate mofetil (Co Mycophenolate), Mycophenolic acid, Prednisolone, Triamcinolone (Kirkland Signature Aller Cort) | 5件: Triamcinolone
Triamcinolone
,
Prednisolone
(Delta-cortef (TN)),
Dapsone
,
Mycophenolate mofetil
,
Mycophenolic acid
💬 | 3件: IMPDH1 IMPDH1, IMPDH2, NR3C1 💬 | 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬 | 1件: 162 162 💬 |
817 | Lentiviral vector containing ABCA4 gene | - | - | - | - | 1件: 301 301 💬 |
818 | Lentiviral vector containing MYO7A gene | - | - | - | - | 2件: 90 90, 303 💬 |
819 | Lentiviral vector containing the human MY07A gene | - | - | - | - | 2件: 90 90, 303 💬 |
820 | Levodopa CR (controlled release) | 1件: Levodopa Levodopa (Corbilta) | 1件: Levodopa
Levodopa
💬 | 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
821 | Levodopa, carbidopa, entacapone (Comtan (TN)) | 3件: Carbidopa Carbidopa (Corbilta), Entacapone (Comtan), Levodopa (Corbilta) | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
(Comtan (TN)) 💬 | 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
822 | Levodopa, decarboxylase inhibitor and COMT inhibitor | 1件: Levodopa Levodopa (Corbilta) | 1件: Levodopa
Levodopa
💬 | 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
823 | Levodopa-carbidopa-entacapone (Comtan (TN)) | 3件: Carbidopa Carbidopa (Corbilta), Entacapone (Comtan), Levodopa (Corbilta) | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
(Comtan (TN)) 💬 | 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
824 | Levodopa/carbidopa/entacapone (Comtan (TN)) | 3件: Carbidopa Carbidopa (Corbilta), Entacapone (Comtan), Levodopa (Corbilta) | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
(Comtan (TN)) 💬 | 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
825 | Lidocaine 2% without vessel constrictor | 1件: Lidocaine Lidocaine (Cool and Heat Evora Labs) | 2件: Lidocaine
Lidocaine
,
Lidocaine hydrochloride monohydrate
💬 | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 51 51 💬 |
826 | Linaclotide (Constella (TN)) | 1件: Linaclotide Linaclotide (Constella) | 1件: Linaclotide
Linaclotide
(Constella (TN)) 💬 | 1件: GUCY2C GUCY2C 💬 | 2件: Metabolic pathways Metabolic pathways, Purine metabolism 💬 | 2件: 6 6, 97 💬 |
827 | Lipasa ácida lisosómica, esterasa, colesterol (gen humano LIPA), lipasa ácida lisosómica (gen humano LIPA) | - | - | - | - | 1件: 19 19 💬 |
828 | Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules | 1件: Lactobacillus delbrueckii bulgaricus Lactobacillus delbrueckii bulgaricus | - | - | - | 1件: 6 6 💬 |
829 | Lo-Ovral Oral Contraceptive Pills | - | - | - | - | 1件: 60 60 💬 |
830 | Locally approved intravenous contrast medium for contrast enhanced magnetic resonance imaging (MRI) | - | - | - | - | 1件: 13 13 💬 |
831 | Lodotra (delayed release prednisolone) (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬 |
832 | Long-circulating liposomal prednisolone (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬 |
833 | Low antigen content diet | - | - | - | - | 1件: 66 66 💬 |
834 | Low copper diet | 1件: Copper Copper | - | - | - | 1件: 171 171 💬 |
835 | Low dose prednisolone (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 💬 |
836 | Low dose vehicle control | - | - | - | - | 1件: 46 46 💬 |
837 | LUM/IVA fixed-dose combination | - | - | - | - | 1件: 299 299 💬 |
838 | Lumacaftor Plus Ivacaftor Combination | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: Ivacaftor
Ivacaftor
,
Lumacaftor
💬 | 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬 |
839 | Lumacaftor, Ivacaftor Drug Combination | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: Ivacaftor
Ivacaftor
,
Lumacaftor
💬 | 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬 |
840 | LZRSE-Col7A1 Engineered Autologous Epidermal Sheets | - | - | - | - | 1件: 36 36 💬 |
841 | MABCAMPATH 10 mg/ml concentrado para solución para perfusión | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 1件: 13 13 💬 |
842 | MabThera 100 mg concentrate for solution for infusion | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 💬 |
843 | MabThera 500 mg (10 mg/ml) concentrate for solution for infusion | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
844 | MABTHERA 500 mg concentrado para solución para perfusión | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
845 | MabThera 500 mg concentrate for solution for infusion | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 46 46, 222 💬 |
846 | MabThera®, 100 mg Concentrado para solución para perfusión | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
847 | MabThera®, 100 mg concentrate for solution for infusion | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
848 | Macimorelin Consilient Health | 1件: Macimorelin Macimorelin | 1件: Macimorelin
Macimorelin
💬 | 1件: GHSR GHSR 💬 | 3件: Growth hormone synthesis, secretion and action Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 78 78 💬 |
849 | MACITENTAN COMPRESSE | 1件: Macitentan Macitentan | 1件: Macitentan
Macitentan
💬 | 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 88 💬 |
850 | Magnesium sulfate (Conclyte-Mg (TN)) | 3件: Magnesium Magnesium (Omega-3 Rx Complete), Magnesium sulfate (Concept OB), Sulfate ion | 1件: Magnesium sulfate
Magnesium sulfate
(Conclyte-Mg (TN)) 💬 | - | - | 3件: 11 11, 296, 297 💬 |
851 | Marketed plasma-derived VWF/FVIII concentrate | - | - | - | - | 1件: 288 288 💬 |
852 | MAVENCLAD - 10 MG - COMPRESSA - USO ORALE - BLISTER (AL/AL) - 6 COMPRESSE | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬 | 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬 |
853 | Mayzent 2 mg film-coated tablets | 1件: Siponimod Siponimod | 1件: Siponimod
Siponimod
💬 | 2件: S1PR1 S1PR1, S1PR5 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬 |
854 | Medical Air vs Oxygen (COMPRESSED OXYGEN) | 2件: Medical air Medical air, Oxygen (Compressed Oxidizing) | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN) 💬 | - | - | 1件: 193 193 💬 |
855 | Medical Grade Oxygen (COMPRESSED OXYGEN) | 1件: Oxygen Oxygen (Compressed Oxidizing) | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN) 💬 | - | - | 1件: 299 299 💬 |
856 | Medium dose prednisolone (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 💬 |
857 | MEDROL - 4 MG COMPRESSE 30 COMPRESSE | - | - | - | - | 1件: 56 56 💬 |
858 | MENINGOCOCCAL GROUP A OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (beta197) M8 (CRM197) PROTEIN | 2件: Corynebacterium diphtheriae Corynebacterium diphtheriae, Corynebacterium diphtheriae CRM197 protein | - | - | - | 1件: 11 11 💬 |
859 | MENINGOCOCCAL GROUP A OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (ß197) M8 (CRM197) PROTEIN | 2件: Corynebacterium diphtheriae Corynebacterium diphtheriae, Corynebacterium diphtheriae CRM197 protein | - | - | - | 1件: 11 11 💬 |
860 | MENINGOCOCCAL GROUP W OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (beta197) M8 (CRM197) PROTEIN | 2件: Corynebacterium diphtheriae Corynebacterium diphtheriae, Corynebacterium diphtheriae CRM197 protein | - | - | - | 1件: 11 11 💬 |
861 | MENINGOCOCCAL GROUP W OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (ß197) M8 (CRM197) PROTEIN | 2件: Corynebacterium diphtheriae Corynebacterium diphtheriae, Corynebacterium diphtheriae CRM197 protein | - | - | - | 1件: 11 11 💬 |
862 | MENINGOCOCCAL GROUP Y OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (Â197) M8 (CRM197) PROTEIN | 2件: Corynebacterium diphtheriae Corynebacterium diphtheriae, Corynebacterium diphtheriae CRM197 protein | - | - | - | 1件: 11 11 💬 |
863 | Meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent) | - | - | - | - | 1件: 13 13 💬 |
864 | MENVEO - POLV.E SOLUZ.PER SOLUZ. INIETT.-USO INTRAMUSCOLARE-COMP. CONIUG.LIOFILIZZ.MENA:FLAC.(VETRO) COMP. GONIUG.LIQUI.MENCWY:FLAC.(VETRO)-1 FLAC+1FLAC | 9件: Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine, Meningococcal polysaccharide vaccine group A (Menomune - A/c/y/w-135 Combined), Meningococcal polysaccharide vaccine group C (Meningococcal group CCRM197 conjugate vaccine), Meningococcal polysaccharide vaccine group W-135 (Menomune - A/c/y/w-135 Combined), Meningococcal polysaccharide vaccine group Y (Menomune - A/c/y/w-135 Combined), Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen, Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen, Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen, Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen | 2件: Meningococcal polysaccharide vaccine group A
Meningococcal polysaccharide vaccine group A
,
Meningococcal polysaccharide vaccine group C
💬 | - | - | 2件: 62 62, 66 💬 |
865 | Mesalazine with hydrocortisone sodium succinate (Colocort (TN)) | 2件: Hydrocortisone Hydrocortisone (Cortane-B), Mesalazine (Salofalk 5-asa Enteric Coated Tab- 250mg) | 2件: Hydrocortisone
Hydrocortisone
(Colocort (TN)),
Mesalamine
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬 |
866 | Metformin and clemastine in combination | 2件: Clemastine Clemastine, Metformin (Competact) | 2件: Clemastine
Clemastine
,
Metformin
💬 | 3件: HRH1 HRH1, PRKAA1, PRKAA2 💬 | 23件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Calcium signaling pathway, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Inflammatory mediator regulation of TRP channels, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 13 13 💬 |
867 | METFORMINA - 500 30 COMPRESSE 500 MG | 1件: Metformin Metformin (Competact) | 1件: Metformin
Metformin
💬 | 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 113 113 💬 |
868 | Methotrexate - etanercept - prednisolone arm (Delta-cortef (TN)) | 3件: Etanercept Etanercept, Methotrexate, Prednisolone | 3件: Methotrexate
Methotrexate
,
Prednisolone
(Delta-cortef (TN)),
Etanercept
💬 | 5件: DHFR DHFR, DHFR2, LTA, NR3C1, TNF 💬 | 72件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 107 💬 |
869 | Methyl prednisolone (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 43 43, 49, 96 💬 |
870 | Methylmalonyl-coenzyme A | 2件: (R)-methylmalonyl-CoA (R)-methylmalonyl-CoA, Coenzyme A | - | - | - | 1件: 246 246 💬 |
871 | Methylphenidate, fluoxetin, risperidone (RISPERDAL CONSTA) | 3件: Fluoxetine Fluoxetine, Methylphenidate (Concerta), Risperidone (Risperdal Consta) | 3件: Fluoxetine
Fluoxetine
,
Risperidone
(RISPERDAL CONSTA),
Methylphenidate
💬 | 5件: DRD2 DRD2, HTR2A, SLC6A2, SLC6A3, SLC6A4 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway 💬 | 2件: 179 179, 206 💬 |
872 | Methylprednisolone or Prednisolone (Delta-cortef (TN)) | 2件: Methylprednisolone Methylprednisolone, Prednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 65 65 💬 |
873 | METOCLOPRAMIDE ACCORD - 10 MG COMPRESSE 28 COMPRESSE IN BLISTER PVC/PVDC/AL | 1件: Metoclopramide Metoclopramide | 1件: Metoclopramide
Metoclopramide
💬 | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 51 51 💬 |
874 | Metopirone 250 mg capsules/ Cormeto | 1件: Metyrapone Metyrapone | 1件: Metyrapone
Metyrapone
💬 | 1件: CYP11B1 CYP11B1 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬 | 1件: 75 75 💬 |
875 | Metopirone 250 mg capsules/Cormeto | 1件: Metyrapone Metyrapone | 1件: Metyrapone
Metyrapone
💬 | 1件: CYP11B1 CYP11B1 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬 | 1件: 75 75 💬 |
876 | METOTREXATO SANDOZ - 2.5 MG COMPRESSE 50 COMPRESSE IN FLACONE PP | 1件: Methotrexate Methotrexate | 1件: Methotrexate
Methotrexate
💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
877 | METOTREXATO-LEDERLE 2,5 MG COMPRIMIDOS | 1件: Methotrexate Methotrexate | 1件: Methotrexate
Methotrexate
💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
878 | Microgynon® 30 (Oral contraceptive) | - | - | - | - | 1件: 46 46 💬 |
879 | Minibody against CD8 conjugated to desferrioxamine labeled with zirconium Zr 89 | 1件: Deferoxamine Deferoxamine | 1件: Deferoxamine
Deferoxamine
💬 | - | - | 2件: 51 51, 53 💬 |
880 | Minocycline 100 mg Film-coated Tablets | 1件: Minocycline Minocycline | 1件: Minocycline
Minocycline
💬 | - | - | 1件: 13 13 💬 |
881 | Moderna COVID-19 Vaccine | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: Elasomeran
Elasomeran
(COVID-19 mRNA vaccine (nucleotide modified)) 💬 | - | - | 1件: 46 46 💬 |
882 | Modified cobratoxin | - | - | - | - | 1件: 20 20 💬 |
883 | Modified mRNA encoding human methylmalonyl-coenzyme A mutase | 2件: (R)-methylmalonyl-CoA (R)-methylmalonyl-CoA, Coenzyme A | - | - | - | 1件: 246 246 💬 |
884 | Monovalent [B.1.351] CoV2 preS dTM-AS03 | - | - | - | - | 7件: 13 13, 35, 46, 49, 50, 51, 107 💬 |
885 | MRI contrast-enhancing preparations | - | - | - | - | 1件: 13 13 💬 |
886 | MRNA che codifica l’enzima umano deramificante del glicogeno formulato in una nanopaticella lipidica | - | - | - | - | 1件: 257 257 💬 |
887 | MRNA COVD19 vaccine | - | - | - | - | 3件: 49 49, 53, 271 💬 |
888 | Myeloablative conditioning regimen | - | - | - | - | 1件: 164 164 💬 |
889 | Myeloablative Conditioning-Closed with amendment L | - | - | - | - | 1件: 65 65 💬 |
890 | Myozyme 50 mg powder for concentrate for solution for infusion | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: Alglucosidase alfa
Alglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
891 | Méthotrexate Bellon Comprimé | 1件: Methotrexate Methotrexate | 1件: Methotrexate
Methotrexate
💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 271 271 💬 |
892 | N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO | - | - | - | - | 1件: 11 11 💬 |
893 | N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 ADSORBED ON ALUMINUM HYDROXIDE | 5件: Aluminium Aluminium, Aluminum hydroxide (AHC Premium Intense Contour Balm), Corynebacterium diphtheriae, Corynebacterium diphtheriae CRM197 protein, Hydroxide ion | 1件: Aluminum hydroxide
Aluminum hydroxide
💬 | - | - | 1件: 11 11 💬 |
894 | N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197 | 1件: Corynebacterium diphtheriae CRM197 protein Corynebacterium diphtheriae CRM197 protein | - | - | - | 1件: 13 13 💬 |
895 | Nadolol (Corgard (TN)) | 1件: Nadolol Nadolol (Corgard Tab 160mg) | 1件: Nadolol
Nadolol
(Corgard (TN)) 💬 | 2件: ADRB1 ADRB1, ADRB2 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬 |
896 | National Drug Code: 59762-0074 | - | - | - | - | 1件: 81 81 💬 |
897 | Nebulized combination ipratropium bromide with salbutamol | 2件: Ipratropium Ipratropium (Teva-combo Sterinebs), Salbutamol (Teva-combo Sterinebs) | 1件: Albuterol
Albuterol
💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
898 | NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED WITH TETANUS TOXOID CARRIER PROTEIN | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) | - | - | - | 1件: 50 50 💬 |
899 | NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETA | 1件: Triethylenetetramine Triethylenetetramine | - | - | - | 1件: 50 50 💬 |
900 | NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) | - | - | - | 1件: 50 50 💬 |
901 | Neoral soft gelatin capsules (Asini corii collas) | 2件: Cyclosporine Cyclosporine, Gelatin (Sulfur Colloid) | 3件: Gelatin
Gelatin
,
Cyclosporine
,
Donkey glue
(Asini corii collas) 💬 | 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 97 97, 269 💬 |
902 | NERIXIA*INFUS IV CONC 2F 100MG | - | - | - | - | 1件: 274 274 💬 |
903 | Nifurtimox-Eflronithine Combination Treatment (NECT) | 1件: Nifurtimox Nifurtimox | 1件: Nifurtimox
Nifurtimox
💬 | - | - | 1件: 65 65 💬 |
904 | Nitisinone 10 mg Tablet High Compritol | 1件: Nitisinone Nitisinone | 1件: Nitisinone
Nitisinone
💬 | 1件: HPD HPD 💬 | 5件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 1件: 241 241 💬 |
905 | Nitric Oxide plus Oxygen (COMPRESSED OXYGEN) | 2件: Nitric Oxide Nitric Oxide, Oxygen (Compressed Oxidizing) | 2件: Oxygen
Oxygen
(COMPRESSED OXYGEN),
Nitric oxide
💬 | - | - | 1件: 86 86 💬 |
906 | Non ATG Conditioning regimen | - | - | - | - | 1件: 60 60 💬 |
907 | NON COMMERCIAL | - | - | - | - | 1件: 75 75 💬 |
908 | Non-enteric coated pancreatic enzyme preparation | - | - | - | - | 1件: 298 298 💬 |
909 | Norvir 100 mg film-coated tablets | - | - | - | - | 1件: 299 299 💬 |
910 | Novartis Pharmaceuticals Corporation | - | - | - | - | 1件: 13 13 💬 |
911 | Nutraceutical Combination | - | - | - | - | 1件: 96 96 💬 |
912 | Nutritional Formulation Containing Exogenous Ketones | - | - | - | - | 1件: 201 201 💬 |
913 | O-15 Water (Purified water in containers (JP18)) | 1件: Water Water (FIRST AID Contains 202 PIECES) | 1件: Water
Water
(Purified water in containers (JP18)) 💬 | - | - | 1件: 6 6 💬 |
914 | Omidubicel (former CordIn) | 1件: Omidubicel Omidubicel | - | - | - | 1件: 60 60 💬 |
915 | Ondansetron 8 mg film-coated tablets | 1件: Ondansetron Ondansetron | 1件: Ondansetron
Ondansetron
💬 | 5件: HTR3A HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 | 2件: Serotonergic synapse Serotonergic synapse, Taste transduction 💬 | 1件: 6 6 💬 |
916 | Optivate® (Human Coagulation Factor VIII) | 2件: Antihemophilic factor human Antihemophilic factor human (Wilate - von Willebrand Factor/Coagulation Factor VIII Complex), Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex) | - | - | - | 1件: 288 288 💬 |
917 | Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone | 2件: Mesalazine Mesalazine (Salofalk 5-asa Enteric Coated Tab- 250mg), Methylprednisolone | 2件: Mesalamine
Mesalamine
,
Methylprednisolone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬 |
918 | Oral bovine type I collagen | 1件: Bovine type I collagen Bovine type I collagen | - | - | - | 1件: 51 51 💬 |
919 | Oral bovine type II collagen | - | - | - | - | 1件: 46 46 💬 |
920 | Oral ciprofloxacin plus inhaled colistin | 2件: Ciprofloxacin Ciprofloxacin, Colistin | 2件: Ciprofloxacin
Ciprofloxacin
,
Colistin
💬 | - | - | 1件: 299 299 💬 |
921 | Oral corticosteroids | - | - | - | - | 5件: 13 13, 46, 97, 171, 251 💬 |
922 | Oral corticosteroids (OCS) | - | - | - | - | 1件: 162 162 💬 |
923 | Oral prednisolone (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 49 49, 96, 145 💬 |
924 | ORENCIA 250 mg polvo para concentrado para sol. para perfusión | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬 | 2件: CD80 CD80, CD86 💬 | 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬 |
925 | ORENCIA 250mg powder for concentrate for solution for infusion | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬 | 2件: CD80 CD80, CD86 💬 | 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬 |
926 | Orkambi 100 mg/125 mg film-coated tablets | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: Ivacaftor
Ivacaftor
,
Lumacaftor
💬 | 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬 |
927 | Orkambi 200 mg/125 mg film-coated tablets | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: Ivacaftor
Ivacaftor
,
Lumacaftor
💬 | 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬 |
928 | Orkambi: contains lumacaftor and ivacaftor | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: Ivacaftor
Ivacaftor
,
Lumacaftor
💬 | 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬 |
929 | OTEZLA - 10 MG + 20 MG + 30 MG COMPRESSA RIVESTITA CON FILM USO ORALE - BLISTER (PVC/ALU) IN UN ASTUCCIO - 4 COMPRESSE DA 10 MG + 4 COMPRESSE DA 20 MG +19 COMPRESSE DA 30 MG | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬 | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 2件: 56 56, 107 💬 |
930 | OTEZLA - 30 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PVC/ALU) - 56 COMPRESSE | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬 | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 107 107 💬 |
931 | Other COX-2 inhibitor | - | - | - | - | 1件: 271 271 💬 |
932 | Other Cox-2 inhibitors | - | - | - | - | 1件: 271 271 💬 |
933 | Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain NZ98/254measured as amount of total protein containing the PorA P1.4 | - | - | - | - | 1件: 11 11 💬 |
934 | Over the counter DHA/EPA dietary supplementation | - | - | - | - | 1件: 301 301 💬 |
935 | Over-encapsulated Entacapone Tablets (Comtan (TN)) | 1件: Entacapone Entacapone (Comtan) | 1件: Entacapone
Entacapone
(Comtan (TN)) 💬 | 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬 |
936 | Overencapsulated Prednisolone Tablets (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬 |
937 | Ovine Corticotropin-Releasing Hormone (oCRH) | 2件: Corticorelin Corticorelin, Corticotropin | 2件: Corticotropin
Corticotropin
,
Corticorelin
💬 | 3件: CRHR1 CRHR1, CRHR2, MC2R 💬 | 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬 |
938 | Oxygen (COMPRESSED OXYGEN) | 1件: Oxygen Oxygen (Compressed Oxidizing) | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN) 💬 | - | - | 13件: 6 6, 49, 70, 85, 86, 88, 90, 96, 168, 193, 271, 299, 330 💬 |
939 | Oxygen 40 % (COMPRESSED OXYGEN) | 1件: Oxygen Oxygen (Compressed Oxidizing) | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN) 💬 | - | - | 1件: 85 85 💬 |
940 | Oxygen supplementation (COMPRESSED OXYGEN) | 1件: Oxygen Oxygen (Compressed Oxidizing) | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN) 💬 | - | - | 1件: 86 86 💬 |
941 | Oxygen, liquid (COMPRESSED OXYGEN) | 1件: Oxygen Oxygen (Compressed Oxidizing) | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN) 💬 | - | - | 2件: 86 86, 88 💬 |
942 | Oxygen-15 Water (Purified water in containers (JP18)) | 2件: Oxygen Oxygen (Compressed Oxidizing), Water (FIRST AID Contains 202 PIECES) | 2件: Water
Water
(Purified water in containers (JP18)),
Oxygen
(COMPRESSED OXYGEN) 💬 | - | - | 1件: 6 6 💬 |
943 | Oxytocin (OXT) continuous | 1件: Oxytocin Oxytocin | 1件: Oxytocin
Oxytocin
💬 | 1件: OXTR OXTR 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 1件: 193 193 💬 |
944 | Pancreatic enzyme(Pancreatin Enteric-coated Capsules or Oryz-Aspergillus Enzyme and Pancreatin Table), antidiabetic medicine(Acarbose Tablets, Glucophage, Glimepirde Tablets) | 2件: Acarbose Acarbose, Pancrelipase | 2件: Acarbose
Acarbose
,
Pancrelipase
(Cotazym (TN)) 💬 | 5件: AMY2A AMY2A, AMY2B, GAA, GANC, MGAM 💬 | 7件: Carbohydrate digestion and absorption Carbohydrate digestion and absorption, Galactose metabolism, Lysosome, Metabolic pathways, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬 | 1件: 298 298 💬 |
945 | PANCRECARB® (pancrelipase) (Cotazym (TN)) | 1件: Pancrelipase Pancrelipase | 1件: Pancrelipase
Pancrelipase
(Cotazym (TN)) 💬 | - | - | 1件: 299 299 💬 |
946 | Pancrelipase (Cotazym (TN)) | 2件: Pancrelipase Pancrelipase, Pancrelipase amylase (Cotazym Ecs 4) | 1件: Pancrelipase
Pancrelipase
(Cotazym (TN)) 💬 | - | - | 2件: 298 298, 299 💬 |
947 | PANCRELIPASE AMYLASE (Cotazym (TN)) | 2件: Pancrelipase Pancrelipase, Pancrelipase amylase (Cotazym Ecs 4) | 1件: Pancrelipase
Pancrelipase
(Cotazym (TN)) 💬 | - | - | 1件: 299 299 💬 |
948 | Pancrelipase Delayed Release (Cotazym (TN)) | 1件: Pancrelipase Pancrelipase | 1件: Pancrelipase
Pancrelipase
(Cotazym (TN)) 💬 | - | - | 1件: 299 299 💬 |
949 | Pancrelipase Delayed Release Capsule (Cotazym (TN)) | 1件: Pancrelipase Pancrelipase | 1件: Pancrelipase
Pancrelipase
(Cotazym (TN)) 💬 | - | - | 2件: 298 298, 299 💬 |
950 | Pancrelipase Microtablets (Cotazym (TN)) | 1件: Pancrelipase Pancrelipase | 1件: Pancrelipase
Pancrelipase
(Cotazym (TN)) 💬 | - | - | 1件: 299 299 💬 |
951 | Pancrelipase with bicarbonate (Cotazym (TN)) | 1件: Pancrelipase Pancrelipase | 1件: Pancrelipase
Pancrelipase
(Cotazym (TN)) 💬 | - | - | 1件: 299 299 💬 |
952 | Pancrelipase/Pancreas Powder (Cotazym (TN)) | 1件: Pancrelipase Pancrelipase | 1件: Pancrelipase
Pancrelipase
(Cotazym (TN)) 💬 | - | - | 2件: 298 298, 299 💬 |
953 | PARACETAMOLO DOC GENERICI - 1000 MG COMPRESSA 16 COMPRESSE | - | - | - | - | 1件: 19 19 💬 |
954 | PARACETAMOLO NOVA ARGENTIA - 500 MG COMPRESSE 20 COMPRESSE | - | - | - | - | 1件: 300 300 💬 |
955 | Paroxetine & Prednisolone (Delta-cortef (TN)) | 2件: Paroxetine Paroxetine (PAROXETINE HYDROCHLORIDE Controlled-Release), Prednisolone | 2件: Prednisolone
Prednisolone
(Delta-cortef (TN)),
Paroxetine
💬 | 2件: NR3C1 NR3C1, SLC6A4 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 46 46 💬 |
956 | Paroxetine hydrochloride 10 & 20 mg and Prednisolone 1 mg BP (Delta-cortef (TN)) | 2件: Paroxetine Paroxetine (PAROXETINE HYDROCHLORIDE Controlled-Release), Prednisolone | 2件: Prednisolone
Prednisolone
(Delta-cortef (TN)),
Paroxetine
💬 | 2件: NR3C1 NR3C1, SLC6A4 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 46 46 💬 |
957 | Paroxetine Hydrochloride tablets 10 & 20 mg and Prednisolone 1 mg BP (Delta-cortef (TN)) | 2件: Paroxetine Paroxetine (PAROXETINE HYDROCHLORIDE Controlled-Release), Prednisolone | 2件: Prednisolone
Prednisolone
(Delta-cortef (TN)),
Paroxetine
💬 | 2件: NR3C1 NR3C1, SLC6A4 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 46 46 💬 |
958 | Part 1, JM-010 component Group A | - | - | - | - | 1件: 6 6 💬 |
959 | Part 1, JM-010 component Group B | - | - | - | - | 1件: 6 6 💬 |
960 | Part 1, JM-010 component Group C | - | - | - | - | 1件: 6 6 💬 |
961 | Part 2, JM-010 combination Group A | - | - | - | - | 1件: 6 6 💬 |
962 | Part 2, JM-010 combination Group B | - | - | - | - | 1件: 6 6 💬 |
963 | Part 2, JM-010 component Group C | - | - | - | - | 1件: 6 6 💬 |
964 | PCT (PureCell Technologies Complex) | - | - | - | - | 1件: 97 97 💬 |
965 | PEG-liposomal Prednisolone Sodium Phosphate (Delta-cortef (TN)) | 2件: Phosphate ion Phosphate ion, Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 97 💬 |
966 | Pentasa Compact 2g, granulate with prolonged release | 2件: Manganese citrate Manganese citrate (Collag-EN), Mesalazine (Salofalk 5-asa Enteric Coated Tab- 250mg) | 1件: Mesalamine
Mesalamine
💬 | - | - | 1件: 97 97 💬 |
967 | Pentasa Compact 4g, granulate with prolonged release | 2件: Manganese citrate Manganese citrate (Collag-EN), Mesalazine (Salofalk 5-asa Enteric Coated Tab- 250mg) | 1件: Mesalamine
Mesalamine
💬 | - | - | 1件: 97 97 💬 |
968 | Peptide-conjugated phosphorodiamidate morpholino oligomer for exon 51 skipping | - | - | - | - | 1件: 113 113 💬 |
969 | Perfluorinated gas/oxygen mixture (COMPRESSED OXYGEN) | 1件: Oxygen Oxygen (Compressed Oxidizing) | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN) 💬 | - | - | 1件: 299 299 💬 |
970 | PGT-1 gene lipid complex | - | - | - | - | 1件: 299 299 💬 |
971 | Phase 1: Conventiaonal DMARD | - | - | - | - | 1件: 46 46 💬 |
972 | Phase 2a, SQY51 (cohort 1) | - | - | - | - | 1件: 113 113 💬 |
973 | Phase 2a, SQY51 (cohort 2) | - | - | - | - | 1件: 113 113 💬 |
974 | Phase 2a, SQY51 (cohort 3) | - | - | - | - | 1件: 113 113 💬 |
975 | Physiological serum (Sodium chloride) (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 1件: 193 193 💬 |
976 | Piperacillin-tazobactam combination product | 2件: Piperacillin Piperacillin (Zosyn in Galaxy Containers), Tazobactam (Zosyn in Galaxy Containers) | 3件: Tazobactam
Tazobactam
,
Piperacillin
,
Piperacillin
💬 | - | - | 1件: 299 299 💬 |
977 | Pittsburgh Compound B | 1件: Pittsburgh Compound B Pittsburgh Compound B | - | - | - | 1件: 127 127 💬 |
978 | Pittsburgh Compound B (C-11 PiB) | 1件: Pittsburgh Compound B Pittsburgh Compound B | - | - | - | 1件: 127 127 💬 |
979 | PL 12185/0002 & PL 12185/0005(WATER FOR INJECTION) (Purified water in containers (JP18)) | 1件: Water Water (FIRST AID Contains 202 PIECES) | 1件: Water
Water
(Purified water in containers (JP18)) 💬 | - | - | 1件: 57 57 💬 |
980 | Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracellular matrix | 1件: Placental Mesenchymal Stem Cells Placental Mesenchymal Stem Cells | - | - | - | 1件: 118 118 💬 |
981 | Plaquenil - Hydroxychloroquine 200mg Film coated tablets | 1件: Hydroxychloroquine Hydroxychloroquine (HYDROXYCHLOROQUINE SULFATE film coated) | 1件: Hydroxychloroquine
Hydroxychloroquine
💬 | - | - | 3件: 43 43, 44, 45 💬 |
982 | Plasma rico en plaquetas y coagulo de fibrina procesados mediante la tecnología PRGF-System (BTI) | - | - | - | - | 1件: 96 96 💬 |
983 | Plasma-derived FVIII/VWF concentrate | - | - | - | - | 1件: 288 288 💬 |
984 | Plerixafor for Conditioning before HSCT. | 1件: Plerixafor Plerixafor | 1件: Plerixafor
Plerixafor
💬 | 1件: CXCR4 CXCR4 💬 | 14件: Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | 1件: 65 65 💬 |
985 | Pneumococcal conjugate vaccine | - | - | - | - | 1件: 46 46 💬 |
986 | PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) | - | - | - | - | 2件: 13 13, 14 💬 |
987 | PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) CONJUGATED TO CRM197 CARRIER PROTEIN AND ADSORBED ON ALUMINIUM PHOSPHATE | 4件: Aluminium Aluminium, Aluminium phosphate, Corynebacterium diphtheriae CRM197 protein, Phosphate ion | - | - | - | 1件: 46 46 💬 |
988 | Prednisolone (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 42件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
989 | Prednisolone & dipyridamole (Delta-cortef (TN)) | 2件: Dipyridamole Dipyridamole, Prednisolone | 2件: Dipyridamole
Dipyridamole
,
Prednisolone
(Delta-cortef (TN)) 💬 | 3件: NR3C1 NR3C1, PDE4A, PDE5A 💬 | 7件: Metabolic pathways Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 💬 |
990 | Prednisolone + mabthera (Delta-cortef (TN)) | 2件: Prednisolone Prednisolone, Rituximab | 2件: Prednisolone
Prednisolone
(Delta-cortef (TN)),
Rituximab
💬 | 2件: MS4A1 MS4A1, NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 61 61 💬 |
991 | Prednisolone 1mg Tablets (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
992 | Prednisolone 2,5 mg Tablets (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
993 | Prednisolone 20 mg (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬 |
994 | Prednisolone 40 mg (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬 |
995 | Prednisolone 5 mg (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 46 46, 51 💬 |
996 | Prednisolone 5 mg JENAPHARM (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬 |
997 | Prednisolone 5 mg Tablets (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
998 | Prednisolone 5mg Gastro-resistant Tablets (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 51 51 💬 |
999 | Prednisolone 5mg Tablet (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
1000 | PREDNISOLONE ACETATE (Delta-cortef (TN)) | 3件: Acetate Acetate, Prednisolone, Prednisolone acetate | 2件: Prednisolone
Prednisolone
(Delta-cortef (TN)),
Prednisolone acetate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 222 222 💬 |
1001 | Prednisolone and chlorambucil (Delta-cortef (TN)) | 2件: Chlorambucil Chlorambucil, Prednisolone | 2件: Chlorambucil
Chlorambucil
,
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 222 222 💬 |
1002 | Prednisolone and mycophenolate mofetil (Delta-cortef (TN)) | 3件: Mycophenolate mofetil Mycophenolate mofetil (Co Mycophenolate), Mycophenolic acid, Prednisolone | 3件: Prednisolone
Prednisolone
(Delta-cortef (TN)),
Mycophenolate mofetil
,
Mycophenolic acid
💬 | 3件: IMPDH1 IMPDH1, IMPDH2, NR3C1 💬 | 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬 | 1件: 222 222 💬 |
1003 | Prednisolone and taper (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 51 51 💬 |
1004 | Prednisolone Labesfal (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬 |
1005 | Prednisolone sodium metasulphobenzoate (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬 |
1006 | PREDNISOLONE SODIUM PHOSPHATE (Delta-cortef (TN)) | 2件: Phosphate ion Phosphate ion, Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 3 3, 13, 97 💬 |
1007 | PREDNISOLONE SODIUM SUCCINATE (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 95 95 💬 |
1008 | Prednisolone Tablets B.P. 5mg (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬 |
1009 | Prednisolone Tablets BP (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬 |
1010 | Prednisolone Tablets BP 1 mg (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬 |
1011 | Prednisolone Tablets USP 5 mg (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬 |
1012 | Prednisolone-Dipyridamole (Delta-cortef (TN)) | 2件: Dipyridamole Dipyridamole, Prednisolone | 2件: Dipyridamole
Dipyridamole
,
Prednisolone
(Delta-cortef (TN)) 💬 | 3件: NR3C1 NR3C1, PDE4A, PDE5A 💬 | 7件: Metabolic pathways Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 💬 |
1013 | Prednisolone/Prednisone (Delta-cortef (TN)) | 2件: Prednisolone Prednisolone, Prednisone (Contrast Allergy PreMed Pack) | 2件: Prednisolone
Prednisolone
(Delta-cortef (TN)),
Prednisone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 49 49 💬 |
1014 | Prednisone + Inhibace/Cozaar | 1件: Prednisone Prednisone (Contrast Allergy PreMed Pack) | 1件: Prednisone
Prednisone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 💬 |
1015 | PREDNISONE DOC GENERICI - 5 MG COMPRESSE 10 COMPRESSE IN BLISTER PVC-PVDC/ALU | 1件: Prednisone Prednisone (Contrast Allergy PreMed Pack) | 1件: Prednisone
Prednisone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 19 19 💬 |
1016 | PREDNISONE DOC GENERICI - 5 MG COMPRESSE 30 COMPRESSE IN BLISTER PVC-PVDC/ALU | 1件: Prednisone Prednisone (Contrast Allergy PreMed Pack) | 1件: Prednisone
Prednisone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 300 300 💬 |
1017 | Prednisone or Prednisolone (Delta-cortef (TN)) | 2件: Prednisolone Prednisolone, Prednisone (Contrast Allergy PreMed Pack) | 2件: Prednisolone
Prednisolone
(Delta-cortef (TN)),
Prednisone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 66 66, 84 💬 |
1018 | Prednisone/Prednisolone (Delta-cortef (TN)) | 2件: Prednisolone Prednisolone, Prednisone (Contrast Allergy PreMed Pack) | 2件: Prednisolone
Prednisolone
(Delta-cortef (TN)),
Prednisone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 35 35 💬 |
1019 | Prevenar® (7-valent pneumococcal conjugate vaccine) | - | - | - | - | 1件: 65 65 💬 |
1020 | Probiotic capsules containing Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 | 1件: Lactobacillus delbrueckii bulgaricus Lactobacillus delbrueckii bulgaricus | - | - | - | 1件: 46 46 💬 |
1021 | PROCAPTAN - 10 MG COMPRESSE RIVESTITE CON FILM 60 COMPRESSE IN CONTENITORE PER COMPRESSE PP | - | - | - | - | 1件: 58 58 💬 |
1022 | PROCAPTAN - 5 MG COMPRESSE RIVESTITE CON FILM 10 COMPRESSE IN CONTENITORE PER COMPRESSE PP | - | - | - | - | 1件: 58 58 💬 |
1023 | Products containing aminosalicylate | - | - | - | - | 1件: 97 97 💬 |
1024 | Products containing azathioprine or 6-mercaptopurine | 2件: Azathioprine Azathioprine, Mercaptopurine | 3件: Mercaptopurine
Mercaptopurine
,
Azathioprine
,
Mercaptopurine
💬 | 1件: HPRT1 HPRT1 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 1件: 97 97 💬 |
1025 | Prophylactic Corticosteroid Taper Regimen | - | - | - | - | 1件: 251 251 💬 |
1026 | Prothrombin Complex Concentrate | 2件: Factor IX Complex (Human) Factor IX Complex (Human), Prothrombin (Coagulation factor II human) | - | - | - | 1件: 288 288 💬 |
1027 | PROVIGIL - 100 MG COMPRESSE 30 COMPRESSE | 1件: Modafinil Modafinil | 1件: Modafinil
Modafinil
💬 | - | - | 1件: 113 113 💬 |
1028 | PS188 (company code) | - | - | - | - | 1件: 113 113 💬 |
1029 | Pseudoephedrine + 480 ml water (Purified water in containers (JP18)) | 2件: Pseudoephedrine Pseudoephedrine (Daytime Relief Complete), Water (FIRST AID Contains 202 PIECES) | 2件: Water
Water
(Purified water in containers (JP18)),
Pseudoephedrine
💬 | 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 17 17 💬 |
1030 | Pseudoephedrine + 50 ml water (Purified water in containers (JP18)) | 2件: Pseudoephedrine Pseudoephedrine (Daytime Relief Complete), Water (FIRST AID Contains 202 PIECES) | 2件: Water
Water
(Purified water in containers (JP18)),
Pseudoephedrine
💬 | 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 17 17 💬 |
1031 | PTC0161480, PTC124 Compound 1a, RPS2505, PTC-C124, 291844 | - | - | - | - | 1件: 113 113 💬 |
1032 | PURINETHOL - 50 MG COMPRESSE25 COMPRESSE | 1件: Mercaptopurine Mercaptopurine | 2件: Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬 | 1件: HPRT1 HPRT1 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 1件: 96 96 💬 |
1033 | Pyridoxine plus prednisolone (Delta-cortef (TN)) | 2件: Prednisolone Prednisolone, Pyridoxine (Stresstabs + Zinc-copper) | 2件: Prednisolone
Prednisolone
(Delta-cortef (TN)),
Pyridoxine
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 145 145 💬 |
1034 | RAAV1.tMCK.human-alpha-sarcoglycan- First cohort | - | - | - | - | 1件: 113 113 💬 |
1035 | RAAV1.tMCK.human-alpha-sarcoglycan- Second cohort | - | - | - | - | 1件: 113 113 💬 |
1036 | RANEXA - 750 MG - COMPRESSA A RILASCIO PROLUNGATO- USO ORALE - BLISTER (PVC/PVDC/ALLUMINIO) 60 COMPRESSE | 1件: Ranolazine Ranolazine (Corzyna) | 1件: Ranolazine
Ranolazine
💬 | - | - | 1件: 58 58 💬 |
1037 | RAPAMUNE - 1 MG 100 COMPRESSE RIVESTITE IN BLISTER USO ORALE | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬 | 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 2 2 💬 |
1038 | Rapamycin-calcitriol combination | 2件: Calcitriol Calcitriol, Sirolimus | 2件: Calcitriol
Calcitriol
,
Sirolimus
💬 | 2件: MTOR MTOR, VDR 💬 | 55件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Mineral absorption, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Tuberculosis, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 158 158 💬 |
1039 | RAXONE - 150 MG- COMPRESSE RIVESTITE CON FILM- USO ORALE- FLACONE (HDPE)- 180 COMPRESSE | 1件: Idebenone Idebenone | 1件: Idebenone
Idebenone
💬 | - | - | 1件: 113 113 💬 |
1040 | Reactive Corticosteroid Taper Regimen | - | - | - | - | 1件: 251 251 💬 |
1041 | Recombinanat DNA-derived human growth hormone produced in E.coli | 1件: Somatotropin Somatotropin | - | - | - | 1件: 78 78 💬 |
1042 | Recombinant AAV vector serotype 2 containing the human wild type mitochondrial ND4 gene | - | - | - | - | 1件: 302 302 💬 |
1043 | Recombinant AAV vector serotype 2 containing the human wild typemitochondrial ND4 gene | - | - | - | - | 1件: 302 302 💬 |
1044 | Recombinant adeno-associated viral vector serotype 2.7m8 containing the ChrimsonR-tdTomato gene | - | - | - | - | 1件: 90 90 💬 |
1045 | Recombinant Adeno-Associated Viral vector, serotype 2 (rAAV2/2) containing the human wild-type mitochondrial NADH Dehydrogenase 4 gene (ND4) | 1件: NADH NADH | - | - | - | 1件: 302 302 💬 |
1046 | Recombinant adenovirus containing the ornithine transcarbamylase gene | 1件: Ornithine Ornithine | 1件: Ornithine
Ornithine
💬 | - | - | 1件: 251 251 💬 |
1047 | Recombinant coagulation FVIII Fc – von Willebrand factor – XTEN fusion protein | 1件: Von Willebrand factor human Von Willebrand factor human (Factor con Willebrand) | - | - | - | 1件: 288 288 💬 |
1048 | Recombinant coagulation FVIII Fc –von Willebrand factor – XTEN fusion protein | 1件: Von Willebrand factor human Von Willebrand factor human (Factor con Willebrand) | - | - | - | 1件: 288 288 💬 |
1049 | Recombinant DNA-derived human growth hormone produced in E.coli | 1件: Somatotropin Somatotropin | - | - | - | 1件: 78 78 💬 |
1050 | Recombinant form of human nerve growth factor produced in Escherichia Coli. | 2件: Escherichia coli Escherichia coli, Nerve Growth Factor | - | - | - | 1件: 53 53 💬 |
1051 | Recombinant granulocyte - colony stimulating factor | - | - | - | - | 1件: 39 39 💬 |
1052 | RECOMBINANT HUMAN ?-GLUCOSIDASE CONJUGATED WITH SYNTHETIC BISMANNOSE-6-PHOSPHATE-MAN6 GLYCAN | 1件: Phosphate ion Phosphate ion | - | - | - | 1件: 256 256 💬 |
1053 | Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan (NEOGAA) | 3件: Avalglucosidase alfa Avalglucosidase alfa, Mannose, Phosphate ion | 1件: Avalglucosidase alfa
Avalglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
1054 | Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan Avalglucosidase Alfa (NeoGAA) | 3件: Avalglucosidase alfa Avalglucosidase alfa, Mannose, Phosphate ion | 1件: Avalglucosidase alfa
Avalglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
1055 | RECOMBINANT HUMAN ALFA-GLUCOSIDASE CONJUGATED WITH SYNTHETIC BISMANNOSE-6-PHOSPHATE-MAN6 GLYCAN | 1件: Phosphate ion Phosphate ion | - | - | - | 1件: 256 256 💬 |
1056 | Recombinant Human Angiotensin-Converting Enzyme 2 | 2件: Alunacedase alfa Alunacedase alfa (Recombinant Human Angiotensin-Converting Enzyme 2), Angiotensin II | 2件: Angiotensin II
Angiotensin II
,
Angiotensin II
💬 | 2件: AGTR1 AGTR1, AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
1057 | Recombinant Human Angiotensin-converting enzyme 2 (ACE2), APN01 | 2件: Alunacedase alfa Alunacedase alfa (Recombinant Human Angiotensin-Converting Enzyme 2), Angiotensin II | 2件: Angiotensin II
Angiotensin II
,
Angiotensin II
💬 | 2件: AGTR1 AGTR1, AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
1058 | Recombinant Human Apolipoprotein A-I/Phospholipids Complex | 1件: Omega-3 fatty acids Omega-3 fatty acids (Tricare Prenatal Compleat) | - | - | - | 1件: 79 79 💬 |
1059 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTO | 2件: Antihemophilic factor human Antihemophilic factor human (Wilate - von Willebrand Factor/Coagulation Factor VIII Complex), Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex) | - | - | - | 1件: 288 288 💬 |
1060 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR - | 3件: Antihemophilic factor human Antihemophilic factor human (Wilate - von Willebrand Factor/Coagulation Factor VIII Complex), Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex), Von Willebrand factor human (Factor con Willebrand) | - | - | - | 1件: 288 288 💬 |
1061 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR - XTEN FUSION PROTEIN | 3件: Antihemophilic factor human Antihemophilic factor human (Wilate - von Willebrand Factor/Coagulation Factor VIII Complex), Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex), Von Willebrand factor human (Factor con Willebrand) | - | - | - | 1件: 288 288 💬 |
1062 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR -XTEN FUSION PROTEIN | 3件: Antihemophilic factor human Antihemophilic factor human (Wilate - von Willebrand Factor/Coagulation Factor VIII Complex), Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex), Von Willebrand factor human (Factor con Willebrand) | - | - | - | 1件: 288 288 💬 |
1063 | RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E.COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE | 5件: Aluminium Aluminium, Aluminum hydroxide (AHC Premium Intense Contour Balm), Hydroxide ion, Iron polymaltose (Iron-hydroxide polymaltose complex), Lactobacillus casei | 2件: Aluminum hydroxide
Aluminum hydroxide
,
Lactobacillus casei
💬 | - | - | 1件: 11 11 💬 |
1064 | Recombinant porcine coagulation factor VIII (B domain deleted) | 1件: Beroctocog alfa Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex) | - | - | - | 1件: 288 288 💬 |
1065 | Recombinant porcine coagulation factor VIII (B-domain deleted) | 1件: Beroctocog alfa Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex) | - | - | - | 1件: 288 288 💬 |
1066 | Recombinant self-complementary adeno-associated viral vector serotype 9 containing the human CLN6 gene | - | - | - | - | 1件: 19 19 💬 |
1067 | Reduced Intensity Conditioning | - | - | - | - | 2件: 19 19, 65 💬 |
1068 | Regimen Selection Phase Group 1 (COMPLETED) | - | - | - | - | 1件: 113 113 💬 |
1069 | REMICADE - 100 MG POLVERE PER CONCENTRATO PER INFUSIONE ENDOVENOSA 1 FLACONE VETRO 20 ML USO EV | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
1070 | REMICADE 100 mg polvo para concentrado para solución para perfusión | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 271 💬 |
1071 | Remicade 100 mg powder for concentrate for solution for infusion. | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬 |
1072 | REMSIMA - 100 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLANCONCINO (VETRO) - 1 FLACONCINO | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 4件: 46 46, 96, 97, 271 💬 |
1073 | Repository corticotropin injection | 1件: Corticotropin Corticotropin | 1件: Corticotropin
Corticotropin
💬 | 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 5件: 2 2, 13, 46, 84, 222 💬 |
1074 | Retrovirus Construct | - | - | - | - | 1件: 285 285 💬 |
1075 | Revatio 20 mg film coated tablets | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
1076 | Revatio 20 mg film-coated tablets | - | - | - | - | 1件: 86 86 💬 |
1077 | REVATIO 20 mg, comprimidos recubiertos con película | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
1078 | Revatio ® 20 mg film-coated tablets | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
1079 | REVOLADE - 25 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER(PA/ALU/PVC/ALU) 28 COMPRESSE | 1件: Eltrombopag Eltrombopag | - | - | - | 1件: 60 60 💬 |
1080 | REVOLADE - 50 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER(PA/ALU/PVC/ALU | 1件: Eltrombopag Eltrombopag | - | - | - | 1件: 60 60 💬 |
1081 | Revolade 25 mg film-coated tablets | 1件: Eltrombopag Eltrombopag | - | - | - | 1件: 63 63 💬 |
1082 | Revolade 50 mg film-coated tablets | 1件: Eltrombopag Eltrombopag | - | - | - | 1件: 63 63 💬 |
1083 | RhTPO in combination with Rituximab | 2件: Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin, Rituximab | 1件: Rituximab
Rituximab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 💬 |
1084 | RIBAVIRIN (Copegus (TN)) | 1件: Ribavirin Ribavirin (Copegus) | 1件: Ribavirin
Ribavirin
(Copegus (TN)) 💬 | - | - | 2件: 2 2, 96 💬 |
1085 | Rifaximin delayed release 400 mg film coated tablet | 1件: Rifaximin Rifaximin | 1件: Rifaximin
Rifaximin
💬 | - | - | 1件: 96 96 💬 |
1086 | Rilutek 50 mg film-coated tablets | 1件: Riluzole Riluzole | 1件: Riluzole
Riluzole
💬 | 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 💬 |
1087 | RILUTEK 50 mg, film-coated tablets | 1件: Riluzole Riluzole | 1件: Riluzole
Riluzole
💬 | 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 💬 |
1088 | RILUZOLO TEVA - 50 MG COMPRESSE RIVESTITE CON FILM 90 COMPRESSE IN BLISTER AL/PVC | - | - | - | - | 1件: 114 114 💬 |
1089 | Riociguat coated tablet 0.5 mg | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬 |
1090 | Riociguat coated tablet 1.0 mg | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬 |
1091 | Riociguat coated tablet 1.5 mg | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬 |
1092 | Riociguat coated tablet 2.0 mg | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬 |
1093 | Riociguat coated tablet 2.5 m | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬 |
1094 | Riociguat coated tablet 2.5 mg | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬 |
1095 | Risperidone (RISPERDAL CONSTA) | 1件: Risperidone Risperidone (Risperdal Consta) | 1件: Risperidone
Risperidone
(RISPERDAL CONSTA) 💬 | 2件: DRD2 DRD2, HTR2A 💬 | 11件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | 5件: 8 8, 156, 179, 187, 206 💬 |
1096 | Risperidone 1Mg Tab (RISPERDAL CONSTA) | 1件: Risperidone Risperidone (Risperdal Consta) | 1件: Risperidone
Risperidone
(RISPERDAL CONSTA) 💬 | 2件: DRD2 DRD2, HTR2A 💬 | 11件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | 1件: 8 8 💬 |
1097 | Rituximab combined with Omalizumab | 2件: Omalizumab Omalizumab, Rituximab | 2件: Rituximab
Rituximab
,
Omalizumab
💬 | 2件: FCER1A FCER1A, MS4A1 💬 | 5件: Asthma Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | 1件: 162 162 💬 |
1098 | Rituximab combined with tacrolimus induction + rituximab maintenance | 2件: Rituximab Rituximab, Tacrolimus | 3件: Tacrolimus
Tacrolimus
,
Rituximab
,
Tacrolimus
💬 | 6件: MS4A1 MS4A1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 34件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬 |
1099 | Rituximab combined with tacrolimus induction + tacrolimus maintenance | 2件: Rituximab Rituximab, Tacrolimus | 3件: Tacrolimus
Tacrolimus
,
Rituximab
,
Tacrolimus
💬 | 6件: MS4A1 MS4A1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 34件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬 |
1100 | Rituximab, Cyclophosphamide, and Corticosteroids | 2件: Cyclophosphamide Cyclophosphamide, Rituximab | 3件: Cyclophosphamide
Cyclophosphamide
,
Rituximab
,
Cyclophosphamide
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 💬 |
1101 | Rituximab-EU+ Rituximab-Pfizer x 2 Courses | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
1102 | Rituximab-Pfizer (PF-05280586) x 3 courses | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
1103 | Rituximab-US + Rituximab-Pfizer x 2 Courses | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
1104 | ROACTEMRA - 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 4ML 1 FLACONCINO | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬 | 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬 |
1105 | RoActemra 20 mg/ml concentrado para solución para perfusión | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬 | 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬 |
1106 | RoActemra 20 mg/ml Concentrate for solution for infusion | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬 | 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬 |
1107 | RoActemra 20 mg/ml concentrate for solution for infusion. | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬 | 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬 |
1108 | ROACTEMRA 20 mg/ml, concentrado para solución para perfusión | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬 | 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 3件: 46 46, 107, 271 💬 |
1109 | RoActemra®EV Product Code: PRD82321 | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬 | 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬 |
1110 | Ropinirole controlled-release (REQUIP CR) for RLS | 1件: Ropinirole Ropinirole | 1件: Ropinirole
Ropinirole
💬 | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
1111 | RVA576 (COVERSIN) | 1件: Nomacopan Nomacopan (COVERSIN) | 1件: Nomacopan
Nomacopan
💬 | 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 2件: 62 62, 109 💬 |
1112 | S95011 concentrate for solution for infusion | - | - | - | - | 1件: 53 53 💬 |
1113 | SARS-COV-2 mRNA Vaccine | 2件: CVnCoV CVnCoV (SARS-CoV-2 mRNA vaccine), SARS-CoV-2 mRNA vaccine | - | - | - | 1件: 13 13 💬 |
1114 | SECUKINUMAB (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 8件: 13 13, 37, 41, 46, 107, 160, 269, 271 💬 |
1115 | Secukinumab (150 mg) (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 💬 |
1116 | Secukinumab (75 mg) (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 💬 |
1117 | Secukinumab (AIN457) (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 46 46 💬 |
1118 | Secukinumab (AIN457) 150 mg s.c. (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 💬 |
1119 | Secukinumab 150 mg (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 💬 |
1120 | Secukinumab 150 mg (2 injections per dose (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 269 269 💬 |
1121 | Secukinumab 150 mg provided in 1.0 mL pre-filled syringes (PFSs) for sc injection. (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 💬 |
1122 | Secukinumab 150 mg/1 ml Solution for injection (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 2件: 37 37, 271 💬 |
1123 | Secukinumab 150 mg/ml (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 💬 |
1124 | Secukinumab 150 milligram [Cosentyx] | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 💬 |
1125 | Secukinumab 150mg (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 37 37 💬 |
1126 | Secukinumab 300 mg (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 💬 |
1127 | Secukinumab 300 mg, s.c. (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 💬 |
1128 | Secukinumab 300mg (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 37 37 💬 |
1129 | Secukinumab 75 mg/0.5 ml Solution for injection (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 💬 |
1130 | Secukinumab Injection (Cosentyx (TN)) | 1件: Secukinumab Secukinumab (Cosentyx) | 1件: Secukinumab
Secukinumab
(Cosentyx (TN)) 💬 | 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 160 160 💬 |
1131 | Semi continuous intra-oral administration of LD/CD | - | - | - | - | 1件: 6 6 💬 |
1132 | Serum containing Avonex | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬 | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬 |
1133 | Short-course Ocrelizumab | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬 |
1134 | Simvastatin 40 mg film-coated tablets | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬 | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬 |
1135 | Simvastatina Sandoz 40 mg comprimidos recubiertos con película EFG | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬 | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬 |
1136 | SIN LV Mediated ex vivo transduced autologous fibroblasts expressing codon-optimised COL7A1 | - | - | - | - | 1件: 36 36 💬 |
1137 | SIN RV-mediated COL7A1 corrected autologous skin equivalent | - | - | - | - | 1件: 36 36 💬 |
1138 | Sinemet (comparator) | 1件: Carbidopa Carbidopa (Corbilta) | 1件: Carbidopa
Carbidopa
💬 | 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬 |
1139 | SINEMET - 100 MG + 25 MG COMPRESSE 50 COMPRESSE DIVISIBILI | 2件: Carbidopa Carbidopa (Corbilta), Levodopa (Corbilta) | 2件: Levodopa
Levodopa
,
Carbidopa
💬 | 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
1140 | SINEMET 100 mg + 25 mg compresse | 2件: Carbidopa Carbidopa (Corbilta), Levodopa (Corbilta) | 2件: Levodopa
Levodopa
,
Carbidopa
💬 | 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
1141 | Sinemet® controlled release (Carbidopa/levodopa) | 2件: Carbidopa Carbidopa (Corbilta), Levodopa (Corbilta) | 2件: Levodopa
Levodopa
,
Carbidopa
💬 | 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
1142 | Sinvastatina Sandoz 40 mg comprimidos revestidos por película | - | - | - | - | 1件: 13 13 💬 |
1143 | Site specific standard of care comparison | - | - | - | - | 2件: 38 38, 39 💬 |
1144 | Sivatin 40 mg film-coated tablets | - | - | - | - | 1件: 13 13 💬 |
1145 | Sodium chloride (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 20件: 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299 💬 |
1146 | Sodium chloride (7%) (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 1件: 299 299 💬 |
1147 | Sodium chloride (NaCl) (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 1件: 67 67 💬 |
1148 | Sodium chloride 0,9% (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 1件: 299 299 💬 |
1149 | Sodium Chloride 0.9% (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 2件: 14 14, 227 💬 |
1150 | Sodium chloride 6% (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 1件: 299 299 💬 |
1151 | SODIUM CHLORIDE 7% (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 1件: 299 299 💬 |
1152 | SODIUM CHLORIDE PH. EUR. (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 1件: 299 299 💬 |
1153 | Sodium Chloride solution (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 4件: 11 11, 13, 51, 228 💬 |
1154 | SODIUM CHLORIDE SOLUTION 0.9% (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 4件: 51 51, 60, 288, 299 💬 |
1155 | Sodium Chloride Solvent (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 1件: 228 228 💬 |
1156 | Sodium Pyruvate in 0.9% Sodium Chloride Solution (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 1件: 299 299 💬 |
1157 | SOLIRIS - 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML (10 MG/ML) | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬 | 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 3件: 13 13, 62, 109 💬 |
1158 | SOLIRIS 300 mg concentrado para solución para perfusión | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬 | 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 109 109 💬 |
1159 | Soliris 300 mg concentrate for solution for infusion | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬 | 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬 |
1160 | Solu-Cortef | 3件: Hydrocortisone Hydrocortisone (Cortane-B), Hydrocortisone cypionate (Cortisol 21-cyclopentanepropionate), Hydrocortisone succinate (Solu-Cortef) | 3件: Hydrocortisone
Hydrocortisone
(Colocort (TN)),
Hydrocortisone cypionate
,
Hydrocortisone succinate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 81, 83 💬 |
1161 | Solu-Cortef (hydrocortisone) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 💬 |
1162 | Solu-Cortef 100 MG Injection | 3件: Hydrocortisone Hydrocortisone (Cortane-B), Hydrocortisone cypionate (Cortisol 21-cyclopentanepropionate), Hydrocortisone succinate (Solu-Cortef) | 3件: Hydrocortisone
Hydrocortisone
(Colocort (TN)),
Hydrocortisone cypionate
,
Hydrocortisone succinate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 💬 |
1163 | Solu-Cortef, powder for solution for injection, 100mg, and 'Act-O-Vial' | 3件: Hydrocortisone Hydrocortisone (Cortane-B), Hydrocortisone cypionate (Cortisol 21-cyclopentanepropionate), Hydrocortisone succinate (Solu-Cortef) | 3件: Hydrocortisone
Hydrocortisone
(Colocort (TN)),
Hydrocortisone cypionate
,
Hydrocortisone succinate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬 |
1164 | SOLUBLE PREDNISOLONE TABLETS (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 145 145 💬 |
1165 | Solucion de cloruro de sodio Sodium Chloride Solution (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 1件: 228 228 💬 |
1166 | Solvente Cloruro de Sodio Sodium Chloride Solvent (CORVATROL 0.9%) | 2件: Chloride ion Chloride ion, Sodium chloride (Acid Concentrate D 12219 Liq) | 1件: Sodium chloride
Sodium chloride
(CORVATROL 0.9%) 💬 | - | - | 1件: 228 228 💬 |
1167 | Somatropin (INN) recombinant DNA orgin, Escherichia coli | 2件: Escherichia coli Escherichia coli, Somatotropin | - | - | - | 1件: 78 78 💬 |
1168 | Somatropin (recombinant DNA origin produced in E. coli) | 1件: Somatotropin Somatotropin | - | - | - | 1件: 78 78 💬 |
1169 | Somatropin - adult cohort | 1件: Somatotropin Somatotropin | - | - | - | 1件: 193 193 💬 |
1170 | Somatropin - GH naïve pediatric cohort | 1件: Somatotropin Somatotropin | - | - | - | 1件: 193 193 💬 |
1171 | Somatropin - GH treated cohort | 1件: Somatotropin Somatotropin | - | - | - | 1件: 193 193 💬 |
1172 | Sorbitol (Sorbitol 3% in plastic container (TN)) | 1件: Sorbitol Sorbitol | 1件: Sorbitol solution
Sorbitol solution
(Sorbitol 3% in plastic container (TN)) 💬 | - | - | 1件: 10 10 💬 |
1173 | Sparsentan compresse | 1件: Sparsentan Sparsentan | 1件: Sparsentan
Sparsentan
💬 | 2件: AGTR1 AGTR1, EDNRA 💬 | 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 66 66 💬 |
1174 | Spironolactone and conivaptan | 2件: Conivaptan Conivaptan, Spironolactone | 2件: Spironolactone
Spironolactone
,
Conivaptan
💬 | 3件: AVPR1A AVPR1A, AVPR2, NR3C2 💬 | 6件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬 | 1件: 86 86 💬 |
1175 | Spironolactone captopril carvedilol (Coreg (TN)) | 3件: Captopril Captopril, Carvedilol (Coreg CR), Spironolactone | 3件: Captopril
Captopril
,
Carvedilol
(Coreg (TN)),
Spironolactone
💬 | 7件: ACE ACE, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, NR3C2 💬 | 19件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
1176 | Ss-Adrenergic cocktail | - | - | - | - | 1件: 299 299 💬 |
1177 | Stalevo (levodopa/ carbidopa/ entacapone) (Comtan (TN)) | 3件: Carbidopa Carbidopa (Corbilta), Entacapone (Comtan), Levodopa (Corbilta) | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
(Comtan (TN)) 💬 | 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
1178 | Stalevo (levodopa/carbidopa/entacapone) (Comtan (TN)) | 3件: Carbidopa Carbidopa (Corbilta), Entacapone (Comtan), Levodopa (Corbilta) | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
(Comtan (TN)) 💬 | 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
1179 | Standard analgesia use [Oxygen] (COMPRESSED OXYGEN) | 1件: Oxygen Oxygen (Compressed Oxidizing) | 1件: Oxygen
Oxygen
(COMPRESSED OXYGEN) 💬 | - | - | 1件: 70 70 💬 |
1180 | Standard continuous antiretroviral therapy | - | - | - | - | 1件: 265 265 💬 |
1181 | Standard gadolinium contrast | 1件: Gadolinium Gadolinium | - | - | - | 1件: 13 13 💬 |
1182 | Standard treatment with a conventional drug | - | - | - | - | 1件: 13 13 💬 |
1183 | STELARA 130 mg concentrate for solution for infusion | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬 | 3件: IL12A IL12A, IL12B, IL23A 💬 | 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 96 96 💬 |
1184 | Stelara 130mg / 26mL concentrate for solution for | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬 | 3件: IL12A IL12A, IL12B, IL23A 💬 | 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 96 96 💬 |
1185 | Stelara 130mg / 26mL concentrate for solution for infusion | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬 | 3件: IL12A IL12A, IL12B, IL23A 💬 | 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 96 96 💬 |
1186 | Sterile Water for Injection (Purified water in containers (JP18)) | 1件: Water Water (FIRST AID Contains 202 PIECES) | 1件: Water
Water
(Purified water in containers (JP18)) 💬 | - | - | 1件: 78 78 💬 |
1187 | Subcutaneous hydrocortisone 10mg (Colocort (TN)) | 1件: Hydrocortisone Hydrocortisone (Cortane-B) | 1件: Hydrocortisone
Hydrocortisone
(Colocort (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬 |
1188 | Subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP) | - | - | - | - | 1件: 90 90 💬 |
1189 | Sucrose (Sugar, compressible (NF)) | 1件: Sucrose Sucrose | 1件: Sucrose
Sucrose
(Sugar, compressible (NF)) 💬 | - | - | 3件: 62 62, 96, 97 💬 |
1190 | Sulfur Colloid | 1件: Gelatin Gelatin (Sulfur Colloid) | 2件: Gelatin
Gelatin
,
Donkey glue
(Asini corii collas) 💬 | - | - | 1件: 299 299 💬 |
1191 | Sulphsalazine, Pentasa, Asacol, Colazide, Depentum | - | - | - | - | 1件: 97 97 💬 |
1192 | Suspension containing 250 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | 1件: 96 96 💬 |
1193 | Suspension containing 250 embryonated, viable TSO/15ml | - | - | - | - | 1件: 96 96 💬 |
1194 | Suspension containing 2500 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | 1件: 96 96 💬 |
1195 | Suspension containing 2500 embryonated, viable TSO/15ml | - | - | - | - | 1件: 96 96 💬 |
1196 | SUSPENSION CONTAINING 7500 EMBRYONATED VIABLE TRICHURIS SUIS OVA/15ML | - | - | - | - | 1件: 97 97 💬 |
1197 | Suspension containing 7500 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | 1件: 96 96 💬 |
1198 | Symkevi 100mg/150mg Film-coated tablets | 2件: Ivacaftor Ivacaftor, Tezacaftor | 2件: Ivacaftor
Ivacaftor
,
Tezacaftor
💬 | 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬 |
1199 | Symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin) | 3件: Aldosterone Aldosterone, Angiotensin II, Calcium (Revitex Ampoules Et Comprimes) | 3件: Angiotensin II
Angiotensin II
,
Angiotensin II
,
Aldosterone
💬 | 3件: AGTR1 AGTR1, AGTR2, NR3C2 💬 | 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬 |
1200 | Synthetic stereopure antisense oligonucleotide targeting human C9orf72 hexanucleotide repeat-containing mRNA transcripts | - | - | - | - | 2件: 2 2, 127 💬 |
1201 | T-peptide-CRM197 conjugate | 1件: Corynebacterium diphtheriae CRM197 protein Corynebacterium diphtheriae CRM197 protein | - | - | - | 1件: 11 11 💬 |
1202 | TACHIPIRINA - 1000 MG COMPRESSE 8 COMPRESSE | - | - | - | - | 1件: 14 14 💬 |
1203 | TACHIPIRINA - 500 MG COMPRESSE20 COMPRESSE | - | - | - | - | 2件: 13 13, 53 💬 |
1204 | Tacrolimus combined with prednisone | 2件: Prednisone Prednisone (Contrast Allergy PreMed Pack), Tacrolimus | 3件: Tacrolimus
Tacrolimus
,
Prednisone
,
Tacrolimus
💬 | 6件: NR3C1 NR3C1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 34件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬 |
1205 | Tadalafil 20 mg film-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
1206 | Tadalafil and ambrisentan upfront combination therapy | 2件: Ambrisentan Ambrisentan, Tadalafil | 2件: Tadalafil
Tadalafil
,
Ambrisentan
💬 | 2件: EDNRA EDNRA, PDE5A 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 💬 |
1207 | Tafamidis meglumine 20 mg soft gelatin capsules (Asini corii collas) | 3件: Gelatin Gelatin (Sulfur Colloid), Meglumine, Tafamidis | 4件: Gelatin
Gelatin
,
Meglumine
,
Donkey glue
(Asini corii collas),
Tafamidis
💬 | 1件: TTR TTR 💬 | 1件: Thyroid hormone synthesis Thyroid hormone synthesis 💬 | 1件: 28 28 💬 |
1208 | Tafamidis Meglumine 20mg Soft Gelatin Capsule (Clinical trial image) (Asini corii collas) | 3件: Gelatin Gelatin (Sulfur Colloid), Meglumine, Tafamidis | 4件: Gelatin
Gelatin
,
Meglumine
,
Donkey glue
(Asini corii collas),
Tafamidis
💬 | 1件: TTR TTR 💬 | 1件: Thyroid hormone synthesis Thyroid hormone synthesis 💬 | 1件: 28 28 💬 |
1209 | Tafamidis Meglumine 20mg Soft Gelatin Capsule (Commerical image) | 3件: Gelatin Gelatin (Sulfur Colloid), Meglumine, Tafamidis | 4件: Gelatin
Gelatin
,
Meglumine
,
Donkey glue
(Asini corii collas),
Tafamidis
💬 | 1件: TTR TTR 💬 | 1件: Thyroid hormone synthesis Thyroid hormone synthesis 💬 | 1件: 28 28 💬 |
1210 | TAT4 Gel concentration A | - | - | - | - | 1件: 265 265 💬 |
1211 | TAT4 Gel concentration B | - | - | - | - | 1件: 265 265 💬 |
1212 | Technetium Sulfur Colloid | 1件: Gelatin Gelatin (Sulfur Colloid) | 2件: Gelatin
Gelatin
,
Donkey glue
(Asini corii collas) 💬 | - | - | 1件: 299 299 💬 |
1213 | Teriparatide [rDNA origin] contains recombinant human parathyroid hormone (1-34) | 2件: Parathyroid hormone Parathyroid hormone, Teriparatide | 2件: Parathyroid hormone
Parathyroid hormone
,
Teriparatide
💬 | 2件: PTH1R PTH1R, PTH2R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 70 70 💬 |
1214 | Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleava | 2件: Polyethylene glycol Polyethylene glycol (Injoy Constipation Relief), Teriparatide | 2件: Polyethylene glycol 3350
Polyethylene glycol 3350
,
Teriparatide
💬 | 1件: PTH1R PTH1R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 💬 |
1215 | Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleavable linker | 2件: Polyethylene glycol Polyethylene glycol (Injoy Constipation Relief), Teriparatide | 2件: Polyethylene glycol 3350
Polyethylene glycol 3350
,
Teriparatide
💬 | 1件: PTH1R PTH1R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 💬 |
1216 | Tetanus toxoid (TT) containing vaccine (Td, Tdap) | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) | - | - | - | 1件: 13 13 💬 |
1217 | TETRACOSACTIDE (Cosyntropin) | 1件: Tetracosactide Tetracosactide (Corticotropin tetracosapeptide) | 1件: Cosyntropin
Cosyntropin
💬 | 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 4件: 83 83, 113, 145, 222 💬 |
1218 | Tetracosactide Acetate (Cosyntropin) | 2件: Acetate Acetate, Tetracosactide (Corticotropin tetracosapeptide) | 1件: Cosyntropin
Cosyntropin
💬 | 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 2件: 83 83, 145 💬 |
1219 | TETRACOSACTIDE ESACETATO (Cosyntropin) | 1件: Tetracosactide Tetracosactide (Corticotropin tetracosapeptide) | 1件: Cosyntropin
Cosyntropin
💬 | 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 113 113 💬 |
1220 | TETRACOSACTIDE HEXAACETATE (Cosyntropin) | 1件: Tetracosactide Tetracosactide (Corticotropin tetracosapeptide) | 1件: Cosyntropin
Cosyntropin
💬 | 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 113 113 💬 |
1221 | Tetracosactide hexacetaat (Cosyntropin) | 1件: Tetracosactide Tetracosactide (Corticotropin tetracosapeptide) | 1件: Cosyntropin
Cosyntropin
💬 | 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 222 222 💬 |
1222 | The 0.5 mL dose of vaccine contains 25 micrograms of each of the following 23 pneumococcal polysaccharide | - | - | - | - | 1件: 222 222 💬 |
1223 | The Comprehensive Treatment Regimen of Traditional Chinese Medicine | - | - | - | - | 1件: 222 222 💬 |
1224 | The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: | - | - | - | - | 1件: 86 86 💬 |
1225 | The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care: | - | - | - | - | 1件: 86 86 💬 |
1226 | The Yi-Qi-Qing-Jie herbal compound | - | - | - | - | 1件: 66 66 💬 |
1227 | Timolol Alcon 0.5% collyre | 1件: Timolol Timolol (Cosopt) | 2件: Timolol
Timolol
,
Timolol
💬 | 2件: ADRB1 ADRB1, ADRB2 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 227 227 💬 |
1228 | Tissue Selective Estrogen Complex | - | - | - | - | 1件: 13 13 💬 |
1229 | To be confirmed | - | - | - | - | 3件: 46 46, 65, 97 💬 |
1230 | TOBI 300mg/ 5ml solución para inhalación con nebulizador | 1件: Tobramycin Tobramycin | 1件: Tobramycin
Tobramycin
💬 | - | - | 1件: 299 299 💬 |
1231 | Tocilizumab and IV steroids combination | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬 | 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 41 41 💬 |
1232 | Tofacitinib citrate (commercial image) | 1件: Tofacitinib Tofacitinib | 1件: Tofacitinib
Tofacitinib
💬 | 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬 | 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬 |
1233 | Tofacitinib citrate (Proposed commercial formulation - debossed) | 1件: Tofacitinib Tofacitinib | 1件: Tofacitinib
Tofacitinib
💬 | 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬 | 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 2件: 46 46, 97 💬 |
1234 | Tofacitinib citrate (Proposed commercial formulation debossed) | 1件: Tofacitinib Tofacitinib | 1件: Tofacitinib
Tofacitinib
💬 | 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬 | 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬 |
1235 | Tofacitinib citrate (Proposed commercial formulation – debossed) | 1件: Tofacitinib Tofacitinib | 1件: Tofacitinib
Tofacitinib
💬 | 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬 | 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 2件: 46 46, 97 💬 |
1236 | Tofacitinib citrate (Proposed commercial formulation- debossed) | 1件: Tofacitinib Tofacitinib | 1件: Tofacitinib
Tofacitinib
💬 | 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬 | 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬 |
1237 | Tofacitinib citrate (Proposed commercialFormulation - debossed) | 1件: Tofacitinib Tofacitinib | 1件: Tofacitinib
Tofacitinib
💬 | 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬 | 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 97 97 💬 |
1238 | Topical compound tripterygium | 1件: Tripterygium wilfordii whole Tripterygium wilfordii whole | - | - | - | 1件: 46 46 💬 |
1239 | Tozinameran (COVID-19 mRNA vaccine (nucleoside-modified)) | 1件: Tozinameran Tozinameran (Comirnaty) | 1件: Tozinameran
Tozinameran
(COVID-19 mRNA vaccine (nucleoside-modified)) 💬 | - | - | 1件: 299 299 💬 |
1240 | TP05 Coating A | - | - | - | - | 1件: 97 97 💬 |
1241 | TP05 Coating B | - | - | - | - | 1件: 97 97 💬 |
1242 | TP05 Coating D | - | - | - | - | 1件: 97 97 💬 |
1243 | TP05 Coating E | - | - | - | - | 1件: 97 97 💬 |
1244 | TP05 Coating H | - | - | - | - | 1件: 97 97 💬 |
1245 | TPO-RAs combining anti-CD 20 monoclonal antibody | - | - | - | - | 1件: 63 63 💬 |
1246 | TRACLEER 62,5 mg comprimidos recubiertos con película | 1件: Bosentan Bosentan | 2件: Bosentan
Bosentan
,
Bosentan
💬 | 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
1247 | Traditional Chinese Medicinal Mixture (composed of Roucongrong and adjuvant) | - | - | - | - | 1件: 6 6 💬 |
1248 | Tralokinumab cohort 1 | 1件: Tralokinumab Tralokinumab | 1件: Tralokinumab
Tralokinumab
💬 | 1件: IL13 IL13 💬 | 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | 1件: 85 85 💬 |
1249 | Tralokinumab cohort 2 | 1件: Tralokinumab Tralokinumab | 1件: Tralokinumab
Tralokinumab
💬 | 1件: IL13 IL13 💬 | 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | 1件: 85 85 💬 |
1250 | Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a COL17A1-encoding retroviral vector | - | - | - | - | 1件: 36 36 💬 |
1251 | Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a COL7A1-encoding retroviral vector | - | - | - | - | 1件: 36 36 💬 |
1252 | Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a COL7A1-encoding retroviral vector, obtained from secondary culture of ex vivo expanded autologous human keratinocytes. | - | - | - | - | 1件: 36 36 💬 |
1253 | Transplant Conditioning with Mobilization and Alemtuzumab | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 1件: 65 65 💬 |
1254 | Transplant Conditioning with Mobilization Only | - | - | - | - | 1件: 65 65 💬 |
1255 | Treatment vs control bread | - | - | - | - | 1件: 97 97 💬 |
1256 | Treatment with topical superpotent corticosteroid therapy | - | - | - | - | 1件: 162 162 💬 |
1257 | Trexan+Salazopyrin+Oxiklorin+prednisolone (Delta-cortef (TN)) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(Delta-cortef (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬 |
1258 | Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab (Delta-cortef (TN)) | 2件: Infliximab Infliximab, Prednisolone | 2件: Prednisolone
Prednisolone
(Delta-cortef (TN)),
Infliximab
💬 | 2件: NR3C1 NR3C1, TNF 💬 | 68件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
1259 | Triple combination therapy | - | - | - | - | 1件: 299 299 💬 |
1260 | Triptolide-Containing Formulation | 1件: Triptolide Triptolide | - | - | - | 1件: 67 67 💬 |
1261 | Triterpene dry extract from birch cork | - | - | - | - | 1件: 36 36 💬 |
1262 | TYSABRI 300 mg concentrado para solución para perfusión | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬 | 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬 |
1263 | TYSABRI 300 mg concentrate for solution for infusion | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬 | 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬 |
1264 | ULTOMIRIS - 300 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 3 ML (100 MG / ML) - 1 FLACONCINO | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬 | 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬 |
1265 | Umbilical Cord Based Allogenic Mesenchymal Stem Cell | - | - | - | - | 1件: 113 113 💬 |
1266 | Umbilical Cord Blood | - | - | - | - | 1件: 60 60 💬 |
1267 | Umbilical cord blood (UCB) | - | - | - | - | 1件: 60 60 💬 |
1268 | Umbilical Cord Blood After Myeloablative Conditioning | - | - | - | - | 1件: 60 60 💬 |
1269 | Umbilical Cord Blood After Reduced-Intensity Conditioning | - | - | - | - | 1件: 60 60 💬 |
1270 | Umbilical cord blood mononuclear cells | - | - | - | - | 1件: 97 97 💬 |
1271 | Umbilical Cord Blood Transplantation | - | - | - | - | 1件: 60 60 💬 |
1272 | Umbilical Cord Blood Unit | - | - | - | - | 1件: 333 333 💬 |
1273 | Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation | - | - | - | - | 2件: 93 93, 296 💬 |
1274 | Umbilical cord derived Mesenchymal Stem Cells | - | - | - | - | 1件: 13 13 💬 |
1275 | Umbilical Cord Lining Stem Cells | - | - | - | - | 1件: 50 50 💬 |
1276 | Umbilical Cord Mesenchymal Stem Cell | - | - | - | - | 1件: 113 113 💬 |
1277 | Umbilical Cord Mesenchymal Stem Cell (UC-MSC) | - | - | - | - | 1件: 90 90 💬 |
1278 | Umbilical cord mesenchymal stem cells | - | - | - | - | 5件: 13 13, 46, 57, 97, 113 💬 |
1279 | Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs) | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 46 46 💬 |
1280 | Unrelated cord blood | - | - | - | - | 1件: 65 65 💬 |
1281 | Unrelated Umbilical Cord Blood Transplant | - | - | - | - | 1件: 19 19 💬 |
1282 | Upadacitinib - Direct compression-yellow | 1件: Upadacitinib Upadacitinib | 1件: Upadacitinib
Upadacitinib
💬 | 1件: JAK1 JAK1 💬 | 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 97 97 💬 |
1283 | Upadacitinib -Direct compression-yellow | 1件: Upadacitinib Upadacitinib | 1件: Upadacitinib
Upadacitinib
💬 | 1件: JAK1 JAK1 💬 | 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 97 97 💬 |
1284 | URBASON 40 mg comprimidos | - | - | - | - | 1件: 13 13 💬 |
1285 | Ursodeoxycholic acid combination of immunosuppressive agents | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: Ursodiol
Ursodiol
💬 | 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 2件: 93 93, 95 💬 |
1286 | Ursodeoxycholic acid combined with total glucosides of paeony | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: Ursodiol
Ursodiol
💬 | 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 1件: 93 93 💬 |
1287 | Ursofalk® 500 mg film-coated tablets | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: Ursodiol
Ursodiol
💬 | 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 1件: 93 93 💬 |
1288 | US TAP Bupivacaine/Epinephrine (CERTA DOSE EPINEPHRINE CONVENIENCE KIT) | 2件: Bupivacaine Bupivacaine (Cortaren Corticosteroid/Anti-Inflammatory System), Epinephrine (Gingi-pak Cotton Coil) | 2件: Epinephrine
Epinephrine
(CERTA DOSE EPINEPHRINE CONVENIENCE KIT),
Bupivacaine
💬 | 14件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 96 96 💬 |
1289 | UX701 (1.0 × 10^13 genome copies/kg) | - | - | - | - | 1件: 171 171 💬 |
1290 | UX701 (2.0 × 10^13 genome copies/kg) | - | - | - | - | 1件: 171 171 💬 |
1291 | UX701 (5.0 × 10^12 genome copies/kg) | - | - | - | - | 1件: 171 171 💬 |
1292 | V1512 and Entacapone (Comtan (TN)) | 1件: Entacapone Entacapone (Comtan) | 1件: Entacapone
Entacapone
(Comtan (TN)) 💬 | 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬 |
1293 | VACCINO CONTRO IL MEMINGOCOCCO DI GRUPPO B | - | - | - | - | 3件: 61 61, 62, 66 💬 |
1294 | VACCINO HAEMOPHILUS INFLUENZAE B CONIUGATO CON TOSSOIDETETANICO | - | - | - | - | 2件: 61 61, 62 💬 |
1295 | Valproid acid plus corticosteroids | - | - | - | - | 1件: 26 26 💬 |
1296 | Vastarel 20mg film coated tablets | - | - | - | - | 1件: 58 58 💬 |
1297 | Vaxzevria suspension for injection COVID-19 Vaccine (ChAdOx1-S | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 1件: 299 299 💬 |
1298 | Vector viral adenoasociado de serotipo 9 que contiene el gen de la sulfamidasa humana | - | - | - | - | 1件: 19 19 💬 |
1299 | Vehice Control | - | - | - | - | 1件: 96 96 💬 |
1300 | Vehicle Control | - | - | - | - | 1件: 53 53 💬 |
1301 | Vett Lentiviral con gene ABCA4 | - | - | - | - | 1件: 301 301 💬 |
1302 | Viokase 16 (pancrelipase) + Nexium (Cotazym (TN)) | 2件: Esomeprazole Esomeprazole (Nexium Control), Pancrelipase | 2件: Pancrelipase
Pancrelipase
(Cotazym (TN)),
Esomeprazole
💬 | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 1件: 298 298 💬 |
1303 | VIREAD - 245 MG 30 COMPRESSE RIVESTITE CON FILM IN FLACONE USO ORALE | - | - | - | - | 1件: 46 46 💬 |
1304 | VOLIBRIS 10 mg comprimidos recubiertos con película | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬 | 1件: EDNRA EDNRA 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
1305 | VOLIBRIS 5 mg comprimidos recubiertos con película | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬 | 1件: EDNRA EDNRA 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
1306 | Von Willebrand factor and coagulation factor VIII in combination | 2件: Beroctocog alfa Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex), Von Willebrand factor human (Factor con Willebrand) | - | - | - | 1件: 288 288 💬 |
1307 | Von Willebrand Factor Ristocetin Cofactor | 1件: Von Willebrand factor human Von Willebrand factor human (Factor con Willebrand) | - | - | - | 1件: 288 288 💬 |
1308 | VWD factor VIII concentrate | 1件: Beroctocog alfa Beroctocog alfa (Human coagulation factor VIII/von willebrand factor complex) | - | - | - | 1件: 288 288 💬 |
1309 | VWF-containing products | - | - | - | - | 1件: 288 288 💬 |
1310 | VX-661 Plus Ivacaftor Combination | 1件: Ivacaftor Ivacaftor | 1件: Ivacaftor
Ivacaftor
💬 | 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬 |
1311 | Water (Purified water in containers (JP18)) | 1件: Water Water (FIRST AID Contains 202 PIECES) | 1件: Water
Water
(Purified water in containers (JP18)) 💬 | - | - | 21件: 2 2, 5, 6, 13, 17, 22, 35, 46, 53, 57, 63, 65, 67, 78, 84, 96, 97, 206, 226, 278, 299 💬 |
1312 | WATER FOR INJECTION (Purified water in containers (JP18)) | 1件: Water Water (FIRST AID Contains 202 PIECES) | 1件: Water
Water
(Purified water in containers (JP18)) 💬 | - | - | 1件: 35 35 💬 |
1313 | Water for injections (Purified water in containers (JP18)) | 1件: Water Water (FIRST AID Contains 202 PIECES) | 1件: Water
Water
(Purified water in containers (JP18)) 💬 | - | - | 1件: 299 299 💬 |
1314 | WATER FOR INJECTIONS, EP (Purified water in containers (JP18)) | 1件: Water Water (FIRST AID Contains 202 PIECES) | 1件: Water
Water
(Purified water in containers (JP18)) 💬 | - | - | 1件: 299 299 💬 |
1315 | White chocolate (0% cocoa) | 1件: Cocoa Cocoa | - | - | - | 1件: 6 6 💬 |
1316 | XADAGO - 100 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- BLISTER (PVC/PVDC/ALLUMINIO)- 30 COMPRESSE | 1件: Safinamide Safinamide | 1件: Safinamide
Safinamide
💬 | 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬 |
1317 | XADAGO - 50 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- BLISTER (PVC/PVDC/ALLUMINIO)- 30 COMPRESSE | 1件: Safinamide Safinamide | 1件: Safinamide
Safinamide
💬 | 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬 |
1318 | XELJANZ 5 mg film-coated tablets | 1件: Tofacitinib Tofacitinib | 1件: Tofacitinib
Tofacitinib
💬 | 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬 | 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 2件: 46 46, 97 💬 |
1319 | Xeljanz 5mg film-coated tablets | 1件: Tofacitinib Tofacitinib | 1件: Tofacitinib
Tofacitinib
💬 | 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬 | 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 97 97 💬 |
1320 | Xenon contrast agent | 1件: Xenon Xenon | 2件: Xenon
Xenon
,
Xenon Xe 133
💬 | - | - | 1件: 22 22 💬 |
1321 | XYZAL - 20 COMPRESSE RI | 1件: Levocarnitine Levocarnitine | 1件: Levocarnitine
Levocarnitine
💬 | - | - | 1件: 53 53 💬 |
1322 | YONDELIS 0,25 mg polvo para concentrado para solución para perfusión | 1件: Trabectedin Trabectedin | 1件: Trabectedin
Trabectedin
💬 | - | - | 1件: 159 159 💬 |
1323 | Yondelis 0.25 mg powder for concentrate for solution for infusion. | 1件: Trabectedin Trabectedin | 1件: Trabectedin
Trabectedin
💬 | - | - | 1件: 159 159 💬 |
1324 | YONDELIS 1 mg polvo para concentrado para solución para perfusión | 1件: Trabectedin Trabectedin | 1件: Trabectedin
Trabectedin
💬 | - | - | 1件: 159 159 💬 |
1325 | Yondelis 1 mg powder for concentrate for solution for infusion. | 1件: Trabectedin Trabectedin | 1件: Trabectedin
Trabectedin
💬 | - | - | 1件: 159 159 💬 |
1326 | Z102 (Prednisolone and Dipyridamole). (Delta-cortef (TN)) | 2件: Dipyridamole Dipyridamole, Prednisolone | 2件: Dipyridamole
Dipyridamole
,
Prednisolone
(Delta-cortef (TN)) 💬 | 3件: NR3C1 NR3C1, PDE4A, PDE5A 💬 | 7件: Metabolic pathways Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 💬 |
1327 | Zinc and Copper | 2件: Copper Copper, Zinc (Nioxin Recharging Complex) | - | - | - | 1件: 2 2 💬 |
1328 | ZUGLIMET - 500 MG COMPRESSE RIVESTITE CON FILM 30 COMPRESSE IN BLISTER PVC/AL | - | - | - | - | 1件: 67 67 💬 |
1329 | ZYTIGA - 250 MG - COMPRESSA - USO ORALE - FLACONE 120 COMPRESSE | 1件: Abiraterone Abiraterone (Apo-abiraterone Film Coated Tablets) | - | - | - | 1件: 75 75 💬 |